,nct_id,unique_condition_regex,unique_drug_regex,unique_condition_target,unique_drug_target,unique_control_target,unique_physical_target,unique_behavioural_target,unique_surgical_target,unique_radiotherapy_target,unique_other_target,unique_condition_BioLinkBERT-base,unique_drug_BioLinkBERT-base,unique_control_BioLinkBERT-base,unique_physical_BioLinkBERT-base,unique_behavioural_BioLinkBERT-base,unique_surgical_BioLinkBERT-base,unique_radiotherapy_BioLinkBERT-base,unique_other_BioLinkBERT-base,unique_condition_biobert-v1.1,unique_drug_biobert-v1.1,unique_control_biobert-v1.1,unique_physical_biobert-v1.1,unique_behavioural_biobert-v1.1,unique_surgical_biobert-v1.1,unique_radiotherapy_biobert-v1.1,unique_other_biobert-v1.1,unique_condition_bert-base-uncased,unique_drug_bert-base-uncased,unique_control_bert-base-uncased,unique_physical_bert-base-uncased,unique_behavioural_bert-base-uncased,unique_surgical_bert-base-uncased,unique_radiotherapy_bert-base-uncased,unique_other_bert-base-uncased,unique_behavioural_aact,unique_control_aact,unique_drug_aact,unique_other_aact,unique_physical_aact,unique_radiotherapy_aact,unique_surgical_aact,unique_condition_aact,unique_behavioural_gpt-3.5-turbo,unique_surgical_gpt-3.5-turbo,unique_radiotherapy_gpt-3.5-turbo,unique_physical_gpt-3.5-turbo,unique_other_gpt-3.5-turbo,unique_control_gpt-3.5-turbo,unique_condition_v1_gpt-3.5-turbo,unique_drug_v1_gpt-3.5-turbo,unique_condition_v2_gpt-3.5-turbo,unique_drug_v2_gpt-3.5-turbo,unique_behavioural_gpt-4,unique_surgical_gpt-4,unique_radiotherapy_gpt-4,unique_physical_gpt-4,unique_other_gpt-4,unique_control_gpt-4,unique_condition_v1_gpt-4,unique_drug_v1_gpt-4,unique_condition_v2_gpt-4,unique_drug_v2_gpt-4
0,NCT04045665,,,coronary artery bypass graft|isolated coronary artery bypass graft (cabg) surgery|new-onset post-operative atrial fibrillation|post-operative atrial fibrillation,anticoagulants|anticoagulation|antiplatelet therapy|antiplatelets|oral anticoagulation,,,,,,,cabg) surgery|coronary artery bypass graft|isolated coronary artery bypass graft (|new-onset post-operative atrial fibrillation|post-operative atrial fibrillation,anticoagulants|anticoagulation|antiplatelet therapy|antiplatelets|oral|oral anticoagulation,,,,,,anticoagulation,cabg) surgery|coronary artery bypass graft|isolated coronary artery bypass graft (|new-onset post-operative atrial fibrillation|poaf event|post-operative atrial fibrillation,anti|anticoagulation|antiplatelet|oral anticoagulation,,,,,,,coronary artery bypass graft|isolated coronary artery bypass graft|new-onset post-operative atrial fibrillation|poaf event|post-operative atrial fibrillation|surgery,anti|anticoagulation|oral anticoagulation,,,,,,,,,antiplatelet-only strategy|oral anticoagulant plus background antiplatelet therapy,,,,,stroke|bleeding|atrial fibrillation,none,isolated coronary artery bypass graft (cabg) surgery,none,none,oral anticoagulation (oac)|none,adding oral anticoagulation (oac) to background antiplatelet therapy,atrial fibrillation|thromboembolic events|major bleeding|none|coronary artery bypass graft,antiplatelets|oral anticoagulation|anticoagulants|antiplatelet therapy,atrial fibrillation|thromboembolic events|major bleeding,none,none,coronary artery bypass graft (cabg) surgery,none,none,oral anticoagulation (oac)|antiplatelets|anticoagulants|antiplatelet therapy,background antiplatelet therapy,atrial fibrillation|coronary artery bypass graft surgery|thromboembolic events,oral anticoagulation (oac)|antiplatelets|anticoagulants|antiplatelet therapy,new-onset post-operative atrial fibrillation|thromboembolic events|major bleeding,none
1,NCT02311036,,,-cerebrovascular diseases,,,comprehensive rehabilitation,,,,,post-acute care-cerebrovascular diseases,,,,,,,comprehensive rehabilitation,post-acute care-cerebrovascular diseases,,,,,,,comprehensive rehabilitation,post-acute care-cerebrovascular diseases,,,,,,,comprehensive rehabilitation,,,,comprehensive rehabilitation,,,,cerebrovascular diseases,none,none,none,none,none,none,cerebrovascular diseases,none,none|cerebrovascular diseases,none,,,,,none,,cerebrovascular diseases,none,cerebrovascular diseases,
2,NCT05369793,diabetic neuropathy,roflumilast,diabetic neuropathy|type 2 diabetic,roflumilast,,,,,,,diabetic neuropathy|type 2 diabetic,roflumilast,,,,,,,diabetic neuropathy|type 2 diabetic,roflumilast,,,,,,,diabetic neuropathy|type 2 diabetic,roflumilast,,,,,,,,,alpha lipoic acid|roflumilast,,,,,type 2 diabetes (adult onset)|diabetic neuropathies,none,none,none,roflumilast,none,none,diabetic neuropathy|type 2 diabetes,roflumilast,diabetic neuropathy|type 2 diabetes,roflumilast,,,,roflumilast,roflumilast,,diabetic neuropathy|type 2 diabetes,roflumilast,glycemic parameters|insulin resistance|type 2 diabetes|inflammatory markers|diabetic neuropathy|oxidative markers,roflumilast
3,NCT04483310,paralyses|narcolepsy|sleep paralysis,aim,narcolepsy|sleep paralyses|sleep paralysis,,sham,,meditation relaxation therapy|meditation-relaxation|mr therapy,,,,narcolepsy|sleep paralyses|sleep paralysis,,sham,medi|mr,therapy,,,,narcolepsy|sleep paralyses|sleep paralysis,,sham,,meditation-relaxation (|meditation relaxation therapy|mr therapy,,,,na|narcolepsy|sleep paralyses|sleep paralysis,,sham,,,,,meditation-relaxation|meditation relaxation therapy|mr therapy,mr therapy.|breathing-distraction exercise,,,,,,,sleep paralysis|narcolepsy type 1,meditation relaxation therapy,sham|meditation relaxation therapy,sham|meditation relaxation therapy,meditation-relaxation therapy|sham,meditation relaxation therapy,sham,sleep paralysis|narcolepsy,meditation-relaxation therapy|none,sleep paralysis|narcolepsy,none,meditation relaxation therapy,,,meditation relaxation therapy,sham|meditation relaxation therapy,sham,sleep paralysis|narcolepsy,none,sleep paralysis|narcolepsy,none
4,NCT01418976,brain injury,balance,"chronic, mild-to-moderate, traumatic brain injury|traumatic brain injury",,,intensive mobility training,,,,,"chronic, mild-to-moderate, traumatic brain injury|impairment|traumatic brain injury",,,intensive mobility training,,,,,"chronic , mild-to-moderate , traumatic brain injury|locomotor impairment|neural insult|traumatic brain injury|traumatic brain injy|v",,,intensive mobility training,,,,,"chronic, mild-to-moderate, traumatic brain injury|locomotor impairment|neural insult|traumatic brain injury",,,intensive mobility training,,,,,intensive mobility training (imt),,,,,,,"difficulties, ambulation|brain injuries, traumatic",rehabilitation focusing on gait and balance|intensive mobility training (imt),intensive mobility training (imt),none,rehabilitation focusing on gait and balance|intensive mobility training (imt),intensive mobility training (imt),none,tbi|traumatic brain injury,intensive mobility training (imt),locomotor impairment|balance|gait|traumatic brain injury,none,"3 hours of rehabilitation per day for 20 days, focusing on gait and balance|intensive mobility training (imt)",none,none,"3 hours of rehabilitation per day for 20 days, focusing on gait and balance|intensive mobility training (imt)",magnetic resonance imaging (mri) exam|rehabilitation|intensive mobility training (imt),none,traumatic brain injury,none,locomotor impairment|gait and balance issues|traumatic brain injury,intensive mobility training (imt)
5,NCT03689491,stroke,no,stroke,,,,,,,repetitive transcranial magnetic stimulation|visual feedback training,motor deficits|stroke,,,visual feedback training,,,,repetitive transcranial magnetic stimulation|rtms,motor deficit|stroke,,,,,,,repetitive transcranial magnetic stimulation|rtms extremity dysfunction|visual feedback training,motor deficit|stroke,,,,,,,repetitive transcranial magnetic stimulation|rt|rtms|visual feedback training,rtms|visual feedback training|traditional rehabilitation,,,,,,,stroke,repetitive transcranial magnetic stimulation (rtms)|visual feedback training,none,none,repetitive transcranial magnetic stimulation (rtms)|visual feedback training,visual feedback training|application of repetitive transcranial magnetic stimulation (rtms),none,stroke|none,rtms|none,stroke|motor deficits|gait function|lower extremity movement,rtms,visual feedback training|rtms (repetitive transcranial magnetic stimulation),none,none,visual feedback training|rtms (repetitive transcranial magnetic stimulation),visual feedback training|rtms,none,stroke,none,motor deficits|abnormally high interhemispheric inhibition|lower extremity movement interruption|lower extremity dysfunction|stroke|alterations in cortical excitability|gait function interruption,rtms
6,NCT01075672,,,,,,,cognitive behavioral therapy|cognitive-behavioral therapy,,,,,,,,cbt)|cognitive-behavioral therapy interventions|cognitive behavioral therapy (,,,interventions|unlicensed professionals,,,,,cognitive-behavioral therapy|cognitive behavioral therapy,,,,,,,,cognitive-behavioral therapy|cognitive behavioral therapy,,,interventions,cognitive behavioral therapy (cbt),,,,,,,eating disorder|specific phobia|generalized anxiety disorder|trichotillomania|social phobia|general medical condition|tourette syndrome|panic disorder|depression|body dysmorphic disorder|attention deficit hyperactivity disorder|post-traumatic stress disorder|obsessive compulsive disorder,none,none,none,none,none,none,none|general hospital setting,cbt|none,none,none,cognitive behavioral therapy (cbt),,none,,none,none,none,none,none,none
7,NCT00701363,,lanreotide|octreotide,acromegalic,lanreotide|octreotide,,,,,,,acromegalic,lanreotide|octreotide lar,,,,,,,acromegalic,lanreotide autogel|lanreotidegel|octreotide,,,,,,,,lanreotide|octreotide,,,,,,autogel,,,lanreotide autogel 120 mg,,,,,acromegaly,none,none,none,none,none,octreotide lar 20 mg|octreotide lar 10 mg,acromegalic|none,lanreotide autogel 120 mg|octreotide lar 10 or 20 mg,lanreotide autogel|biochemically controlled|octreotide lar|acromegaly|long term treatment|extended injection interval schedule,octreotide lar 20 mg|octreotide lar 10 mg|lanreotide autogel 120 mg,none,none,,extended injection interval schedule of lanreotide autogel 120 mg|long term treatment with octreotide lar 10 or 20 mg,octreotide lar 20 mg|octreotide lar 10 mg|lanreotide autogel 120 mg,octreotide lar 20 mg|octreotide lar 10 mg,acromegaly,lanreotide autogel 120 mg|octreotide lar 10 or 20 mg,acromegaly,octreotide lar 20 mg|octreotide lar 10 mg|lanreotide autogel 120 mg
8,NCT05534880,,met|as,blurred vision|cybersickness|dizziness|eyestrain|motion sickness|oculomotor disorders|sc|spatial disorientation|visually induced motion sickness,,video only,,,,,binaural audio|binaural stimulation|multi-sensory conditions in virtual reality|virtual environments|virtual reality,cybersickness|sc,,video only,,,,,binaural audio|binaural stimulation|virtual reality|with,cybersickness|sc|v,,,,,,,binaural audio|binaural stimulation|v|video|virtual reality,-|blurred|cybersickness|di|motion sickness|sc|sickness|virtual reality|visually induced motion sickness,,,,,,,binaural stimulation|virtual content,,,,binaural beats,,,,cybersickness|reduced sensation,none,associated with binaural audio|video only,associated with binaural audio|video only,none,binaural audio stimulation,c1 - video only|c2 - associated with binaural audio,none|cybersickness,none|cybersickness,blurred vision|eyestrain|spatial disorientation|oculomotor disorders|dizziness|cybersickness,none,none,none,none,none,electroencephalography (eegq)|virtual reality exposure|binaural audio stimulation,c1 - video only|c2 - associated with binaural audio,covid-19|cybersickness,none,blurred vision|eyestrain|spatial disorientation|oculomotor disorders|dizziness|cybersickness,none
9,NCT02897024,cerebral palsy,cp,cerebral palsy|cp,,usual weekly,focused and high intense treatment per weekday|high intense periodic vs. every week therapy|physical therapy,,,,,cerebral palsy|cp,,every week|usual weekly,focused|high intense treatment|intensities|intensity|physical therapy|physical therapy treatment|therapy,and,,,high|high intense periodic|of|periodic,cerebral palsy|cp,,every week therapy|usual weekly,physical therapy treatment,,,,focused and high intense treatment|high intense periodic|high intensity periodic,achieve|cerebral palsy|cp,,,physical therapy,,,,every week therapy|focused and|high intense periodic|high intense treatment|high intensity periodic|physical therapy treatment|usual weekly,,,,,physical therapy,,,cerebral palsy,high intense periodic therapy|usual weekly therapy,none,2 hours of focused and high intense treatment per weekday for 4 weeks,high intense periodic|every week,none,every week therapy (usual weekly therapy considered standard of care)|high intense periodic therapy|high intense periodic therapy (2 hours of focused and high intense treatment per weekday for 4 weeks)|every week therapy,cerebral palsy,none,cerebral palsy,none,usual weekly therapy (standard of care)|high intensity periodic therapy (2 hours of focused and high intense treatment per weekday for 4 weeks),none,none,usual weekly physical therapy treatment|high intensity periodic physical therapy treatment for 2 hours per weekday for 4 weeks,usual weekly treatment|high intensity periodic treatment,usual weekly therapy|high intensity periodic therapy,cerebral palsy,none,cerebral palsy,none
10,NCT00300222,postherpetic neuralgia,,postherpetic neuralgia,ngx-4010,,,,,,,postherpetic neuralgia,ngx-4010,,,,,,,postherpetic neuralgia,ngx-4010,,,,,,,postherpetic neuralgia,ngx-4010,,,,,,,,,ngx-4010,,,,,herpes zoster|pain|neuralgia|peripheral nervous system diseases|shingles,none,none,none,ngx-4010 applied for 60 minutes,none,none,postherpetic neuralgia,ngx-4010,none|postherpetic neuralgia,ngx-4010,,,,ngx-4010 applied for 60 minutes,ngx-4010,none,postherpetic neuralgia,ngx-4010,postherpetic neuralgia,ngx-4010
11,NCT00105638,dementia,tep,dementia|moderate to severe dementia,,,,teleconference|telehealth education program,,,,dementia|moderate to severe dementia,,,,telehealth education program,,,,dementia|moderate to severe dementia,,,,stress and coping|telehealth education program,,,,dementia|moderate to severe dementia,,,,coping|program,,,teleheal|telehealth education|telehealth education program,"educational program, by telephone",,,,,,,dementia|alzheimer disease,separated by the|coping skills|symbol|education|problem solving|support,none,none,none,none,none,dementia,telehealth education program|none,none,none,coping skills|telehealth education program (tep)|education|problem solving|support,,,none,telehealth education program,none,dementia,none,dementia,none
12,NCT04909398,,as,retinal pathologies|visual and color vision pathologies,,,,,,,,retinal pathologies|visual and color vision pathologies,,,,,,,,rel path|visual and color vision pathologies,,,,,,,,retinal pathologies|visual and color vision pathologies,,,,,,,devices|dynamic pupillometrics,dynamic pupillometry sessions,,,,,,,retinitis pigmentosa|stargardt disease|leber's hereditary optic neuropathy,none,none,none,none,none,none,pathologies|color vision|retinal|visual,none,retinal pathologies|visual and color vision pathologies|pupillometrics,none,none,none,none,none,oculometry techniques|innovative devices,none,visual pathologies|retinal pathologies|color vision pathologies,none,visual pathologies|retinal pathologies|color vision pathologies,none
13,NCT04937452,frontotemporal dementia,rtg|rotigotine,behavioral ftd|behavioural frontotemporal dementia|frontotemporal dementia,dopaminergic therapy|rotigotine,placebo,,,,,,behavioral ftd|behavioural frontotemporal dementia|bvftd|frontotemporal dementia|newly diagnosed,dopaminergic|rotigotine,placebo,,,,,therapy,behavioral ftd|behavioural frontotemporal dementia|frontotemporal dementia|newly diagnosed,dopaminergic therapy|rotigotine,placebo,,,,,,behavioral ftd|behavioural frontotemporal dementia|bvftd|frontotemporal dementia,dopamine|rot|rt,place,,,,,placebo|rotigotine,,placebo,rotigotine 4mg/24hrs patch|rotigotine 6mg/24hrs patch,,,,,"pick disease of the brain|proteostasis deficiencies|neurologic manifestations|metabolic disease|frontotemporal lobar degeneration|aphasia|nervous system diseases|mental disorders|neurobehavioral manifestations|speech disorders|aphasia, primary progressive|brain diseases|central nervous system diseases|communication disorders|dementia|neurocognitive disorders|language disorders|frontotemporal dementia|tdp-43 proteinopathies|neurodegenerative diseases",none,rtg 4 mg/day|rtg 6 mg/day|placebo,rtg 4 mg/day|rtg 6 mg/day|placebo,placebo (plc)|rotigotine (rtg) transdermal administration at the dosage of 4 mg or 6 mg per day,brain metabolism|dopaminergic tration|fdg-pet,placebo (plc)|rotigotine (rtg) transdermal administration at the dosage of 4 mg or 6 mg per day,frontotemporal dementia|none,placebo|rotigotine,behavioral ftd|frontotemporal dementia,placebo|rotigotine,none,none,none,placebo (plc) administration|rotigotine (rtg) transdermal administration at the dosage of 4 mg per day|rotigotine (rtg) transdermal administration at the dosage of 6 mg per day,placebo (plc)|dopaminergic tration at the dosage of 4 mg or 6 mg per day,placebo (plc),behavioral frontotemporal dementia|frontotemporal dementia|probable bvftd,placebo|rtg|fdg-pet|rotigotine|dopaminergic therapy,behavioral frontotemporal dementia|frontotemporal dementia,placebo|rotigotine
14,NCT03317067,delirium,dexmedetomidine,delirium,dexmedetomidine,,,,,,,agitated delirium|delirium|ici|icu|non -|non-intubated,dexmedetomidine,,,,,,,agitated delirium|delirium|non-intubated ici|non-intubated icu,dexmedetomidine,,,,,,,agitated delirium|deliri|non-intubated ici|non-intubated icu,dexmedetomidine,,,,,,,,placebo,dexmedetomidine,,,,,delirium|agitation,none,none,none,none,none,none,delirium|none,dexmedetomidine,delirium|agitated delirium,none,none,,,none,dexmedetomidine,,delirium,dexmedetomidine,delirium|agitated delirium,dexmedetomidine
15,NCT02583386,multiple sclerosis,,multiple sclerosis,,,exercise,educational classroom program,,,comprehensive fall prevention,multiple sclerosis,,,exercise,and educational classroom program,,,,fall|falls|multiple sclerosis,,,exercise and educational classroom program,,,,,falls|multiple sclerosis,,,exercise,,,,and educational classroom program,free from falls fall prevention program,,,electronic fall detector,,,,multiple sclerosis,e and educational classroom program,none,none,exercise|educational classroom program,none,none,multiple sclerosis,comprehensive fall prevention and detection in multiple sclerosis|none,multiple sclerosis|falls,none,exercise program|educational classroom program,,,exercise and educational classroom program,exercise and educational classroom program,,multiple sclerosis,none,multiple sclerosis|frequent falls,
16,NCT04856514,neurofibromatosis,,neurofibromatosis type 1,,,,telehealth|telehealth group,,,,neurofibromatosis type 1,,,,,,,telehealth|telehealth group|ucla peers protocol,neurofibromatosis type 1|neurofibromatosis type 1 peers,,,,,,,telehealth|telehealth group,ne,,,,,,,telehealth|telehealth group|ucla peers,peers,,,,,,,neurofibromatosis 1|social skills,ucla peers protocol,none,none,none,none,none,neurofibromatosis type 1,ucla peers protocol|none,neurofibromatosis type 1|difficulty making and keeping friends,none,ucla peers protocol delivered via telehealth,,,none,ucla peers protocol delivered via telehealth,,neurofibromatosis type 1,none,neurofibromatosis type 1|difficulty making and keeping friends,none
17,NCT04256382,dementia,,,,,,educational program,,,,dementia pain,,,,educational program,,,,dementia pain,,,,educational program,,,,dementia pain|dementia pain management,,,,,,,program,dementia pain care education|dementia care education|dementia care education|dementia pain care education,,,,,,,dementia,none,none,none,none,none,none,dementia|none,none|dementia pain management,dementia|pain|dementia pain management|dementia pain,none,none,,,none,none,,dementia pain,none,dementia pain management|dementia pain,none
18,NCT01028209,parkinson disease|alzheimer disease|multiple sclerosis,as,alzheimer disease|multiple sclerosis|parkinson disease,,,,,,,,alzheimer disease|microglial activation|multiple sclerosis|parkinson disease,,,,,,,,alzheimer disease|multiple sclerosis|parkinson disease,,,,,,,,alzheimer disease|multiple sclerosis|parkinson disease,,,,,,,,,,[18f] pbr06,,,,,parkinson disease|multiple sclerosis|alzheimer disease,none,none,none,none,none,none,alzheimer disease,pbr06|none,multiple sclerosis|parkinson disease|alzheimer disease,none,,,,,[18f] pbr06 pet imaging,,alzheimer disease,[18f] pbr06,multiple sclerosis|parkinson disease|alzheimer disease|microglial activation,[18f] pbr06
19,NCT00029146,stroke,oxygen,ipsilateral stroke|symptomatic carotid occlusion,,,,,carotid occlusion surgery|extracranial-intracranial bypass surgery,,,carotid occlusion|ipsilateral stroke|recently symptomatic carotid occlusion,,,,,,,best medical therapy|extracranial-intracranial bypass surgery,carotid occlusion surgery|ipsila|recently symptomatic carotid occlusion|stroke,,best medical therapy,,,extracranial-intracranial bypass surgery,,,carotid occlusion|carotid occlusion surgery|extracranial|increased|intracranial bypass|ipsilateral stroke,,,,,-,,surgery,,,best medical therapy,extracranial-intracranial bypass surgery,,,,"stroke|ischemic attack, transient|cerebral infarction",none,extracranial-intracranial bypass surgery,none,best medical therapy|extracranial-intracranial bypass surgery,none,best medical therapy,carotid occlusion|stroke|none,best medical therapy|none|extracranial-intracranial bypass surgery,carotid occlusion|increased cerebral oxygen extraction fraction|ipsilateral stroke,none,,extracranial-intracranial bypass surgery,,extracranial-intracranial bypass surgery,best medical therapy|positron emission tomography (pet)|extracranial-intracranial bypass surgery,best medical therapy,carotid occlusion|stroke,none,carotid occlusion|increased cerebral oxygen extraction fraction|ipsilateral stroke,none
20,NCT04088630,intracerebral hemorrhage,fingolimod|as,cerebral edema|intracerebral hemorrhage|primary spontaneous intracerebral hemorrhage,fingolimod,,,,,,,cerebral edema|intracerebral hemorrhage|primary spontaneous intracerebral hemorrhage,fingolimod,,,,,,,cerebral edema|intracerebral hemorrhage|primary spontaneous intracerebral hemorrhage,fingolimod,,,,,,,cerebral edema|intracerebral hemorrhage|primary spontaneous intracerebral hemorrhage,fingolimod,,,,,,,,placebo,fingolimod 0.5 mg,standard of care,,,,"cerebral edema|intracerebral hemorrhage|intracerebral hemorrhage intraparenchymal|stroke hemorrhagic|intracerebral hemorrhage, hypertensive",none,none,none,none,none,none,cerebral edema|intracerebral hemorrhage|none,fingolimod|none,cerebral edema|intracerebral hemorrhage,fingolimod,none,,,none,fingolimod,,cerebral edema|intracerebral hemorrhage,fingolimod,cerebral edema|intracerebral hemorrhage,fingolimod
21,NCT03747848,,other|aim|as,fatigue|parkinson's disease|pd,,,physical exercise,cognitive behavioral therapy,,,proper sleep hygiene,fatigue|parkinson's disease|pd,,,,cognitive behavioral therapy|treatment,,,protocol,fatigue|parkinson's disease|pd|pd fatigue,,,,cognitive behavioral therapy,,,,fatigue|parkinson's disease|pd,,,physical exercise,,,,behavioral therapy|cognitive behavioral therapy,cbt group,,,,,,,parkinson disease,sleep hygiene habits|cognitive behavioral therapy|physical exercise routine,cognitive behavioral therapy|physical exercise routine,none,physical exercise routine,sleep hygiene habits|physical exercise routine,none,parkinson's disease|none,cognitive behavioral therapy|none,fatigue|parkinson's disease,none,cognitive behavioral hing proper sleep hygiene habits|physical exercise routine,none,none,physical exercise routine|establish proper sleep hygiene habits,cognitive behavioral therapy,none,parkinson's disease,none,fatigue|parkinson's disease,none
22,NCT00437372,,sunitinib,cancer|tumor,sunitinib,,,,,radiation,,cancer|tumor,antiangiogenic agents|sunitinib,,,,,,radiation,cancer|tumor,antiangiogenic agents|sunitinib,,,,,radiation,,cancer|tumor,anti|sunitini,,,,,,radiation,,,sunitinib,,,external beam radiation therapy|external beam radiation therapy|sunitinib,,head and neck cancer|pelvic cancer|cancer|thoracic neoplasms|nervous system neoplasms,none,none,sunitinib and radiation,sunitinib|radiation,antiangiogenic agents,none,cancer,sunitinib|none,cancer|none,sunitinib,,,radiation,sunitinib|radiation,sunitinib|antiangiogenic agents,none,cancer,sunitinib|radiation|antiangiogenic agents,cancer,sunitinib
23,NCT05663034,,as,depressive|insomnia|mild to moderate tbi|post-traumatic stress|post-traumatic stress symptoms|tbi-related insomnia,,,,cbt|cognitive behavioral therapy|cognitive-behavioral vs. mindfulness-based treatment|mindfulness-based treatment|mindfulness-based treatment for insomnia,,,,combat|depressive symptoms|insomnia|mild to moderate tbi|post-traumatic stress symptoms|post-traumatic stress symptoms|tbi,,,,"- delivered, 6-session, standardized cognitive behavioral therapy for|cbt-i|cognitive-behavioral|mindfulness-based treatment|mindfulness-based treatment for|mindfulness-based treatment for insomnia",,,telemedicine,depressive symptoms|insomnia|insomniasomnia|mild to moderate tbi|post-traumatic stress|post-traumatic stress soms|post-traumatic stress symptoms|tbi,,,,cbt-i|cognitive-behavioral|mindfulness-based treatment|mindfulness-based treatment insomnia|mindfulness-based treatment for insomnia|standardized cognitive behavioral therapy,,,telemedicine -,am|comorbid|de|ins|insomnia|mild to moderate|post|post-traumatic stress symptoms|post-traumatic stress symptoms|tbi,,,,cognitive,,,behavioral therapy|cb|cognitive-behavioral vs. mindfulness-based treatment|mb|mindfulness-based treatment|telemedicine-delivered,mindfulness-based treatment for insomnia (mbti)|cognitive behavioral therapy for insomnia (cbt-i)|cognitive behavioral therapy for insomnia (cbt-i)|mindfulness-based treatment for insomnia (mbti),,,,,,,"brain injury traumatic mild|sleep|concussion, brain|traumatic brain injury|head injury|depression|insomnia|memory impairment|cognitive behavioral therapy|post-traumatic stress",cognitive behavioral therapy for insomnia (cbt-i)|mindfulness-based treatment for insomnia (mbti),none,cbt-i|mbti,cognitive behavioral therapy for insomnia (cbt-i)|mindfulness-based treatment for insomnia (mbti),psychosocial questionnaires|mindfulness-based treatment for insomnia (mbti)|sleep monitoring|standardized cognitive behavioral therapy for insomnia (cbt-i)|telemedicine-delivered|neurocognitive testing,cognitive behavioral therapy for insomnia (cbt-i) and mindfulness-based treatment for insomnia (mbti)|cognitive behavioral therapy for insomnia (cbt-i)|mindfulness-based treatment for insomnia (mbti),insomnia|tbi|depressive symptoms|post-traumatic stress symptoms,cbt-i|mbti,tbi-related insomnia|depressive symptoms|post-traumatic stress symptoms|insomnia symptoms,cbt-i|mbti,cognitive behavioral therapy for insomnia (cbt-i)|mindfulness-based treatment for insomnia (mbti),none,none,cognitive behavioral therapy for insomnia (cbt-i)|mindfulness-based treatment for insomnia (mbti),psychosocial questionnaires|telemedicine-delivered treatment|mindfulness-based treatment for insomnia (mbti)|cognitive behavioral therapy for insomnia (cbt-i)|sleep monitoring|neurocognitive testing,cognitive-behavioral therapy for insomnia (cbt-i)|mindfulness-based treatment for insomnia (mbti),mild to moderate tbi|post-traumatic stress symptoms|insomnia|tbi-related insomnia|depressive symptoms,none,tbi-related insomnia|depressive symptoms|post-traumatic stress symptoms|insomnia symptoms,none
24,NCT03213002,,other|capecitabine|temozolomide,glioblastoma|glioblastoma multiforme,capecitabine|capecitabine and temozolomide|temozolomide,,,,,radiation,,glioblastoma multiforme|newly diagnosed glioblastoma|newly diagnosed glioblastoma multiforme,capecitabine|capecitabine and temozolomide|temozolomide,,,,,,,cancer|glioblastoma multiforme|newly diagnosed glioblastoma|newly diagnosed glioblastoma multiforme (|radiation,ca|capecitabine|temozolomide,,,,,,,cancer|glioblastoma multiforme|newly diagnosed glioblastoma|newly diagnosed glioblastoma multiforme,capecitabine|capt|te|temozolomide,,,,,,,,,capecitabine|temozolomide,,,,,"brain tumor|brain tumor, primary|brain tumor adult|cancer|glioblastoma, adult|glioblastoma multiforme (gbm)|brain cancer|glioblastoma|glioma of brain",none,none,capecitabine|temozolomide,capecitabine|temozolomide,capecitabine,temozolomide|temozolomide alone,gbm|glioblastoma,capecitabine|temozolomide,gbm|glioblastoma,capecitabine|temozolomide,none,none,none,none,temozolomide (captem)|oral capecitabine,temozolomide alone,cancer|glioblastoma,capecitabine|temozolomide,glioblastoma,capecitabine|temozolomide
25,NCT02125760,stroke,as,stroke,,,dual training|respiratory muscle training,,,,,muscle dysfunction|respiratory muscle dysfunction|stroke,,,dual training|respiratory muscle training,,,,,muscle dysfunction|respiratory muscle dysfunction|stroke,,,dual training|respiratory muscle training,,,,,muscle dysfunction|respiratory muscle dysfunction|stroke,,,dual training|respiratory|training,,,,muscle,,,,inspiratory muscle training (imt)|high-intensity imt,,,,muscle weakness,none,none,none,respiratory muscle training,respiratory muscle training,none,stroke,none,stroke rehabilitation|respiratory muscle dysfunction|mortality|morbidity|stroke|muscle dysfunction|costs of care,none,respiratory muscle training,none,none,respiratory muscle training,respiratory muscle training,none,stroke|respiratory muscle dysfunction,none,stroke|respiratory muscle dysfunction,none
26,NCT03787693,stroke,other|aim,asymmetries during walking|stroke|walking asymmetry,,,walking training,,,,virtual reality|virtual reality augmented gait adaptation,asymmetry|stroke|walking asymmetry,,,,,,,virtual reality,as|asym|asymmetries|stroke|walking asymmetry,,,,,,,virtual reality,stroke|walking asymmetry,,,,,,,virtual reality,vr - virtual reality,,,,,,,stroke,virtual reality augmented gait adaptation,none,none,virtual reality augmented gait adaptation,virtual reality,none,stroke|none,"drug names found: none|being addressed in this research project is walking asymmetry, ie, difference between the legs during walking (eg steps on the more affected side are longer than the other) a potential solution to this problem is using new technology like virtual reality during walking training to make stroke survivors have a better sense of their asymmetry a second problem that we aim to address in this study is whether asymmetry is accurately felt by the stroke survivors and how we can address it our ongoing work on the effects of virtual reality on learning new walking tasks in stroke survivors indicates that virtual reality maybe particularly important for those with walking asymmetry in this study, we plan to recruit stroke survivors who have such asymmetries during walking and have them learn a new walking task in virtual reality we will also test the stroke survivors to determine if there is a relationship between how well they learn the new task with their ability to feel asymmetry accurately|virtual reality augmented gait adaptation in stroke survivors",ability to feel asymmetry accurately|sense of asymmetry|stroke|new technology|walking asymmetry|learning new walking tasks|steps length difference|virtual reality,none,learning new walking tasks in virtual reality|virtual reality during walking training,none,none,learning new walking tasks in virtual reality|virtual reality during walking training,virtual reality augmented gait adaptation,none,stroke,none,walking asymmetry|stroke,none
27,NCT00295139,,,drug abuse|spmi,,supportive control treatment,,behavioral treatment|case management component|critical time intervention|cti|multifaceted treatment for substance abuse,,,,abuse|drug abuse|dual disordered|spmi,,supportive control treatment,,behavioral treatment|case management|critical time intervention|cti|multifaceted treatment for substance,,,,drug abuse|drug use|dual disordered|spmi|substance abuse,,supportive control treatment,,behavioral treatment|case management component|critical time intervention|cti|multifaceted treatment for,,,,drug|drug abuse|dual disordered|spmi|substance abuse,,,,case management component|critical time intervention|supportive control treatment|treatment,,,ct,behavioral treatment for substance abuse in spmi (btsas)|supportive treatment in addiction recovery (star)|critical time intervention (cti),,,,,,,substance dependence|mood disorders|schizophrenia,case management component (critical time intervention; cti)|multifaceted treatment for substance abuse in dual disordered patients|supportive control treatment,none,none,none,critical time intervention (cti),critical time intervention (cti)|supportive control treatment,drug abuse|substance abuse|dual disordered|spmi|none,cti|none,none,none,critical time intervention (cti)|multifaceted treatment for substance abuse in dual disordered patients|supportive control treatment,,,none,critical time intervention; cti,critical time intervention; cti|supportive control treatment,drug abuse|substance abuse|spmi|dual disorders,none,drug abuse|substance abuse|dual disorders,none
28,NCT01831414,paralysis,la|des|water,respiratory failure|spinal cord injury,,,balneotherapy|water immersion,,,,,paralysis|respiratory failure|spinal cord injury,,,,,,,bal|water|water immersion,paralysis|respiratory failure|spinal cord injury,,,,,,,water immersion|water immersion levels,balneo|paralysis|respiratory failure|spinal cord injury,,,,,,,balneotherapy|water immersion,,,,water immersion at cervical level|water immersion at xyphoid level,,,,spinal cord injury,balneotherapy,balneotherapy,balneotherapy,balneotherapy,balneotherapy,different water immersion levels,respiratory failure|spinal cord injury,none|balneotherapy,respiratory failure|paralysis,none,balneotherapy,none,none,balneotherapy,balneotherapy,none,respiratory failure|tetraplegia|spinal cord injury,none,respiratory failure|paralysis|spinal cord injury,none
29,NCT05850585,schizophrenia,met|as,psychotic|schizophrenia,antipsychotic|antipsychotics,placebo,,,,,fmt|oral fecal bacteria capsules|oral fecal capsules,psychotic|schizophrenia,antipsychotic|antipsychotic drugs|antipsychotics,placebo,,,,,fecal bacteria capsules|fmt|repeated oral fecal capsules,psychotic|schizophrenia|schizophrenia fecal capsule,anticho fecal bacteria capsules|antipsychotic|antipsychotic drugs|antipsychotics|antitic|fmt,placebo,,,,,,psychotic|schizophrenia,anti|antipsychotic|antipsychotic drugs|antipsychotics|fm|fmt,place,,,,,fecal capsules|oral fecal bacteria capsules,,placebo,fecal microbiota transplantation(fmt),,,,,schizophrenia,none,none,none,oral fecal bacteria capsules|antipsychotic drugs,fmt combined with antipsychotic drugs was used to improve the efficacy of schizophrenia treatment in the study|fecal microbiota transplantation (fmt),oral placebo + antipsychotic group,eases mentioned in the provided text are: schizophrenia,oral fecal bacteria capsules|antipsychotic drugs|antipsychotics|fmt,schizophrenia|psychotic symptoms,antipsychotic drugs,none,none,none,oral fecal bacteria capsules|antipsychotic drugs,oral fecal bacteria capsules|fmt (fecal microbiota transplantation)|antipsychotic drugs,oral placebo + antipsychotic group,schizophrenia,antipsychotic drugs|fmt,schizophrenia|psychotic symptoms,antipsychotic drugs|fmt
30,NCT02551705,neurodegenerative disorder,,emotion comprehension deficit|huntington's disease|prehd|premanifest huntington's disease,,,,,,,,huntington's disease|huntington's disease|prehd|premanifest,,,,,,,,huntington's disease|huntington's disease|prehd|premanifest huntington's disease,,,,,,,,deficit|emotion|huntington's disease|huntington's disease|premanifest huntington's disease,,,,,,,,,,,functional imaging,,,,huntington's disease,none,none,none,none,functional imaging,none,none|huntington's disease,none|huntington's disease,cognitive deterioration|emotion comprehension deficit|body language comprehension|involuntary movements|behavioural disturbances|huntington's disease,none,none,none,none,none,none,none,huntington's disease,none,cognitive deterioration|emotion comprehension deficit|deficit in perception of emotions|involuntary movements|behavioural disturbances|huntington's disease,none
31,NCT04654286,,,brachial plexus injury|upper tbpi,,,,,human amniotic membrane and allogeneic adipose-derived mesenchymal stem cells|human amniotic membrane and allogeneic mesenchymal stem cells composite augmentation|nerve transfer,,,brachial plexus injury|nerve transfer|upper tbpi,,,,,allogeneic adipose-derived mesenchymal stem cells|allogeneic mesenchymal stem cells|ham-admsc|human amniotic membrane,,and|composite augmentation|composite wrapping comprising,brachial plexus injury|upper tbpi,,,,,ham-admsc|human amniotic membrane and allogeneic adipose-derived mesenchymal stem cells|human amniotic membrane and allogeneic mesenchymal stem cells composite augmentation|nerve transfer,,au|composite wrapping,bra|tbpi,,,,,allogeneic adipose-derived mesenchymal stem cells|allogeneic mesenchymal stem cells|human amniotic membrane|transfer,,and|composite augmentation|composite wrapping comprising|nerve|nerve transfer procedure|procedure,,,,nerve transfer procedure|nerve transfer with ham-admsc composite wrapping|nerve transfer procedure|nerve transfer with ham-admsc composite wrapping,,,,brachial plexus neuropathies,none,none,none,human amniotic membrane and allogeneic mesenchymal stem cells,ham-admsc composite augmentation,human amniotic membrane|allogeneic mesenchymal stem cells,none|brachial plexus injury,human amniotic membrane|allogeneic mesenchymal stem cells,nerve transfer procedure|brachial plexus injury,ham-admsc,,nerve transfer procedure in brachial plexus injury patients|composite wrapping comprising human amniotic membrane and allogeneic adipose-derived mesenchymal stem cells (ham-admsc) for augmentation of nerve transfer procedure,,composite wrapping comprising human amniotic membrane and allogeneic adipose-derived mesenchymal stem cells (ham-admsc) augmentation|nerve transfer procedure,human amniotic membrane|allogeneic mesenchymal stem cells composite|allogeneic adipose-derived mesenchymal stem cells (ham-admsc),none,brachial plexus injury,none,brachial plexus injury,human amniotic membrane|allogeneic adipose-derived mesenchymal stem cells|ham-admsc
32,NCT00716066,,melphalan|cytarabine|etoposide|carmustine|beam,autoimmune neurologic disease|autoimmune neurologic diseases|autoimmune neurological diseases,antithymocyte globulin|beam|carmustine|chemotherapy|cytarabine|etoposide|melphalan|thymoglobulin,,,,(autologous) stem cells|stem cell transplant|syngeneic or autologous hematopoietic cell transplantation,,,autoimmune neurologic disease|autoimmune neurologic diseases|autoimmune neurological diseases,antithymocyte globulin|beam|carmustine|cytarabine|etoposide|melphalan|thymoglobulin,,,,patient's own (autologous) stem cells|stem cell transplant|syngeneic or autologous hematopoietic cell transplantation,,high-dose immunosuppressive therapy,autoimmune neurologic disease|autoimmune neurologic diseases|autoimmune neurological diseasesem,antithymocyte globulin|beam|carmustine|cytarabine|etoposide|melphalan|thymoglobulin,,,,stem cell transplant|stem cell transplant (autologous) stem cells|syngeneic or autologous hematopoietic cell transplantation,,,autoimmune neurologic disease|autoimmune neurologic diseases|autoimmune neurological,antithy|antithymocyte|beam|car|carmustine|chemotherapy|cytarabine|etoposide|melphalan|thymoglobulin,,,,cell|stem cell,,,,,anti-thymocyte globulin|carmustine|cytarabine|etoposide|melphalan|prednisone,autologous hematopoietic stem cell transplantation|laboratory biomarker analysis|peripheral blood stem cell transplantation|syngeneic bone marrow transplantation|autologous hematopoietic stem cell transplantation|laboratory biomarker analysis|peripheral blood stem cell transplantation|syngeneic bone marrow transplantation,,,,multiple sclerosis stem cell transplant|autoimmune disease|rasmussen subacute encephalitis|multiple sclerosis transplant|opsoclonus myoclonus syndrome|neuromyelitis optica|lambert eaton myasthenic syndrome|cidp transplant|central nervous system vasculitis|ms stem cell transplant|hct for neurologic autoimmune disorders|chronic inflammatory demyelinating polyneuropathy|stiff person syndrome|cerebellar degeneration|myasthenia gravis|autologous transplant autoimmune|autoimmune nervous system disorder|neurologic autoimmune disease|myasthenia gravis transplant,none,thymoglobulin|syngeneic or autologous hematopoietic cell transplantation|melphalan|etoposide|high-dose immunosuppressive therapy using carmustine|cytarabine,none,thymoglobulin|melphalan|etoposide|high-dose immunosuppressive therapy using carmustine|cytarabine,antithymocyte globulin|autologous stem cells|stem cell transplant|high-dose chemotherapy,none,none|autoimmune neurologic diseases,melphalan|etoposide|antithymocyte globulin|cytarabine|carmustine,brain/spinal cord|attacks the nervous system|peripheral nerves|autoimmune neurologic diseases,thymoglobulin|melphalan|etoposide|cytarabine|carmustine,none,syngeneic hematopoietic cell transplantation|autologous hematopoietic cell transplantation,none,"syngeneic or autologous hematopoietic cell transplantation|high-dose immunosuppressive therapy using carmustine, etoposide, cytarabine, and melphalan (beam) + thymoglobulin",melphalan (beam)|thymoglobulin|syngeneic hematopoietic cell transplantation|stem cell transplant|high-dose immunosuppressive therapy|antithymocyte globulin|cytarabine|autologous hematopoietic cell transplantation|etoposide|carmustine,none,autoimmune neurologic diseases,thymoglobulin|melphalan|etoposide|antithymocyte globulin|cytarabine|carmustine,autoimmune neurologic diseases,melphalan|etoposide|antithymocyte globulin|cytarabine|carmustine
33,NCT02354508,acromegaly,somatostatin|pasireotide,acromegaly inadequately controlled|inadequately controlled acromegaly,pasireotide|somatostatin analogues,,,,,,,acromegaly|inadequately controlled,pasireotide|pasireotide lar|somatostatin analogues,,,,,,,acromegaly somatostatin analogue|inadequately controlled acromegaly,pasireotide|pasireotide lar|somatostatin analogue,,,,,,,acromegaly inadequately controlled|generation|inadequately controlled acromegaly,pasireotide|somatostatin,,,,,,,,,pasireotide lar,,,,,acromegaly,none,pasireotide lar 40 mg|pasireotide lar 60 mg,pasireotide lar 40 mg|pasireotide lar 60 mg,none,none|pasireotide lar,first generation somatostatin analogues,acromegaly,pasireotide,acromegaly|somatostatin analogues|inadequately controlled,pasireotide,none,none,none,pasireotide lar 40 mg|pasireotide lar 60 mg,pasireotide lar 40 mg|first generation somatostatin analogues|pasireotide lar 60 mg,first generation somatostatin analogues,acromegaly,pasireotide|somatostatin analogues|pasireotide lar,acromegaly,pasireotide|somatostatin analogues
34,NCT02885285,,,anxiety|depression|fatigue|parkinson's disease,,,exercise,,,,,anxiety|depression|fatigue|parkinson's disease,,,exercise,,,,,anxiety|depression|fatigue|parkinson's disease,,,di|exercise|exercise type,,,,,anxiety|depression|fatigue|parkinson's disease,,,exercise|exercise types,,,,,spinning class|yoga class|dance class,,,no exercise class,,,,parkinson's disease,none,none,none,none,none,none,parkinson's disease,none|exercise,fatigue|parkinson's disease|depression|anxiety,none,none,,,three distinct exercise types,none,none,parkinson's disease,none,fatigue|parkinson's disease|depression|anxiety,none
35,NCT05507385,anhedonia,other|aim|as,anhedonia|depression,,,,brief talking therapy,,,,anhedonia|depression,,,,brief talking therapy,,,brief intervention,anhedonia|depression|low mood,,,,brief intervention|talking therapy,,,brief,affect|an|depression|low|suicidal,,,,,,,brief talking therapy|future mental imagery,imagine-positive,control,,,,,,depression|anhedonia,positive future mental imagery,none,none,none,none,none,none|depression,none|anxiety,depression|anhedonia,none,targeting positive future mental imagery|brief talking therapy for anhedonia in adolescent depression,none,none,none,positive future mental imagery|brief talking therapy for anhedonia in adolescent depression,none,suicidality|depression|anhedonia,none,suicidality|low positive affect|depression|anhedonia,none
36,NCT04097418,multiple sclerosis,as,depression|fatigue|multiple sclerosis,,conventional motor training,aerobic training,,,,,depression|fatigue|multiple sclerosis,,,aerobic training|conventional motor training,,,,,depression|fatigue|multiple sclerosis,,conventional motor training,aerobic training,,,,,aerobic training|depression|fatigue|multiple sclerosis,,,aerobic training|conventional motor training,,,,,aerobic training compared to conventional motor training,,,,,,,multiple sclerosis,conventional motor training|therapeutic behavioural interventions extracted from the clinical trial:|aerobic training,none,aerobic training (at)|conventional motor training,aerobic training (at)|conventional motor training,cognitive performance|functional connectivity|neuropsychological scales|cardiovascular parameters|depression|gray matter volumes|fatigue|clinical scales|white matter architecture|functional activations,conventional motor training,ms|none,none|aerobic training,cognitive performance|functional connectivity|structural plasticity|motor networks|motor scales|depression|gray matter volumes|fatigue|clinical scales|resting state|white matter architecture|neuropsychological scales|neuropsychological functions|cognitive networks|ms|physical functions|cardiovascular parameters|functional activations,aerobic training,conventional motor training|aerobic training,none,none,conventional motor training|aerobic training,conventional motor training|aerobic training,conventional motor training,multiple sclerosis,none,motor performances|cognitive performances|depression|fatigue|multiple sclerosis,none
37,NCT03542474,,as,mild cognitive impairment|parkinson's disease,,,endurance exercise|exercise|high intensity endurance exercise,,,,,mild cognitive impairment|parkinson's disease,,,endurance exercise|high intensity endurance exercise,,,,,mild cognitive impairment|parkinson's disease,,,endurance exercise|high intensity endurance exercise,,,,,mild cognitive impairment|parkinson's disease,,,endurance exercise|exercise|high intensity endurance exercise,,,,,high intensity endurance exercise,,,,,,,mild cognitive impairment|parkinson disease,none,none,none,endurance exercise,none,none,mild cognitive impairment|parkinson's disease,none,mild cognitive impairment|parkinson's disease,'none',none,,,high intensity endurance exercise,high intensity endurance exercise,none,mild cognitive impairment|parkinson's disease,none,mild cognitive impairment|parkinson's disease,none
38,NCT05415956,multiple sclerosis,as,multiple sclerosis,,,moderate-to-high intensity outdoor walking|outdoor walking|walking exercise,,,,,deterioration of walking capacity|ms|multiple sclerosis,,,moderate-to-high intensity outdoor walking exercise therapy|outdoor walking|outdoor walking exercise therapy|walking exercise therapy,,,,,det capacity|multiple sclerosis|outwalk ms,,,moderate-to-high intensity|outdoor walking|outdoor walking exercise therapy|walking exercise therapy,,,,,deterioration|ms|multiple sclerosis|p|pwms,,,moderate-to-high intensity outdoor walking exercise therapy|outdoor walking|outdoor walking exercise therapy|outwalk|walking exercise therapy,,,,,walking exercise therapy,,,,,,,multiple sclerosis,walking exercise therapy|group intervention|outdoor walking exercise therapy|interaction with nature,none,none,outdoor walking exercise therapy,nature interaction,none,multiple sclerosis|none,none|outwalk ms,multiple sclerosis|deterioration of walking capacity,none,group intervention facilitating interaction between pwms|interaction with nature|outdoor walking exercise e therapy,none,none,7 weeks of outdoor walking exercise therapy|outdoor walking exercise e therapy,outdoor walking exercise therapy|moderate-to-high intensity outdoor walking exercise therapy,none,multiple sclerosis,none,negative influence on well-being|multiple sclerosis|deterioration of walking capacity,none
39,NCT02016638,,,osa|pregnancy|pregnant|sdb,,,,,,,,hypertensive disorders of pregnancy|osa|pregnancy|sdb|sleep disorders,,,,,,,,hypertensive disorders|osa|sdb|sleep disorders,,,,,,,,hypertensive disorders|osa|sd|sleep disorders,,,,,,,,,,,polysomnography and ambulatory blood pressure recording,,,,"obstructive sleep apnea|restless leg syndrome|high-risk pregnancy|pregnancy induced hypertension|infant, very low birth weight",none,none,none,none,overnight polysomnography|ambulatory blood pressure monitoring,none,sdb|hypertensive disorders of pregnancy|osa|sleep disorders,osa|sdb|none,hormonal-induced hyperaemia of the nasopharyngeal passages|hypertensive disorders of pregnancy|sleep disorders|weight gain|adverse fetal outcomes|osa|sdb|adverse maternal outcomes|pregnancy related disorders|upper displacement of the diaphragm,none,none,none,none,overnight polysomnography|ambulatory blood pressure monitoring,overnight polysomnography|ambulatory blood pressure monitoring,none,hypertensive disorders of pregnancy|osa|sleep disorders|pregnancy related disorders,none,sdb|hypertensive disorders of pregnancy|osa|sleep disorders,none
40,NCT04435301,,as,disorders of consciousness,,,,,,,acoustic and electric stimulation at gamma frequency|acoustic-electric therapy|modulation of gamma oscillations with rhythmic stimulation,disorders of consciousness,,,,,,,acoustic-electric therapy|acoustic and electric stimulation|rhythmic stimulation,disorders of consciousness,,,,,,,acoustic-electric therapy|acoustic and electric stimulation|rhythmic stimulation,altered gamma activity|disorders of consciousness,,,,,,,acoustic-electric therapy|acoustic and electric stimulation at|rhythmic stimulation,,,,"dc-stimulator, neuroconn, germany",,,,consciousness disorder,acoustic stimulation|electric stimulation,acoustic and electric stimulation at gamma frequency,none,acoustic stimulation|electric stimulation,acoustic-electric stimulation at gamma frequency,none,disorders of consciousness,acoustic|none|electric,disorders of consciousness|altered gamma activity,none,acoustic stimulation at gamma frequency|electric stimulation at gamma frequency,,,acoustic stimulation at gamma frequency|electric stimulation at gamma frequency,acoustic stimulation|electric stimulation|modulation of gamma oscillations with rhythmic stimulation,none,neurological and psychiatric disorders|disorders of consciousness,none,disorders of consciousness|reduction in gamma synchronization|altered gamma activity,none
41,NCT03562351,seizure,lorazepam|diazepam|midazolam|other|rms,emergent seizure|seizure,,,,caregiver education in a simulation setting|educational program|educational quality improvement program|educational video reviewing rm administration|simulation training model/mannequin for rectal diazepam administration,,,,rm|seizure|seizure rm,diazepam|lor,,,,,,program|simulation training model,emergent seizure rm|seizure|seizure rm|seizure rms,diazep|lorazepa|midola,,,,,,simulation training model,seizure|seizure rm|seizure rms,lo,,,,,,diazep|educational quality improvement program|mannequin|program|rescue medication|simulation training model|video reviewing rm,verbal instructions educational intervention|video educational intervention|mannequin educational intervention,,,,,,,status epilepticus,"expand training to other seizure rms (eg intranasal midazolam, buccal lorazepam) and transition the most effective educational model back to the clinics/bedside to standardize caregiver teaching throughout the department/hospital|develop and validate a simulation training model/mannequin for rectal diazepam administration|create an educational video reviewing rm administration","expand training to other seizure rms (eg intranasal midazolam, buccal lorazepam) and transition the most effective educational model back to the clinics/bedside to standardize caregiver teaching throughout the department/hospital|develop and validate a simulation training model/mannequin for rectal diazepam administration|create an educational video reviewing rm administration",intranasal midazolam|none|buccal lorazepam,"develop and validate a simulation training model/mannequin for rectal diazepam administration|expand training to other seizure rms (eg intranasal midazolam, buccal lorazepam)|create an educational video reviewing rm administration",intranasal midazolam|buccal lorazepam,none,seizure|none,lorazepam|diazepam|midazolam,none,lorazepam|diazepam|midazolam,"expand training to other seizure rms (eg intranasal midazolam, buccal lorazepam) and transition the most effective educational model back to the clinics/bedside to standardize caregiver teaching throughout the department/hospital|design an educational quality improvement program to assess the most effective educational approach on caregiver seizure rm application|create an educational video reviewing rm administration|develop and validate a simulation training model/mannequin for rectal diazepam administration",none,none,none,rectal diazepam|intranasal midazolam|buccal lorazepam,none,seizure,lorazepam|diazepam|midazolam,seizure,lorazepam|diazepam|midazolam
42,NCT02730065,stroke|dementia,as,cerebral small vessel disease|small vessel disease,,health education|simple stretching,aerobic dance training|aerobic dance training with home practice,,,,,cerebral small vessel disease|dementia|depression|small vessel disease|stroke,,health education control|simple stretching plus,aerobic dance training|home practice|physical exercise|structured aerobic dance training|structured therapist-led group aerobic dance training,,,,,cerebral small vessel disease|dementia|depression|small vessel disease|stroke,,health education control|simple stretching,aerobic dance training|aerobic dance training practice|physical exercise,,,,,cerebral small vessel disease|dementia|depression|functional impairment|physical|significant|small vessel disease|stroke,,,aerobic dance training|cerebral vasomotor reactivity|group aerobic dance training|home practice|physical exercise|simple stretching|structured aerobic dance training|structured therapist,,,,,structured aerobic dance training group|stretching plus education,,,,,,,cerebrovascular disease,simple stretching plus health education|therapist-led group aerobic dance training,structured therapist-led group aerobic dance training|simple stretching,none,structured aerobic dance training|simple stretching,structured therapist-led group aerobic dance training|simple stretching plus health education control group,simple stretching plus health education control group|structured therapist-led group aerobic dance training with home practice,age-related disabilities|mri|treatment outcomes|simple stretching|caucasians|stroke|home practice|transcranial doppler|depression|cerebral autoregulation|mood|chinese|wml|physical exercise|mixed effects models|cognitive functions|community dwelling|aerobic dance training|dementia|t-led group aerobic dance training|mediation models|intent-to-treat|health education|lacunes|cerebral small vessel disease|physical functions|multiple imputations|rct|cerebral vasomotor reactivity|elderly persons,none|aerobic dance training,dementia|functional impairment|cerebral small vessel disease|physical impairment|physical functions|depression|mood|cognitive functions,none,24-week structured aerobic dance training with home practice|simple stretching plus health education control group,none,none,simple stretching plus health education|24-week structured aerobic dance training with home practice,simple stretching plus health education control group|24-week structured therapist-led group aerobic dance training with home practice,simple stretching plus health education control group,dementia|stroke|depression|cerebral small vessel disease,none,physical and functional impairment|dementia|depression|cerebral small vessel disease,none
43,NCT02820441,sleep apnea,zopiclone|csa,central sleep apnea|left ventricular dysfunction,zopiclone,placebo,,,,,adaptative servoventilation,central sleep apnea|left ventricular dysfunction|syndrome,hypnotic|zopiclone,placebo,,,,,adaptative servoventilation|adaptative servoventilation (,central sleep apnea|csa) syndrome|left ventricular dysfunction,hypnotic|zopiclone,placebo,,,,,adaptative servoventilation,central sleep apnea|left ventricular dysfunction|syndrome,hypnotic|z,place,,,,,adaptative servoventilation,,placebo,zopiclone,,,,,"sleep apnea, central|ventricular dysfunction",hypnotic (zopiclone),zopiclone treatment|placebo treatment|adaptative servoventilation (asv) initiation,zopiclone|placebo|adaptative servoventilation,zopiclone|adaptative servoventilation (asv),hypnotic (zopiclone),placebo,central sleep apnea|left ventricular dysfunction,zopiclone,left ventricular dysfunction|none|central sleep apnea,zopiclone,none,,,adaptative servoventilation (asv) initiation,zopiclone|adaptative servoventilation (asv)|placebo,placebo,central sleep apnea|left ventricular dysfunction,zopiclone|placebo,central sleep apnea|left ventricular dysfunction,zopiclone|placebo
44,NCT01255046,,donepezil|as,alzheimer's disease|mild to moderate alzheimer's disease,donepezil|sta-1,placebo,,,,,,alzheimer's disease|mild to moderate alzheimer's disease,donepezil|sta,placebo,,,,,- 1,alzheimer's disease|mild to moderate alzheimer's disease,donepezil|sta-1,placebo,,,,,,alzheimer's disease|mild to moderate alzheimer's disease,done|sta-1,place,,,,,,,placebo,"donepezil,|sta-1",,,,,alzheimer disease,none,none,none,none,none,placebo,alzheimer's disease,sta-1|donepezil,alzheimer's disease,sta-1|donepezil,,,,none,sta-1|donepezil,placebo|donepezil,alzheimer's disease,sta-1|donepezil,mild to moderate alzheimer's disease,sta-1|donepezil
45,NCT04164810,fibromyalgia|neuropathic pain,as,chronic pain|neuropathic pain|pain|pain catastrophization|pcs|spinal cord injury,,physical therapy|standard physical therapy,hydrotherapy,,,,,chronic pain|neuropathic pain|pain|spinal cord injury,,physical therapy|standard physical therapy,,,,,hydrotherapy,catastrophi|chronic lumbar pain|chronic pain|fibromyalgia|neuropathic pain|np pain|pain|pain catastrophization|spinal cord injury,,physical therapy|standard physical therapy,,,,,hydrotherapy,chronic lu|chronic pain|fi|ne|neuropathic pain|pain|pain catast|pain catastrophization|painful|pcs|spinal cord injury|traumatic|violence,,,physical therapy|therapy,,,,hydrotherapy,,,,hydrotherapy,physical therapy,,,spinal cord injuries|neuropathic pain,hydrotherapy|standard physical therapy,hydrotherapy|standard physical therapy,hydrotherapy|standard physical therapy,hydrotherapy|standard physical therapy,hydrotherapy,hydrotherapy|standard physical therapy|hydrotherapy and standard physical therapy,fibromyalgia|spinal cord injury|chronic lumbar pain|neuropathic pain|none,hydrotherapy|none,neuropathic pain|pain catastrophization|spinal cord injury,hydrotherapy,hydrotherapy|standard physical therapy,none,none,hydrotherapy|standard physical therapy,hydrotherapy,standard physical therapy,fibromyalgia|chronic diseases|spinal cord injury|chronic lumbar pain|neuropathic pain,none,neuropathic pain|pain catastrophization|spinal cord injury|chronic pain,hydrotherapy
46,NCT00821691,stroke,amantadine|as,aphasic|chronic post stroke|post stroke,amantadine,placebo,,,,,,chronic post stroke aphasic|post stroke aphasic,amantadine|dopa-agonist,placebo,,,,,,chronic post stroke aphasic|post stroke aphasic,amantadine|dopa-agonist,placebo,,,,,,aphasic|chronic post stroke aphasic|post stroke,ama|amantadine|do,place,,,,,,,placebo,amantadin,,,,,cerebral infarction,none,none,none,amantadine|placebo,amantadine,"amantadine, placebo",stroke|aphasic,amantadine|dopa-agonist|placebo,verbal fluency|post stroke aphasia|language and communication,amantadine,none,,,amantadine administration,amantadine|dopa-agonist|placebo,placebo,stroke|aphasia,amantadine,verbal fluency|post stroke aphasia,amantadine
47,NCT05337982,,other,spinal cord injury|subacute sci,,standard rehabilitation,downhill training with muscle stimulation|eccentric motor training|rehabilitation therapy|rehabilitation treatment|training program|walking downhill,,,,neuromodulation,spinal cord injury|subacute sci,,standard of care|standard rehabilitation|standard rehabilitation alone,downhill training|eccentric motor training|rehabilitation|trained|training program|walking downhill,,,,low levels of electricity|muscle stimulation|neuromodulation,sci therapy|spinal cord injury|subacute sci,,standard of care|standard rehabilitation|standard rehabilitation alone,downhill training with muscle stimulation|eccentric motor training,,,,neuromodulation,spinal cord injury|subacute sci,,standard,downhill training with|eccentric motor training|muscle stimulation|on|program|rehabilitation|rehabilitation therapy,,,,,,,,downhill eccentric treadmill training with electrical stimulation,,,,spinal cord injuries|healthy,eccentric motor training|neuromodulation,none,none,eccentric motor training|muscle stimulation using low levels of electricity|walking downhill on a slight slope on a treadmill,biomarkers|neuromodulation,standard rehabilitation alone,sci,none,subacute sci|walking difficulties|muscle weakness|leg movement impairment|trunk movement impairment|overall function impairment,none,eccentric motor training|muscle stimulation|neuromodulation|walking downhill on a slight slope on a treadmill|biomarkers for rehabilitation readiness,none,,eccentric motor training|muscle stimulation|walking downhill on a slight slope on a treadmill,biomarkers|neuromodulation|blood testing|muscle stimulation|mri scans|spinal fluid testing,standard rehabilitation alone,spinal cord injury,none,walking recovery|trunk and leg movement improvement|spinal cord injury|muscle control recovery|overall function improvement,none
48,NCT04073667,ataxia,balance|same|as,chiari type 1 malformation|type 1 cm,,not be intervened,exercise,,,,,chiari type 1 malformation|pain|postoperative|type 1 cm,,,exercise program|exercise programs|exercised,,,,,chiari type 1 malformation|fallia|pain|type 1 cm,,,exercise program|exercise programoper|exercise programs|exercised,,,,,chiari type 1 malformation|pain,,,exercise program|exercise programs,,,,,exercise,,,,,,,arnold chiari malformation,posture evaluation|symbol|separated by the|exercise program,surgical procedure for type 1 cm,none,exercise program,sharpened romberg test|barthel daily living activities index|berg balance scale|pain threshold and pain tolerance tests|neck disability index|8 shaped walk test (f8wt)|grip ability test (gat)|posture evaluation|cervical range of motion evaluation|timed rise walk test|short form 36 questionnaire|visual analogue scale|international ataxia assessment scale (icars)|eating assessment tool (eat-10),not intervened and followed as a control group|second group: not intervened and followed as a control group|exercised for 6 weeks|first group: exercised for 6 weeks,none|chiari type 1 malformation,none,swallowing function evaluation|pain throughout the body|cervical range of motion|fall risk|quality of life|chiari type 1 malformation|posture evaluation|fine motor skill assessment|neck disability|coordination issues|balance impairment|neck pain|daily living activities,none,exercise program,surgical procedure for type 1 cm,,exercise program,none,none,chiari type 1 malformation,none,chiari type 1 malformation,none
49,NCT01182441,,warfarin|as,atrial fibrillation|non-valvular atrial fibrillation|thrombus,warfarin,,,,watchman laa closure device|watchman laa closure technology,,,atrial fibrillation|non-valvular atrial fibrillation,warfarin,,,,,,watchman laa closure device|watchman laa closure technology,atrial fibrillation|non-valvular atrial fibrillation|th,warn,,,,,,watchman laa closure device|watchman laa closure technology|watchman laa closure technologyf,anti|at|atrial fibrillation|long term|non-valvular atrial fibrillation|therapy|war,,,,,,,watchman laa closure device|watchman laa closure technology,,,warfarin,watchman device,,,,stroke|atrial fibrillation,none,watchman laa closure device,none,none,none,long term warfarin therapy,eases mentioned in the sentences are: atrial fibrillation|none,warfarin|watchman,atrial fibrillation|thrombus formation,warfarin|none,none,watchman laa closure device procedure,none,watchman laa closure device,watchman laa closure device|anticoagulation therapy|long term warfarin therapy,long term warfarin therapy,atrial fibrillation|non-valvular atrial fibrillation,watchman laa closure device|warfarin,atrial fibrillation|potential thrombus formation|non-valvular atrial fibrillation,watchman laa closure device|warfarin
50,NCT04854057,,oxygen,cervical spinal cord injury|chronic incomplete spinal cord injury,,,,,,,acute intermittent hypoxia|intermittent hypoxia|mild breathing bouts of low oxygen|transcutaneous electrical spinal cord stimulation,cervical spinal cord injury|chronic incomplete spinal cord injury,,,,,,,acute intermittent hypoxia|intermittent hypoxia|mild breathing bouts of low oxygen|transcutaneous electrical spinal cord stimulation,cervical spinal cord injury|chronic incomplete spinal cord injury,,,,,,,acute intermittent hypoxia|intermittent hypoxia|mild breathing bouts of low oxygen|transcutaneous electrical spinal cord stimulation,acute|cervical spinal cord injury|chronic incomplete spinal cord injury|hypoxia,,,,,,,breathing bouts of low oxygen|intermittent|transcutaneous electrical spinal cord stimulation,,sham - intermittent room air - room air mixture,,aih - intermittent hypoxia - hypoxia air mixture|tess - transcutaneous electrical spinal cord stimulation + functional task practice,,,,spinal cord injuries,none,none,none,mild breathing bouts of low oxygen|transcutaneous electrical spinal cord stimulation,transcutaneous electrical spinal cord stimulation,none,cervical spinal cord injury,intermittent hypoxia|transcutaneous electrical spinal cord stimulation,none|cervical spinal cord injury,none,acute intermittent hypoxia|transcutaneous electrical spinal cord stimulation,,,acute intermittent hypoxia|transcutaneous electrical spinal cord stimulation,combinatorial treatment of acute intermittent hypoxia|transcutaneous electrical spinal cord stimulation,none,acute intermittent hypoxia|cervical spinal cord injury|chronic incomplete spinal cord injury,none,hand function|acute intermittent hypoxia|cervical spinal cord injury,none
51,NCT02444065,bulimia nervosa,no|as,bulimia nervosa|eating disorders|purging disorder,,matched-intensity augmentative motivational interviewing|motivational interviewing,,cbt-based individual intervention for rapid response|cbt-rr|rapid response|rapid response to day hospital treatment|rapid response to treatment -cessation,,,,binge|binge eating|bulimia nervosa|eating disorders|purging disorder|vomiting,,matched-intensity|mi) intervention|motivational interviewing,,augmentative motivational interviewing|cbt-based individual intervention for rapid response|cbt-rr,,,day hospital,binge eating or vomiting episodes|binge eating vomiting|bulimia nervosa|depression|eating disorders|purging disorder,,augmentative motivational interviewing|dh as|mi intervention|motivational interviewing,,cbt-based individual intervention for rapid response|cbt-rr|cbt-rr day hospital dh,,,,bing|binge eating and|bulimia nervosa|day hospital|depression|eating|eating disorders|motivational interviewing|pu|purging disorder|vomiting,,,,-|individual intervention|motivational interviewing,,,cbt-based|cbt-rr,cognitive behavior therapy (cbt)|motivational interviewing (mi),,,,,,,eating disorder|bulimia nervosa,cbt-rr (cognitive behavioral therapy for rapid response)|mi (motivational interviewing),cbt-rr|mi,cbt-rr|mi,cbt-rr|mi,cbt-rr|mi,augmentative motivational interviewing (mi)|augmentative motivational interviewing|cbt-rr (cognitive behavioral therapy for rapid response)|cbt-rr,bulimia nervosa|purging disorder,cbt-rr|none|mi,bulimia nervosa|purging disorder|vomiting episodes|binge eating,cbt-rr|mi,standard day hospital (dh) treatment for bn and purging disorder (pd)|augmentative motivational interviewing (mi) intervention|4-session cbt-based individual intervention for rapid response (cbt-rr),none,none,standard day hospital (dh) treatment for bn and purging disorder (pd)|augmentative motivational interviewing (mi) intervention|4-session cbt-based individual intervention for rapid response (cbt-rr),augmentative motivational interviewing (mi) intervention|cbt-based individual intervention for rapid response (cbt-rr)|standard day hospital (dh) treatment,matched-intensity augmentative motivational interviewing (mi) intervention|standard day hospital (dh) treatment,bulimia nervosa|purging disorder|depression|eating disorders,none,vomiting|depression|bulimia nervosa|purging disorder|binge eating,none
52,NCT01671176,,,,,,,,,,oticon medical ponto 4.5mm wide implant|ponto 4.5mm wide diameter implant,,,,,,,,oticon medical ponto 4. 5mm wide implant|ponto 4. 5mm wide diameter implant|process,,,,,,,,oticon medical ponto 4 . 5mm wide implant|ponto 4 . 5mm wide diameter implant,,,,,,,,oticon medical ponto 4. 5mm wide implant|ponto 4. 5mm wide diameter implant|sound processor,,,,wide diameter bone anchored implant,,,,"unilateral, profound sensori-neural hearing loss|conductive and sensori-neural hearing loss in the same ear|conductive hearing loss",none,none,none,none,none,none,implant loss|quality of life benefit|adverse skin reactions|none|implant stability,ponto 45mm wide implant|none,none,none,,implantation of the ponto 45mm wide diameter implant|fitting the sound processor 3 weeks after surgical implantation,,implantation of the ponto 45mm wide diameter implant|fitting the sound processor 3 weeks after surgical implantation,oticon medical ponto 45mm wide implant,none,none,ponto 45mm wide diameter implant|oticon medical ponto 45mm wide implant,adverse skin reactions,oticon medical ponto 45mm wide implant
53,NCT05622396,,co,parkinson's disease,,,,mindfulness based stress reduction|mindfulness meditation,,,,parkinson's disease,,,,co-constructed program (patients-experts) of mindfulness meditation|mbsr) program|mindfulness based stress reduction (,,,,parkinson's disease,,,,co-constructed program|mindfulness based stress reduction|mindfulness meditation,,,,parkinson's disease,,,,,,,mindfulness based stress reduction|mindfulness meditation,,,,mindfulness based stress reduction,,,,parkinson disease,mindfulness based stress reduction (mbsr),none,none,mindfulness based stress reduction (mbsr),none,mindfulness based stress reduction (mbsr) program,parkinson's disease,mbsr,parkinson's disease,none,mindfulness meditation|mindfulness based stress reduction (mbsr) program,,,mindfulness based stress reduction (mbsr) program,mindfulness based stress reduction (mbsr) program,,parkinson's disease,none,parkinson's disease,none
54,NCT04331392,brain injury,,moderate-severe traumatic brain injury|traumatic brain injury,,,,,,,environmental enrichment|online spatial navigation,moderate-severe traumatic brain injury|traumatic brain injury,,,,,,,environmental enrichment intervention|online spatial navigation intervention|remotely delivered,moderate-severe traumatic brain injury|traumatic brain injury,,,,,,,online spatial navigation intervention|remotely delivered environmental enrichment intervention,moderate-severe traumatic brain injury|traumatic brain injury,,,,,,,environmental enrichment intervention|online spatial navigation intervention|remotely delivered,spatial navigation intervention|educational videos|educational videos|spatial navigation intervention,,,,,,,"brain injury, chronic|brain injury traumatic moderate|brain injuries, traumatic|brain injury traumatic severe",none,none,none,none,none,none,traumatic brain injury,remotely delivered environmental enrichment intervention|none,memory impairment|brain health|traumatic brain injury,none,online spatial navigation intervention,,,online spatial navigation intervention,online spatial navigation intervention,,traumatic brain injury,none,brain health issues|memory impairment|traumatic brain injury,none
55,NCT05387798,,cannabidiol,prader-willi syndrome,cannabidiol|rad011,,,,,,,prader-willi syndrome|prader-willi syndrome,cannabidiol|rad011,placebo,,,,,,prader-willi syndrome|prader-willi syndrome,cannabidiol|rad011,placebo,,,,,,p|prader-willi syndrome,cannabidiol|rad|rad011,place,,,,,,,,rad011,,,,,prader-willi syndrome,none,none,none,none,cannabidiol oral solution (rad011),placebo placebo,prader-willi syndrome,rad011|cannabidiol,prader-willi syndrome|none,rad011,none,,none,none,rad011 (cannabidiol oral solution),none,prader-willi syndrome,cannabidiol oral solution|rad011,prader-willi syndrome,rad011
56,NCT04894513,palsy,,bell's palsy,,,kabat motor control re-education|kabat motor control re-education therapy,,,,,bell's palsy,,,,control|control re-education|education,,,kabat motor|kabat motor control re -|re -|therapy,bell's palsy,,,kabat motor control re-education|kabat motor control re-education therapy,,,,,bell's palsy,,,ka,control re-education|re|re-education,,,- education therapy|kabat motor control|therapy,,kabat motor control re-education therapy,,conventional selected program,,,,bell's palsy|facial nerve palsy,kabat motor control re-education therapy,none,none,kabat motor control re-education therapy,electro physiological responses to kabat motor control re-education on bell's palsy: a randomized controlled study|to investigate the effect of kabat motor control re-education therapy on facial nerve electro physiological responses and facial muscles function in bell's palsy|kabat motor control re-education therapy,none,bell's palsy|none,kabat|none,bell's palsy|facial muscles function|facial nerve electro physiological responses,'none',kabat motor control re-education therapy,,,kabat motor control re-education therapy,electro physiological responses therapy|kabat motor control re-education therapy,none,bell's palsy,none,bell's palsy|facial nerve recovery|facial muscles function|facial nerve electro physiological responses,none
57,NCT00444067,,as,spinal surgery,,standard of care,,,spinal sealant|spinal sealant system|sutured dural repair,,,dural repair|spinal surgery,,standard of care methods|standard of care techniques,,,,,spinal sealant|spinal sealant system|sutured,spinal surgery,,standard of care method|standard of care techniques,,,sutured dural repair,,spinal sealant|spinal sealant system,spinal surgery|su,,standard,,,,,care techniques|spinal sealant|spinal sealant system,,,,spinal sealant|standard of care|spinal sealant|standard of care,,,,"cerebrospinal fluid leakage, subdural",none,sutured dural repair|spinal sealant,none,sutured dural repair,none,standard of care methods,none|spinal surgery,spinal sealant system|none,none,none,,spinal sealant system as an adjunct to sutured dural repair|spinal surgery,,spinal sealant system as an adjunct to sutured dural repair|spinal surgery,standard of care techniques|spinal sealant system,standard of care techniques,none,none,none,spinal sealant system
58,NCT01824472,sleep apnea,as,insomnia|obstructive sleep apnea|sleep apnea,,sham-cpap,,cognitive-behavioral therapy,,,continuous positive airway pressure|cpap,insomnia|obstructive sleep apnea|sleep apnea,,sham,,cognitive-behavioral therapy,,,continuous positive airway pressure|cpap,insomnia|obstructive sleep apnea|sleep apnea,,sham-cpap,,cognitive-behavioral therapy,,,continuous positive airway pressure|cpap,ins|insomnia|obstructive sleep apnea|sleep apnea,,sham,,,,,cognitive -|continuous positive airway pressure|cp|cpap,cbt|cc,sham cpap|cbt|cc|cpap|sham cpap,,cpap,,,,sleep initiation and maintenance disorders|sleep apnea syndromes,cognitive-behavioral therapy for insomnia,none,none,continuous positive airway pressure (cpap),continuous positive airway pressure (cpap) and cognitive-behavioral therapy for insomnia|cognitive-behavioral therapy for insomnia|cpap,continuous positive airway pressure (cpap) and sham-cpap,insomnia|sleep apnea,continuous positive airway pressure|cpap|sham-cpap,insomnia|obstructive sleep apnea,cpap|sham-cpap,cognitive-behavioral therapy for insomnia|continuous positive airway pressure (cpap) treatment,none,none,cognitive-behavioral therapy for insomnia|continuous positive airway pressure (cpap) treatment,continuous positive airway pressure (cpap)|cognitive-behavioral therapy for insomnia,cognitive-behavioral therapy for insomnia|sham-cpap,insomnia|sleep apnea,none,obstructive sleep apnea|insomnia symptoms,cpap
59,NCT01040429,,clonidine,chronic fatigue syndrome,clonidine,,,,,,,chronic fatigue syndrome,clonidine,,,,,,,chronic fatigue syndrome,clonidine,,,,,,,chronic fatigue syndrome,clonidine,,,,,,,,,clonidine|lactose capsula,,,,,chronic fatigue syndrome|myalgic encephalomyelitis,none,none,none,clonidine,clonidine,clonidine,none|chronic fatigue syndrome|cfs,clonidine,autonomic control|infections/immunology|cognitions|chronic fatigue syndrome|endocrinology|genetics,clonidine,none,,,none,clonidine,none,chronic fatigue syndrome,clonidine,chronic fatigue syndrome,clonidine
60,NCT05164211,sleep apnea|hypotonia,wind,obstructive sleep apnea-hypopnea syndrome|obstructive sleep apnoea syndrome|tonsillar hypertrophy,,,,,,,didgeridoo|didgeridoo treatment,adenoidectomy|increased pharyngeal collapsibility|obstructive sleep apnea-hypopnea syndrome|obstructive sleep apnoea syndrome|pharyngeal hypotonia|tonsillar hypertrophy,,,,,,,didgeridoo|didgeridoo treatment,adenoidectomy|increased p co|obstructive sleep apnea-hypopnea syndrome|obstructive sleep apnoea syndrome|obstructive sleep apnoea syndrome surgery|pharyngeal hypotonia|tonsillar hypertrophy,didgeridoo,,,,,,didgeridoo,aden|adenoidect|h|hyper|increased pharyngeal colla|obstructive sleep apnea|obstructive sleep apnoea syndrome|ot|otorhinolaryngology|pathology|pharyngeal hypotonia|syndro,,,,,,,didgeridoo|wind instrument,,,,didgeridoo,,,,obstructive sleep apnea syndrome,playing the didgeridoo for 3 months|therapeutic behavioural interventions extracted from the clinical trial:,adenoidectomy,none,adenoidectomy|playing the didgeridoo|maxillofacial rehabilitation,didgeridoo treatment,otorhinolaryngology surgery (adenoidectomy)|didgeridoo treatment,obstructive sleep apnea-hypopnea syndrome|none,adenoidectomy|none,pharyngeal collapsibility|pharyngeal compliance|pediatric sleep questionnaire|obstructive sleep apnea-hypopnea syndrome|pharyngeal hypotonia|tonsillar hypertrophy|obstructive sleep apnoea syndrome,none,didgeridoo treatment to improve pharyngeal compliance|playing the didgeridoo for 3 months,otorhinolaryngology surgery (adenoidectomy),none,otorhinolaryngology surgery (adenoidectomy)|maxillofacial rehabilitation|didgeridoo treatment,didgeridoo treatment,otorhinolaryngology surgery (adenoidectomy),obstructive sleep apnea-hypopnea syndrome|tonsillar hypertrophy|obstructive sleep apnoea syndrome,none,obstructive sleep apnea-hypopnea syndrome|pharyngeal hypotonia|tonsillar hypertrophy,none
61,NCT04232163,stroke,,stroke,,,exercise,,,,feedback from a wearable device,stroke,,,combines|exercise and|program,,,,feedback from a wearable device,stroke,,,exercise feedback from a wearable device,,,,,stroke,,,exercise,,,,and feedback from a wearable device|program,arm boot camp,,,,,,,stroke|brain ischemia|vascular diseases|brain diseases|brain infarction|central nervous system diseases|cerebral infarction|cerebrovascular disorders|nervous system diseases|infarction|cardiovascular diseases,feedback from a wearable device|exercise,none,none,feedback from a wearable device|exercise,exercise|wearable device,none,stroke,none|exercise,upper limb movement practice|stroke|upper limb function,none,feedback from a wearable device on upper limb movement practice and function|exercise,,,feedback from a wearable device on upper limb movement practice|exercise,feedback from a wearable device|exercise,,stroke,,upper limb movement dysfunction|stroke,none
62,NCT00359944,,,mild to moderate alzheimer's disease,ac-3933,placebo,,,,,,mild to moderate alzheimer's disease,ac-3933,placebo,,,,,,mild to moderate alzheimer's disease,ac-3933,placebo,,,,,,mild to moderate alzheimer's disease,ac-3933,place,,,,,,,,ac-3933,sugar pill,,,,alzheimer's disease,none,none,none,none,none,placebo placebo,alzheimer's disease,ac-3933,alzheimer's disease,ac-3933,,,,ac-3933 tablets twice daily,ac-3933 tablets twice daily,placebo,alzheimer's disease,ac-3933,moderate alzheimer's disease|mild alzheimer's disease|alzheimer's disease,ac-3933
63,NCT02976766,optic neuritis,,acute optic neuritis|optic neuritis,gypenosides,placebo,,,,,,acute optic neuritis|optic neuritis,gypenosides,placebo,,,,,,acute optic neuritis|optic neuritis,gypenosides,place,,,,,,acute optic neuritis|optic neuritis,gypenosides,place,,,,,,,placebo,gypenosides,,,,,optic neuritis,none,none,none,none,none,none,optic neuritis,gypenosides|none,optic neuritis,none,none,,,gypenosides treatment,gypenosides treatment|placebo-controlled trial,placebo,optic neuritis,gypenosides,optic neuritis,gypenosides
64,NCT02470546,hepatic encephalopathy,metformin|aim,liver cirrhosis|minimal hepatic encephalopathy,metformin,,,,,,,liver cirrhosis|minimal hepatic encephalopathy,metformin,,,,,,,liver cirrhosis|minimal hepatic encephalopathy,metformin,,,,,,,liver cirrhosis|minimal hepatic encephalopathy,metform|metformin,,,,,,,,placebo,metformin,,,,,liver cirrhosis|hepatic encephalopathy,none,none,none,none,none,none,liver cirrhosis|minimal hepatic encephalopathy,none|metformin,liver cirrhosis|minimal hepatic encephalopathy,metformin,none,,,metformin use,metformin,none,liver cirrhosis|minimal hepatic encephalopathy,metformin,liver cirrhosis|minimal hepatic encephalopathy,metformin
65,NCT01407341,,phosphate,metastatic cancer|metastatic spine cancer|spine cancer,beta-tricalcium phosphate,,,,bone graft,,,metastatic cancer|metastatic spine cancer|spine cancer|surgery,,,,,,,beta-tricalcium phosphate bone graft|bone graft,metastatic cancer|metastatic spine cancer|surgery for|surgery for spine cancer,,,,,beta-tricalcium phosphate bone graft|bone graft,,,meta|metastatic spine cancer|spine cancer|surgery,beta-trical,,,,,,bone graft,,,,musculoskeletal complications management/prevention|bone graft|quality-of-life assessment|questionnaire administration|bone graft|musculoskeletal complications management/prevention|quality-of-life assessment|questionnaire administration,,,,spinal bone metastases|spinal cord compression|adult spinal cord neoplasm,none,surgery for metastatic spine cancer,none,beta-tricalcium phosphate bone graft,beta-tricalcium phosphate bone graft,none,none|metastatic cancer,beta-tricalcium phosphate|none,none|metastatic cancer,beta-tricalcium phosphate,none,beta-tricalcium phosphate bone graft|surgery for metastatic spine cancer,,beta-tricalcium phosphate bone graft|surgery for metastatic spine cancer,beta-tricalcium phosphate bone graft,none,spine cancer|metastatic spine cancer|metastatic cancer,beta-tricalcium phosphate bone graft,metastatic spine cancer|metastatic cancer,beta-tricalcium phosphate bone graft
66,NCT01093664,,,alzheimer,affitope ad02,,,,,,,alzheimer,affitope ad02,,,,,,,alzheimer,affitope ad02,,,,,,,alzheimer,affitope ad02,,,,,,,,,affitope ad02,,,,,alzheimer's disease,none,affitope ad02 boost immunization,none,affitope ad02,none,none,alzheimer|none,aff002|affitope ad02,alzheimer|none,affitope ad02,,,,none,boost immunization with affitope ad02|vaccine aff002,,alzheimer,affitope ad02,alzheimer,affitope ad02
67,NCT04717323,cerebral palsy|Cerebral Palsy,,cerebral palsy,,,precision gait retraining,,,,mobile pelvic assist device|sensor-based mobile pelvic assist device,cerebral palsy,,,precision gait retraining,,,,mpad|sensor-based mobile pelvic assist device,cerebral palsy,,,pre gait retraining,,,,mobile pelvic assist device|sensor based mobile pelvic assist device,cerebral palsy,,,precision,,,,ga|mpad|retraining|sensor-based mobile pelvic assist device,,,,mpad (or tpad) pelvic assist device|no intervention,,,,"cerebral palsy|gait disorders, neurologic",none|precision gait retraining,none,none,precision gait retraining,none,none,cerebral palsy,none,cerebral palsy,none,none,,,"gait retraining|precise, adaptable, pelvic control|sensor-based mobile pelvic assist device (mpad)",pelvic assist device (mpad),,cerebral palsy,none,cerebral palsy,none
68,NCT00692575,brain injury,,,,,,modular scheduled telephone intervention|problem-based telephone counseling,,,,moderate to severe traumatic brain injury|traumatic brain injury,,,,problem-based telephone counseling|telephone,,,intervention|scheduled,moderate to severe traumatic brain injury|traumatic brain injury,,,,,,,modular scheduled telephone intervention|problem-based telephone counseling,moderate to severe traumatic brain injury|traumatic brain injury,,,,,,,modular scheduled telephone intervention|problem-based telephone counseling,"problem-solving, education based telephone counseling|no intervention|problem-solving, education based telephone counseling",,,no intervention,,,,brain injuries,problem-based telephone counseling,none,none,none,none,none,none|traumatic brain injury,none|traumatic brain injury,emotional well-being|quality of life|traumatic brain injury,none,problem-based telephone counseling,,,none,none,none,traumatic brain injury,none,traumatic brain injury,none
69,NCT05423171,cerebral palsy,as,cerebral palsy,,,intensive bimanual intervention|intensive bimanual therapy,,,,,cerebral palsy|motor disorders,,,,,,,intensive bimanual intervention|intensive bimanual therapy,cerebral palsy|motor disorders,,,intensive bimanual intervention|intensive bimanual therapy,,,,,cerebral palsy|impairment|motor disorders,,,,,,,intensive bimanual intervention|intensive bimanual therapy,,,,intensive bimanual therapy,,,,cerebral palsy,none,none,none,intensive bimanual therapy,neuroimaging variables,none,motor disorders|cerebral palsy,none,cognitive impairments|perceptive impairments|behavioural impairments|communication impairments|motor disorders|cerebral palsy|sensory impairments,none,intensive bimanual intervention,none,none,intensive bimanual therapy|intensive bimanual intervention,intensive bimanual therapy|intensive bimanual intervention,none,cerebral palsy,none,cognitive impairments|uni-manual motor functions|behavioural impairments|communication impairments|arm movement issues|motor disorders|bi-manual motor functions|perceptive impairments|cerebral palsy|sensory impairments,none
70,NCT04622904,,aim|magnesium|lidocaine|ketamine,elective gynecological surgery|postoperative pain,ketamine|lidocaine|magnesium,,,,,,,elective gynecological surgery|postoperative pain,ketamine|lidocaine|magnesium,,,,,,,elective gynecological surgery|postoperative pain,ketamine|lidocaine|magnesium,,,,,,,gyne|pain|post,ketamine|lidocaine|magnesium,,,,,,,,,lidocaine-magnesium infusion|lidocaine-ketamine infusion|lidocaine infusion,,,,,"ketamine|analgesics, non-narcotic|central nervous system depressants|pain, postoperative|lidocaine|analgesics|neurotransmitter agents|pain, neuropathic|magnesium|pain, acute|pain, chronic",none,lidocaine and magnesium|lidocaine and ketamine|lidocaine alone,lidocaine and magnesium|lidocaine and ketamine|lidocaine alone,lidocaine|ketamine|magnesium,none,lidocaine and magnesium|lidocaine and ketamine|lidocaine alone,gynecological surgery|none,lidocaine|ketamine|magnesium,none,lidocaine|ketamine|magnesium,none,none,,intravenous infusions of lidocaine and ketamine|intravenous infusions of lidocaine and magnesium|intravenous infusion of lidocaine alone,intravenous infusions of lidocaine and ketamine|intravenous infusions of lidocaine and magnesium|intravenous infusion of lidocaine alone,intravenous infusions of lidocaine and ketamine|intravenous infusions of lidocaine and magnesium|intravenous infusion of lidocaine alone,none,lidocaine|ketamine|magnesium,postoperative pain,lidocaine|ketamine|magnesium
71,NCT05371041,tics|tic|tourette syndrome,monitor,tic|tics|tourette syndrome,,,,,,,deep brain stimulation|implantable neurostimulator|medtronic percept pc|subcortical closed-loop system,tic|tics|tourette syndrome,,,,,,,deep brain stimulation|devices|medtronic percept pc|subcortical closed-loop system,tic|tics|tourette syndrome stimulation,,,,,,,,ti|tics|tourette syndrome,,,,,,,deep brain stimulation|subcortical closed-loop system,,,,medtronic percept neurostimulator,,,,tourette syndrome,none,use of fda-approved medtronic percept pc device|connecting two leads placed in each brain hemisphere to two percept devices|implantation of subcortical closed-loop system|targeting the cm nucleus of the thalamus and the agpi in each brain hemisphere|monitoring of research subjects,none,targeting the cm nucleus of the thalamus and the agpi in each brain hemisphere|monitoring for detection and suppression of tics|implantation of a subcortical closed-loop system|connecting two leads placed in each brain hemisphere to two percept devices,implantable neurostimulator|thalamus|neurostimulation|neural signals recording|percept devices|agpi,none,tourette syndrome|none,medtronic percept pc|none,tourette syndrome|tics,medtronic percept pc,none,targeting the cm nucleus of the thalamus and the agpi in each brain hemisphere|implantation of the medtronic percept pc device|connection of the two leads placed in each brain hemisphere to two percept devices|implantation of a subcortical closed-loop system for detection and suppression of tics,,targeting the cm nucleus of the thalamus and the agpi in each brain hemisphere|use of fda-approved medtronic percept pc device|connection of the two leads placed in each brain hemisphere to two percept devices|implantation of subcortical closed-loop system for detection and suppression of tics,implantable neurostimulator|deep brain stimulation|medtronic percept pc device|subcortical closed-loop system for detection and suppression of tics,none,tourette syndrome,medtronic percept pc,tourette syndrome|tics,medtronic percept pc
72,NCT03518541,cerebral palsy,as,cerebral palsy,,,,,femoral derotation osteotomies|femoral derotation osteotomy,,electromagnetic tracking|electromagnetic tracking system,cerebral palsy|femoral derotation osteotomy|transversal plane femoral derotation osteotomies,,,,,,,electromagnetic tracking|electromagnetic tracking system,cerebral palsy,,,,,femoral derotation osteotomy|transversal plane femoral derotation osteotomies tracking,,electromagnetic tracking tracking,cerebral palsy|fe|transversal plane femoral derotation osteotomies,,,,,,,electromagnetic tracking|electromagnetic tracking system,,,,femoral derotation osteotomy (fdo),,,,"cerebral palsy|malalignment|gait disorders, neurologic",none,femoral derotation osteotomy,none,electromagnetic tracking||femoral derotation osteotomy,|electromagnetic tracking,base line ct or mri scan,cerebral palsy,electromagnetic tracking|none,electromagnetic tracking|femoral derotation|cerebral palsy,none,none,femoral derotation osteotomy,none,ct scan|3d gait analysis|electromagnetic tracking|mri scan|femoral derotation osteotomy,3d gait analysis|mri scan|ct scan|electromagnetic tracking system,none,cerebral palsy,none,cerebral palsy,none
73,NCT02690896,dementia,,depression,,,,support group intervention,,,,cognitive impairment|dementia|depression,,,,support group intervention,,,,cognitive impairment|dementia|depression,,,,support group intervention,,,,cognitive impairment|dementia|depression,,,,support group,,,intervention,ucf caregiver support group|community support groups,,,,,,,dementia|alzheimer's disease,none,none,none,none,none,none,cognitive impairment|dementia,none,none,none,support group intervention,,,,support group intervention,,cognitive impairment|dementia|depression,none,caregiver burden|cognitive impairment|dementia|depression,none
74,NCT03712748,,as,anxiety|eating disorders,,,,,,,imaginal exposure sessions|imaginal exposure therapy|online format of ie,anxiety|eating disorders,,,,,,,ie|imaginal exposure|imaginal exposure therapy|online format of,anxiety|eating disorders,,,,ie,,,imaginal exposure|imaginal exposure therapy|online format of,anxiety|eating disorders,,,,,,,format|ie|im|imaginal exposure,imaginal exposure therapy,,,,,,,eating disorder|anorexia nervosa|binge-eating disorder|exposure|bulimia nervosa|therapy,imaginal exposure,none,none,imaginal exposure therapy,none,none,eating disorders|anxiety,imaginal exposure|none,eating disorders|anxiety,none,imaginal exposure therapy,,,imaginal exposure therapy,imaginal exposure therapy,none,eating disorders|anxiety,none,eating disorders|anxiety,none
75,NCT05008302,stroke,aim,stroke,,,,,,,,stroke,,,,,,,,stroke,,,,,,,,stroke,,,,,,,,,,,hand motor coordination in a sitting positin,,,,stroke,none,none,none,none,none,none,stroke|none,none,none,none,none,,,none,none,none,stroke,none,stroke|movement coordination issues|hand grip strength issues,
76,NCT00283738,migraine|aura,,aura|refractory migraine|refractory migraine headache with aura,,placebo,,,biostar septal repair implant|patent foramen ovale closure|pfo closure,,,patent foramen ovale|pfo|refractory migraine|refractory migraine headache with aura|with aura,,placebo,,,,,biostar septal repair implant|biostar septal repair implant system|closure,au|refractory migraine|refractory migraine headache,,placebo,,,biostar septal repair implant|biostar septal repair implant system|patent foramen ovale closure|pfo closure,,,aura|refrac|refractory migraine,,place,,,,,biostar septal repair implant|biostar septal repair implant system|patent foramen ovale closure with the|pfo closure,,sham procedure|biostar septal repair implant system|sham procedure,,biostar septal repair implant system,,,,patent foramen ovale|migraine|aura,none,patent foramen ovale closure with the biostar septal repair implant,none,none,none,placebo,none|migraine,biostar septal repair implant|pfo,refractory migraine headache with aura|migraine,biostar septal repair implant,none,patent foramen ovale closure with the biostar septal repair implant,,patent foramen ovale closure with the biostar septal repair implant,patent foramen ovale closure with the biostar septal repair implant|pfo closure with the biostar septal repair implant system|medications,placebo,refractory migraine headache with aura|refractory migraine,none,refractory migraine headache with aura|patent foramen ovale,biostar septal repair implant
77,NCT05285852,migraine,sequel,headache|migraine|pain,,,,,,,dry needling|triggering points dry needling on sternocleidomastoid muscle,headache|migraine|mtrps|pain,,,,,,,dry needling|dry needling technique,disability|headache|migraine|pain,,,,,,,dry needling|triggering points dry needling,headache|migraine|pain|sternocleidomastoid muscle,,,,,,,dry needling|dry needling technique|points,,placebo dry needling,,dry needling,,,,migraine,none,dry needling,none,dry needling,none,none,none|migraine,dry needling|none,sternocleidomastoid muscle|disability|pain|migraine,none,none,triggering points dry needling on sternocleidomastoid muscle,,triggering points dry needling on sternocleidomastoid muscle,dry needling,none,migraine,none,disability|pain|headache|migraine,none
78,NCT01292577,schizophrenia,cannabis|cet|as,cannabis misuse|misuse cannabis|schizophrenia,,tau alone|treatment as usual,,adapted cognitive/affective remediation|affect regulation|cet|cognitive enhancement therapy|cognitive remediation|personal therapy|pt,,,,cannabis|cannabis misuse|schizophrenia,,tau alone|treatment as usual,,affect regulation|cet|cognitive/affective remediation|cognitive enhancement therapy|cognitive remediation|personal therapy|pt,,,,cannabis|schizophrenia,,tau alone|treatment as usual,,affect regulation|cet|cet pt|cognitive/affective remediation|cognitive enhancement therapy|cognitive remediation|personal therapy|pt,,,,cannabis|cannabis mis|mis|schizophrenia,,treatment as usual,,affect regulation|ce|cet|cognitive/affective remediation|cognitive enhancement therapy|cognitive remediation|personal therapy|pt|treatment as,,,,cet/pt|treatment as usual|cet/pt|treatment as usual,,,,,,,schizoaffective disorder|schizophrenia,personal therapy (pt)|cognitive enhancement therapy (cet),treatment as usual (tau)|personal therapy (pt)|cognitive enhancement therapy (cet),treatment as usual (tau)|personal therapy (pt)|cognitive enhancement therapy (cet),personal therapy (pt)|cognitive enhancement therapy (cet),personal therapy [pt]|adapted cognitive/affective remediation for cannabis misuse in schizophrenia|cognitive enhancement therapy [cet],treatment as usual (tau),schizophrenia|cannabis misuse,cognitive enhancement therapy|personal therapy,schizophrenia|cannabis misuse,none,treatment as usual (tau)|personal therapy (pt)|cognitive enhancement therapy (cet),,,treatment as usual (tau)|personal therapy (pt)|cognitive enhancement therapy (cet),personal therapy [pt]|cognitive enhancement therapy [cet]|treatment as usual (tau),tau alone,schizophrenia|cannabis misuse,cannabis,schizophrenia|cannabis misuse,cognitive enhancement therapy|personal therapy
79,NCT00572390,,estrogen,hypopituitary,oestrogen,,,,,,,hypopituitary,estrogen|oestrogen,,,,,,,hypopituitary,estrogen|oest|oestrogen,,,,,,,hypopituitary,est|o|oestrogen,,,,,,,,,oestrogen,,,,,hypopituitarism,none,none,none,none,none,without estrogen substitution|oestrogen treatment|oestrogen treatment and without estrogen substitution,hypopituitary|none,oestrogen|none,oestrogen withdrawal|hypopituitary,none,,,,,oestrogen treatment|estrogen substitution,without estrogen substitution,hypopituitarism,oestrogen,hypopituitarism,oestrogen
80,NCT05291455,status epilepticus,lacosamide,status epilepticus,lacosamide,,,,,,,status epilepticus,lacosamide,,,,,,,neonatal status epilepticus,lacosamide,,,,,,,neon,lacosamide,,,,,,,,,lacosamide|phenobarbital,,,,,epilepsy,none,none,none,lacosamide,none,none,neonatal status epilepticus|none,lacosamide|none,none,lacosamide,,,,,lacosamide,,neonatal status epilepticus,lacosamide,neonatal status epilepticus,lacosamide
81,NCT04732065,brain tumor,other,brain tumor|cancer|diffuse midline glioma|diffuse midline gliomas|newly diagnosed or recurrent diffuse midline glioma|newly diagnosed or recurrent diffuse midline gliomas|recurrent primary malignant central nervous system (cns) tumors|recurrent primary malignant cns tumors|tumor,onc206,,,,,radiation therapy,,back|brain tumor|cancer|diffuse midline glioma|diffuse midline gliomas|newly diagnosed|newly diagnosed or recurrent diffuse midline glioma|newly diagnosed or recurrent diffuse midline gliomas|recurrent)|recurrent primary malignant central nervous system (cns) tumors|recurrent primary malignant cns tumors|tumor,onc206,,,,,,radiation therapy,brain tumor|cancer|diffuse midline glioma|diffuse midline gliomas|newly diagnosed or recurrent diffuse midline glioma|newly diagnosed or recurrent diffuse midline gliomas|recurrent primary malignant central nervous system (cns) tumors|recurrent primary malignant cns tumors|tumor,onc206,,,,,radiation therapy,,brain tumor|cancer|cns) tumors|come back|diffuse midline glioma|diffuse midline gliomas|newly diagnosed|newly diagnosed or recurrent diffuse midline glioma|newly diagnosed or recurrent diffuse midline gliomas|rec|recurrent primary malignant central nervous system|recurrent primary malignant cns tumors|stress|tumor,onc206,,,,,,radiation therapy,,,onc206,,,standard of care radiation therapy|onc206|standard of care radiation therapy,,spinal cord glioma|cns tumor|recurrent malignant central nervous system neoplasm|diffuse midline glioma (dmg)|world health organization (who) grade iii glioma|recurrent ependymoma|glioblastoma|who grade iii glioma|central nervous system tumor,none,surgery: none,radiation therapy,onc206|radiation therapy,onc206,onc206 alone|onc206 in combination with radiation therapy,diffuse midline glioma|cns tumors,onc206,diffuse midline glioma tumors,onc206,none,none,onc206 in combination with radiation therapy,onc206 administration|radiation therapy,onc206 alone or in combination with radiation therapy,none,brain tumor|diffuse midline glioma tumors,onc206,diffuse midline glioma tumors,onc206
82,NCT04156607,down syndrome,balance|other|same,down syndrome,,sham taping,,,,,kinesio tape|kinesiotaping|taping,down syndrome,,sham taping,,,,,kinesio tape|kinesiotaping,down syndrome,,sham taping application,,,,,kinesio tape|kinesiotaping,down syndrome,,,,,,,kinesio tape|kinesio tape application|kinesiotaping|plantar soles|sham taping application,,sham taping|kinesio taping|sham taping,,kinesio taping,,,,balance|down syndrome,none,kinesio tape application to plantar soles|sham taping application,kinesio tape application to plantar soles|sham taping application,kinesiotaping|sham taping,kinesiotaping,sham taping application,down syndrome,kinesiotaping|kinesio,down syndrome|balance issues,none,kinesio tape application to the plantar soles|sham taping application,none,none,kinesio tape application to the plantar soles|sham taping application,kinesio tape application to the plantar soles|sham taping application,sham taping application,down syndrome,kinesio tape,down syndrome|balance issues,kinesio tape
83,NCT05706831,,,neurological diseases,,placebo,,,,,electric (tdcs) and music stimulation|music exposure|music intervention|music-listening|non-invasive brain stimulation|transcranial electrical stimulation,doc|neurological,,placebo,,,,,electric|music-listening intervention|music exposure|music intervention|music stimulation|musical intervention|non-invasive brain stimulation|tdcs|transcranial electrical stimulation,doc,,placebo,,,,,electric|music-listening intervention|music intervention|music stimulation|musical intervention|non-invasive brain stimulationuro|tdcs|transcranial electrical stimulation,doc|neurological,,place,,,,,electric|music-listening intervention|music exposure|music intervention|music stimulation|musical intervention|non-invasive brain stimulation|tdcs|transcranial electrical stimulation,,,,combinatory effect of music stimulation and neurostimulation,,,,stroke|disorder of consciousness,music stimulation,none,none,non-invasive brain stimulation|music stimulation|electric stimulation (tdcs),electric (tdcs) stimulation|non-pharmacological strategies|music stimulation,music intervention|transcranial electrical stimulation,none|neurological diseases,none,caregiver's burden|psychological distress|doc state|neurological diseases,none,music intervention|transcranial electrical stimulation,none,none,music intervention|transcranial electrical stimulation,music intervention|transcranial electrical stimulation,none,neurological diseases,none,doc state|neurological diseases,none
84,NCT03016949,polio,,,fractional dose of inactivated poliovaccine|inactivated polio vaccine|inactivated polio vaccines|inactivated poliovaccine,,,,,,,,inactivated polio vaccine|inactivated polio vaccines|inactivated poliovaccine,,,,,,,,inactivated polio vaccine|inactivated polio vaccines|inactivated poliovaccine,,,,,,,,f|inactivated polio vaccine|inactivated poliovaccine|ip|polio vaccines,,,,,,,,,ipv|f-ipv,,,,,poliomyelitis,none,intramuscular full dose of inactivated polio vaccine|intradermal fractional dose of inactivated polio vaccine,im full dose of inactivated polio vaccine|id fractional dose of inactivated polio vaccine,intramuscular administration (im)|intradermal administration (id),intradermal administration|intramuscular administration,full dose inactivated polio vaccine (ipv) via intramuscular administration (im)|fractional dose of inactivated polio vaccine (f-ipv) via intradermal administration (id),none|inactivated polio vaccine,inactivated poliovaccine|humoral immunogenicity|inactivated polio vaccine,poliovirus|humoral immunogenicity|inactivated polio vaccine|poliovaccine,f-ipv|ipv,none,,,intramuscular full dose of inactivated polio vaccine|intradermal fractional dose of inactivated polio vaccine,intramuscular full dose of inactivated polio vaccine|intradermal fractional dose of inactivated polio vaccine,intramuscular full dose of inactivated polio vaccine|intradermal fractional dose of inactivated polio vaccine,polio,inactivated poliovaccine|inactivated polio vaccine,polio,f-ipv|inactivated polio vaccine
85,NCT02631850,stroke|hemiparesis,as,chronic stroke|chronic upper extremity hemiparesis|stroke,,traditional clinic-based ci therapy,constraint induced movement therapy|gamified constraint-induced movement therapy|physical therapy|therapist-as-consultant virtual reality ci therapy,,,,modified gaming therapy|occupational therapy|rehabilitation game|telerehabilitation|virtual-reality gaming,chronic stroke|chronic upper extremity hemiparesis|stroke,,in-person therapy|occupational therapy|physical therapy|standard occupational therapy|standard ot|traditional clinic-based ci therapy,ci therapy|constraint-induced movement therapy|constraint induced movement therapy|gam|rehabilitation game,,,,in-home gamified|modified|teleconference|telerehabilitation|therapist-as-consultant virtual reality ci therapy|therapist contact|video game rehabilitation|virtual-reality gaming delivery of,chronic stroke|chronic upper extremity hemiparesis|stroke,,in-person therapy|modified gaming therapy|physical therapy|standard occupational therapy ot|standard ot pt|traditional clinic-based ci therapy,constraint induced movement therapy|gamified constraint-induced movement therapy|rehabilitation game|video game rehabilitation,,,,telerehabilitation|therapist-as-consultant virtual reality ci therapy|virtual-reality gaming,chronic stroke|chronic upper extremity hemiparesis|out|stroke,,traditional,ci therapy|clinic -|clinic-based ci therapy|constraint induced movement therapy|consultant virtual reality ci therapy|game play|home gamified constraint-induced movement therapy|modified gaming therapy|occupational therapy|physical therapy|rehabilitation game|standard occupational therapy|therapist|therapist-as-consultant virtual reality ci therapy|therapy|video game rehabilitation|virtual-reality gaming delivery,,,,- as -|based|in -|person,traditional ci therapy|gaming ci therapy|gaming ci therapy with additional contact via video conference,,,,traditional occupational therapy/physical therapy|gaming ci therapy|gaming ci therapy with additional contact via video conference|traditional ci therapy|traditional occupational therapy/physical therapy,,,stroke|hemiparesis,therapist-as-consultant virtual reality ci therapy|ci therapy|virtual reality ci therapy|therapist contact via telerehabilitation|standard occupational therapy (ot) / physical therapy (pt),"traditional clinic-based ci therapy (35 therapist/client contact hours)|therapist-as-consultant virtual reality ci therapy with additional therapist contact via telerehabilitation (5 therapist/client contact hours in the clinic, 26 therapist contact hours via teleconference, and 15 hours of independent game play in the home)|5 hours of standard occupational therapy (ot) / physical therapy (pt)|therapist-as-consultant virtual reality ci therapy (5 therapist/client contact hours in the clinic and 15 hours of independent game play at home)","traditional clinic-based ci therapy (35 therapist/client contact hours)|therapist-as-consultant virtual reality ci therapy with additional therapist contact via telerehabilitation (5 therapist/client contact hours in the clinic, 26 therapist contact hours via teleconference, and 15 hours of independent game play in the home)|5 hours of standard occupational therapy (ot) / physical therapy (pt)|therapist-as-consultant virtual reality ci therapy (5 therapist/client contact hours in the clinic and 15 hours of independent game play at home)",t-as-consultant virtual reality ci therapy|t-as-consultant virtual reality ci therapy with additional therapist contact via telerehabilitation|constraint induced movement therapy (ci therapy)|traditional clinic-based ci therapy|standard occupational therapy (ot) / physical therapy (pt),therapist-as-consultant virtual reality ci therapy|therapist-as-consultant virtual reality ci therapy with additional therapist contact via telerehabilitation|standard occupational therapy (ot) / physical therapy (pt),"traditional clinic-based ci therapy (35 therapist/client contact hours)|therapist-as-consultant virtual reality ci therapy with additional therapist contact via telerehabilitation (5 therapist/client contact hours in the clinic, 26 therapist contact hours via teleconference, and 15 hours of independent game play in the home)|5 hours of standard occupational therapy (ot) / physical therapy (pt)|therapist-as-consultant virtual reality ci therapy (5 therapist/client contact hours in the clinic and 15 hours of independent game play at home)",none|stroke|hemiparesis,ci therapy|ot|pt,stroke|chronic upper extremity hemiparesis,ci therapy|ot|pt,2) therapist-as-consultant virtual reality constraint induced movement therapy|3) therapist-as-consultant virtual reality constraint induced movement therapy with additional therapist contact via telerehabilitation|6) modified gaming therapy condition|4) standard occupational therapy|1) traditional clinic-based constraint induced movement therapy|5) standard physical therapy,none,none,therapist-as-consultant virtual reality ci therapy|modified gaming therapy condition|constraint induced movement therapy (ci therapy)|traditional clinic-based ci therapy|therapist-as-consultant virtual reality ci therapy with additional therapist contact via telerehabilitation|standard occupational therapy (ot)|physical therapy (pt),therapist-as-consultant virtual reality ci therapy|modified gaming therapy condition|virtual-reality gaming delivery of ci therapy|therapist-as-consultant virtual reality ci therapy with additional therapist contact via telerehabilitation|physical therapy (pt)|rehabilitation game without additional therapist contact|constraint induced movement therapy (ci therapy)|standard occupational therapy (ot),"modified gaming therapy condition (a stand-alone application of the rehabilitation game without additional therapist contact)|(1) traditional clinic-based ci therapy (35 therapist/client contact hours)|(3) therapist-as-consultant virtual reality ci therapy with additional therapist contact via telerehabilitation (5 therapist/client contact hours in the clinic, 26 therapist contact hours via teleconference, and 15 hours of independent game play in the home)|(2) therapist-as-consultant virtual reality ci therapy (5 therapist/client contact hours in the clinic and 15 hours of independent game play at home)|(4) 5 hours of standard occupational therapy (ot) / physical therapy (pt)",stroke|chronic upper extremity hemiparesis,none,stroke|chronic upper extremity hemiparesis,none
86,NCT00527579,neurocysticercosis,benzodiazepine,neurocysticercosis,,,,,,,,neurocysticercosis,,,,,,,,neurocysticercosisdia,,,,,,,,ne,benz|benzodiaze,,,,,,,,,[f-18]fbr,,,,,healthy|neurocysticercosis,none,none,none,none,none,none,neurocysticercosis,[f-18]fbr,none|neurocysticercosis,'none',none,,,none,"[f-18]fbr, pet imaging, peripheral benzodiazepine receptors measurement",healthy people,neurocysticercosis,benzodiazepine|[f-18]fbr,neurocysticercosis,[f-18]fbr
87,NCT05483556,aphasia,monitor,aphasia|aphasic,,,,,,,combined language therapy|combined speech therapy|conventional speech therapy|tdcs|transcranial direct current stimulation,aphasia|aphasic,,,,,,,combined language therapy|combined speech therapy|conventional speech therapy|tdcs|transcranial direct current stimulation,aphasia|aphasic,,conventional speech therapy,,,,,combined language therapy|combined speech therapy|tdcs|transcranial direct current stimulation,ap|aphasic,,,,,,,combined language therapy|combined speech therapy|conventional speech therapy|tdcs|transcranial direct current stimulation,,sham tdcs,,real tdcs,,,,stroke|aphasia,none,none,none,combined speech therapy|transcranial direct current stimulation,transcranial direct current stimulation (tdcs),conventional speech therapy alone,none|aphasia,none|speech therapy|transcranial direct current stimulation,brain network plasticity|aphasia,'none',combined language therapy and transcranial direct current stimulation (tdcs),,,transcranial direct current stimulation (tdcs)|combined language therapy,transcranial direct current stimulation (tdcs)|combined language therapy,conventional speech therapy alone,aphasia,none,aphasia,tdcs
88,NCT02473016,trigeminal neuralgia,carbon,classical trigeminal neuralgia,carbon dioxide,placebo,,,,,,classical trigeminal neuralgia,carbon,placebo,,,,,dioxide,classical trigeminal neuralgia,carbon dioxide,place,,,,,,classical trigeminal neuralgia,nasal carbon dioxide,place,,,,,,,,carbon dioxide drug delivery system (cdds),,,,,trigeminal neuralgia,none,none,none,nasal carbon dioxide,nasal carbon dioxide,placebo,classical trigeminal neuralgia,none|nasal carbon dioxide,classical trigeminal neuralgia,none,,,,nasal carbon dioxide,placebo|nasal carbon dioxide,placebo,classical trigeminal neuralgia,nasal carbon dioxide,classical trigeminal neuralgia,nasal carbon dioxide
89,NCT00936286,sleep apnea,,mild to intermediate sleep apnea syndrome|obstructive sleep apnea syndrome,,,normocapnic hyperpnea|respiratory muscle training,,,,,mild to intermediate sleep apnea syndrome|obstructive sleep apnea syndrome,,,normocapnic hyperpnea|of|respiratory muscle training,,,,,mild to intermediate sleep apnea syndrome|obstructive sleep apnea syndrome,,,respiratory muscle training,,,,normocapnic hyperpnea,mild to intermediate sleep apnea syndrome|normocapnic hyperpnea|obstructive sleep apnea syndrome,,,respiratory muscle training|respiratory muscle training by means of,,,,,,,,spirotiger,,,,obstructive sleep apnea syndrome,none,none,none,none,none,none,none|obstructive sleep apnea syndrome,respiratory muscle training|none,osas|obstructive sleep apnea syndrome,none,respiratory muscle training by means of normocapnic hyperpnea,none,,respiratory muscle training by means of normocapnic hyperpnea,respiratory muscle training by means of normocapnic hyperpnea,none,obstructive sleep apnea syndrome|sleep apnea syndrome,none,obstructive sleep apnea syndrome|mild to intermediate sleep apnea syndrome,none
90,NCT03111472,,,parkinson's disease,,,,self-management guide,,,,parkinson's disease,,,,self-management,,,guide,fall|parkinson's disease|parkinson's disease fall,,,,self-management guide|self-management guide of falling,,,,fall|parkinson's disease,,,,,,,self-management guide,,,,self-management guide for people with parkinson's who fall and their informal caregivers,,,,parkinson disease|accidental fall,none,none,none,none,none,none,parkinson's disease,parkinson's disease|none,caregiver burden|parkinson's disease|concern of falling|health related quality of life|falling,none,development and evaluation of a self-management guide,,,none,self-management guide,,parkinson's disease,none,caregiver burden|parkinson's disease|concern of falling|health related quality of life|falling,none
91,NCT00073853,,other|as,"acute, complete spinal cord injury|complete spinal cord injuries|spinal cord injury",,,,,autologous incubated macrophages|procord,,,"acute, complete spinal cord injury|complete spinal cord injuries|spinal cord injury",,,,,,,autologous incubated macrophages|incubated macrophages|procord,"acute , complete spinal cord injury|complete spinal cord injuries|sci injury",,,,,autologous incubated macrophages|macrophage|macrophages|procord,,,"acute, complete spinal cord injury|complete spinal cord injuries|non-cns tissue injury|spinal cord injury",,,,,,,autologous incubated macropha|autologous incubated macrophages|macrophages|procord,,,,autologous incubated macrophages (cell therapy),,,,spinal cord injury,none,autologous incubated macrophages,none,autologous incubated macrophages,autologous incubated macrophages,none,none|spinal cord injuries,autologous incubated macrophages|procord,complete spinal cord injuries|loss of sensory function|loss of motor function,autologous incubated macrophages,none,none,none,"autologous incubated macrophages (procord) treatment for acute, complete spinal cord injury (sci)",autologous incubated macrophages (procord),none,complete spinal cord injuries,autologous incubated macrophages|procord,complete spinal cord injuries|loss of sensory function|loss of motor function,autologous incubated macrophages (procord)
92,NCT04122989,multiple sclerosis,other|dmt,multiple sclerosis,,,,,,,ms-support|shared decision making tool|shared decision-making tool,multiple sclerosis,,,,- support|decision,,,- making tool|multiple sclerosis|shared|shared decision making tool,multiple sclerosis,,,,,,,ms-support|shared decision-making too|shared decision making tool,d|multiple sclerosis,,,,,,,decision-making tool|ms-support,,,,ms-support,,,,multiple sclerosis,none,none,none,none,none,none,multiple sclerosis,ms-support|none,multiple sclerosis|none,none,none,,,none,disease modifying|ms-support,not be given access to ms-support,multiple sclerosis,disease modifying therapies (dmt),multiple sclerosis,none
93,NCT01046370,fibromyalgia|muscle pain,as,chronic fatigue|chronic fatigue syndrome|fatigue|fibromyalgia|impaired memory|insomnia|muscle pain,,control|standard care,,2 day self-management program|amygdala retraining program|arp dvd program|arp program,,,,chronic fatigue|chronic fatigue syndrome|fatigue|fibromyalgia|insomnia|muscle pain,,c|control|standard care,amygdala|ar|mindfulness|yoga,program|retraining program,,,,"cf and|cfs ,|chronic fatigue|chronic fatigue syndrome|fatigue|fibromyalgia",,c|control|standard care,,amygdala retraining program|arp program|cognitive restructuring|mind-body practice|mindfulness based meditation|self-management program,,,,amygdala retraining program|chronic fatigue|chronic fatigue syndrome|fatigue|fi|fibromyalgia|impaired|ins|mala|muscle pain|post-exert|profound fatigue,,,amy|programming,amy|c|control|management|mind|program|re,,,(c|- body practice|amygdala retraining program|ar|arp dvd program|arp program|c,amygdala retraining program,,,,,,,fibromyalgia|chronic fatigue syndrome|chronic fatigue,yoga based breathing|cognitive restructuring via neurolinguistic programming|simple mindfulness based meditation,none,none,yoga based breathing|cognitive restructuring via neurolinguistic programming|simple mindfulness based meditation,"mind-body practices such as cognitive restructuring via neurolinguistic programming, yoga-based breathing, and simple mindfulness-based meditation",control (c),chronic fatigue syndrome,amygdala retraining program (arp)|none,post-exertional malaise|muscle pain|insomnia|profound fatigue|chronic fatigue syndrome|impaired memory,none,yoga based breathing|cognitive restructuring via neurolinguistic programming|amygdala retraining program (arp)|simple mindfulness based meditation,none,none,yoga based breathing|cognitive restructuring via neurolinguistic programming|amygdala retraining program (arp)|mindfulness based meditation,scheduled bi-monthly phone calls for support|2 day self-management program|standard clinical treatment|yoga based breathing|arp dvd program and booklet|neurolinguistic programming|amygdala retraining program (arp)|mindfulness based meditation,standard care|control (c),chronic fatigue syndrome|fibromyalgia|chronic fatigue,none,profound fatigue|chronic fatigue syndrome|chronic fatigue|post-exertional malaise|fibromyalgia|muscle pain|insomnia|impaired memory,none
94,NCT04992910,stroke,,affected upper limbs|stroke,,standard care|usual care rehabilitation,"intensive, repetitive and functional exercises|rehabilitative treatment",,,,fesia grasp|functional electrical stimulation,post-stroke|stroke,,standard care|usual care rehabilitation of upper limb,"intensive, repetitive and functional exercises assisted",,,,"""|by|fesia grasp|fesia grasp "" device|fesia grasp rehabilitation|fesia grasp therapy|functional electrical stimulation|functional electrical stimulation device",post-stroke|stroke,,standard care|usual care,"fesia grasp|fesia grasp therapy|intensive , repetitive and functional exercises assisted by functional electrical stimulation",,,,"fesia grasp|fesia grasp "" device|functional electrical stimulation|functional electrical stimulation device",affected|post-stroke|stroke|upper limbs,,,"intensive,|repetitive and functional exercises",,,,"assisted by|fesia grasp|fesia grasp "" device|fesia grasp rehabilitation|fesia grasp therapy|functional electrical stimulation|functional electrical stimulation device",,,,functional electrical stimulation through medical device|standard therapy|functional electrical stimulation through medical device|standard therapy,,,,stroke|upper extremity paresis,"standard care|intensive, repetitive and functional exercises assisted by functional electrical stimulation","standard care|fesia grasp therapy (intensive, repetitive and functional exercises assisted by functional electrical stimulation)","standard care|fesia grasp therapy (intensive, repetitive and functional exercises assisted by functional electrical stimulation)",repetitive exercises|usual care rehabilitation|intensive exercises|functional exercises|functional electrical stimulation therapy|standard care|functional electrical stimulation,none,standard care|usual care rehabilitation of upper limb,stroke,fesia grasp|none,stroke|affected upper limbs,none,"standard care|fesia grasp therapy (intensive, repetitive and functional exercises assisted by functional electrical stimulation)",none,none,"functional electrical stimulation through the fesia grasp device|standard care|fesia grasp therapy (intensive, repetitive and functional exercises assisted by functional electrical stimulation)",functional electrical stimulation through the fesia grasp device|standard care|fesia grasp therapy,standard care,stroke,none,affected upper limbs after a stroke|stroke,fesia grasp
95,NCT04291027,parkinson disease,balance,idiopathic parkinson disease|parkinson disease,,,aquatic and land-based group exercise|land based or aquatic based group exercise|land based or aquatic based group exercise program,,,,,idiopathic parkinson disease|parkinson disease,,,aquatic and|aquatic based group exercise|aquatic based group exercise program|land-based group exercise|land based,,,,,idiopathic parkinson disease|parkinson disease,,,aquatic and|land-based group exercise|land based or aquatic based group exercise,,,,,idiopathic parkinson disease|parkinson disease,,,aquatic and land-based group exercise|aquatic based group exercise|aquatic based group exercise program|land based or,,,,,,,,land based exercise|aquatic exercise,,,,parkinson disease,aquatic-based group exercise|land-based group exercise,aquatic-based group exercise|land-based group exercise,land based group exercise|aquatic based group exercise,aquatic-based group exercise|land-based group exercise,group exercise program,aquatic-based group exercise|land-based group exercise,parkinson disease,land-based|aquatic|none,balance confidence|parkinson disease|balance|walking|quality of life,none,land based group exercise|aquatic based group exercise,none,,land based group exercise|aquatic based group exercise,land based group exercise|aquatic based group exercise,land-based group exercise program|aquatic-based group exercise program,parkinson disease,none,balance confidence|parkinson disease|balance|walking|quality of life,none
96,NCT01074073,schizoaffective disorder|schizophrenia,lurasidone|lithium,schizoaffective disorder|schizophrenia,lithium|lurasidone|lurasidone hcl,,,,,,,schizoaffective disorder|schizophrenia,lithium|lurasidone|lurasidone hcl,,,,,,,schizoaffective disorder|schizophrenia,lithium|lurasidone,,,,,,,schizoaffective disorder|schizophrenia,lithium|lurasidon|lurasidone,,,,,,,,,lurasidone hcl,,,,,schizophrenia,none,none,none,lurasidone 120 mg qd|lithium 600 mg bid,none,lurasidone 120 mg qd|lithium 600 mg bid|lithium 600 mg bid and lurasidone 120 mg qd,schizophrenia|schizoaffective disorder,lurasidone|lithium,schizophrenia|schizoaffective disorder,lurasidone|lithium,,,,none,lurasidone 120 mg qd|lithium 600 mg bid|lurasidone hcl,lurasidone 120 mg qd|lithium 600 mg bid,schizophrenia|schizoaffective disorder,lurasidone|lurasidone hcl|lithium,schizophrenia|schizoaffective disorder,lurasidone hcl|lithium
97,NCT04474171,,aim|as,spinal cord injury,,usual care,,online self-management program|sci&u|trained peer health coaches,,,,injury|pressure|spinal cord injury,,usual care,,based|online self-management program|online self-management program incorporating trained peer health coaches|sci & u|sci & u intervention|self-management programs,,,,spinal cord injury,,usual care,,"online self-management program|peer health coaches|sci & u|self-management programs health information , skills and telephone-based support|trained",,,,pressure ul|spinal cord injury|tract|ur,,usual,,online self-management program|peer health coaches|self-management,,,- based support|care|programs|sci & u|trained,sci&u online health coaching program,,,,,,,spinal cord injuries,telephone-based support|health information provision|skill acquisition|self-management programs,none,none,none,online self-management program (sci&u)|trained peer health coaches,sci&u intervention|usual care,pressure ulcer|spinal cord injury|urinary tract infection|pneumonia|none,sci&u,urinary tract infection|pneumonia|pressure ulcer,none,telephone-based support|trained peer health coaches|online self-management program for spinal cord injury: sci&u,none,none,none,trained peer health coaches|online self-management program|sci&u intervention,usual care,urinary tract infection|pneumonia|pressure ulcer|spinal cord injury,none,urinary tract infection|pneumonia|pressure ulcer|spinal cord injury,none
98,NCT04404439,migraine|tinnitus,no|as,anxiety|depression|stress|tinnitus,,,,,,,migraine medications,anxiety|depression|stress|tinnitus,migraine medications,,,,,,,anxiety|depression|migraine|stress|tinnitus,,,,,,,,anxiety|depression|migraine|stress|tinnitus,,,,,,,,,placebo,nortriptyline + topiramate|verapamil + paroxetine,,,,,"tinnitus|tinnitus, subjective",none,none,none,medications,pharmacological interventions,none,tinnitus|migraine,migraine medications|none,anxiety|stress|depression|tinnitus|migraine,none,none,none,none,none,migraine medications,none,stress|migraine|depression|somatic disorders|tinnitus|psychological disorders|anxiety,none,anxiety|depression|somatic disorders|tinnitus|psychological disorders|stress,none
99,NCT00248222,stroke,,minor ischemic stroke,,,supervised aerobic exercise program,,,,,minor ischemic stroke,,,early supervised aerobic exercise program,,,,,minor ischemic stroke,,,,,,,,minor ischemic stroke,,,supervised aerobic exercise program,,,,,supervised aerobic training,,,,,,,stroke|cerebrovascular accident,none,none,none,none|supervised aerobic exercise,none,none,minor ischemic stroke,none,none,none,none,,,early supervised aerobic exercise program,early supervised aerobic exercise program,,minor ischemic stroke,,minor ischemic stroke,none
100,NCT03127514,,tudca|tauroursodeoxycholic acid|phenylbutyrate,als,amx0035|phenylbutyrate|tauroursodeoxycholic acid,placebo,,,,,,als,amx0035|phenylbutyrate|tauroursodeoxycholic acid,placebo,,,,,,als,amx0035|phenylbutyrate|tauroursodeoxycholic acid,place,,,,,,als,amx0035|phenylbutyrate|tauroursodeoxycholic acid|tu,place,,,,,,,placebo,amx0035,,,,,neuromuscular diseases|central nervous system diseases|motor neuron disease|tdp-43 proteinopathies|nervous system diseases|amyotrophic lateral sclerosis|neurodegenerative diseases|spinal cord diseases,none,pb and tudca,none,tauroursodeoxycholic acid (tudca)|phenylbutyrate (pb),tauroursodeoxycholic acid (tudca)|phenylbutyrate (pb),placebo|amx0035,als,phenylbutyrate|tauroursodeoxycholic acid|amx0035,none|als,phenylbutyrate|tauroursodeoxycholic acid|amx0035,none,,,none,phenylbutyrate (pb)|tauroursodeoxycholic acid (tudca)|amx0035,placebo,als,phenylbutyrate|tauroursodeoxycholic acid|amx0035,als,phenylbutyrate (pb)|tauroursodeoxycholic acid (tudca)|amx0035
101,NCT01611987,multiple sclerosis,other|aim|as,multiple sclerosis,,general guideline|general guidelines|program based on general guidelines for exercise,exercise|ms tailored exercise program|physical activity|targeted exercise,,,,,fatigue|multiple sclerosis,,general guideline|general guideline approach|general guideline program|general guidelines|program based on general guidelines for exercise,exercise|ms tailored exercise program|mstep program|targeted exercise,,,,,fatigue|multiple sclerosis,,general guideline|general guideline approach|general guideline program|general guidelines|general guidelines for exercise,exercise|ms tailored exercise program|mstep based on,,,,,disabilities|multiple sclerosis|obesity,,,exercise|for|guideline program|ms tailored exercise program|mstep program|physical|targeted exercise,,,,,,,,mstep|general guideline approach,,,,multiple sclerosis,targeted exercise|illness intrusiveness|exercise enjoyment|functional ambulation|fatigue symptoms|strength|health perception|quality of life|exercise capacity|exercise efficiency|ms tailored exercise program (mstep)|exercise self-efficacy|mood|global physical function|general guidelines for exercise,none,none,program based on general guidelines for exercise|ms tailored exercise program (mstep),none,program based on general guidelines for exercise|ms tailored exercise program (mstep),obesity|diabetes|multiple sclerosis|osteoporosis|heart disease|none,ms|mstep|multiple sclerosis|exercise,illness intrusiveness|intensity of fatigue symptoms|functional ambulation|fatigue symptoms|multiple sclerosis|health perception|strength|exercise capacity|frequency of fatigue symptoms|exercise efficiency|mood|global physical function,none,ms tailored exercise program (mstep),none,none,targeted exercise|ms tailored exercise program (mstep)|functional ambulation|exercise capacity measured using cycle ergometry|strength training,ms tailored exercise program (mstep)|general guidelines for exercise,a program based on general guidelines for exercise,obesity|diabetes|multiple sclerosis|osteoporosis|heart disease,none,illness intrusiveness|mood|fatigue symptoms|multiple sclerosis|health perception|global physical function,none
102,NCT04948736,sarcopenia,,metabolic syndrome|sarcopenia|sarcopenic,,conventional medical care,multidisciplinary combined exercise,,,,combined exercise-nutrition intervention|nutrition intervention,metabolic syndrome|sarcopenia|sarcopenic,,conventional medical care,combined exercise-nutrition intervention|multidisciplinary combined exercise and nutrition,intervention,,,,metabolic syndrome|sarcopenia|sarcopenic,,conventional medical care,combined exercise-nutrition intervention|combined exercise and nutrition intervention|multi,,,,,metabolic syndrome|sar|sarcope|sarcopenia,,,combined exercise-nutrition intervention|combined exercise and nutrition intervention|multidis,,,,,,,,combined exercise and nutrition intervention|conventional medial care,,,,sarcopenia,none,none,none,combined exercise-nutrition intervention,nutrition intervention,conventional medical care,metabolic syndrome|none|sarcopenia,dexa|none,metabolic syndrome|sarcopenia,none,combined exercise-nutrition intervention,none,none,combined exercise-nutrition intervention,nutritional assessment|conventional medical care|combined exercise-nutrition intervention,conventional medical care,metabolic syndrome|sarcopenia,none,knee extensor muscle power|activities of daily living|gait speed|handgrip strength|quality of life|physical performance|sarcopenia|nutritional assessment|metabolic syndrome|muscle mass,none
103,NCT00164658,,,,,,,prevention prompts tailored to familial risk|tools for health promotion and disease prevention,,,familial risk assessment,,,,,risk assessment|to familial risk,,,and|familial|prevention prompts tailored,,,,,familial risk assessment and prevention prompts tailored to familial risk,,,,,,,,familial risk|prevention|promotion,,,fa,familial risk assessment and personalized prevention messages,,,,,,,stroke|coronary heart disease|diabetes|ovarian cancer|breast cancer|colorectal cancer,none,none,none,none,none,none,none,none|familial risk assessment,none,none,prevention prompts tailored to familial risk|familial risk assessment,,,none,prevention prompts tailored to familial risk|familial risk assessment,none,none,,none,
104,NCT03172663,hearing loss,,hearing loss|increased body mass index|obesity,,,,,,,,hearing loss|obesity,,,,,,,,hearing loss|o,,,,,,,,hearing loss|obesity,,,,,,,body mass index,,,,pure tone audiometry,,,,hearing loss,none,none,none,none,none,none,obesity|hearing loss,obesity|none,obesity|hearing loss,none,,,,,,,obesity|increased body mass index|hearing loss,none,obesity|hearing loss,
105,NCT04579783,numbness,aim|as,carpal tunnel syndrome|pain,corticosteroid|dextrose|platelet rich plasma|saline,,,,,,ultrasound guided intracarpal hydro-dissection,carpal tunnel syndrome,5|corticosteroid|dextrose,normal saline,,,rich plasma,,hydro-dissection|platelet|ultrasound guided intracarpal hydro-dissection of,carpal tunnel syndrome|pain,corticosteroid|dextrose,normal saline,,,dextrose hydro-dissection|platelet rich plasma,,rep|ultra guided in hydro-dissection,carpal tunnel syndrome|pain|thumb,co|dextrose,,,,,,electrical nerve|hydro|hydro-dissection|repeated,,,triamcinolone acetonide|dextrose 5% in water,,,,,carpal tunnel syndrome,physical modalities|splinting|medication|injection,corticosteroid injection|repeated dextrose hydro-dissection|corticosteroid injection and repeated dextrose hydro-dissection,corticosteroid injection|5% dextrose injection,ultrasound|separated by the|low power laser|symbol|injection|transcutaneous electrical nerve stimulation|surgery,platelet rich plasma|medication|injection,corticosteroid injection|5% dextrose injection|corticosteroid injection and 5% dextrose injection,carpal tunnel syndrome|none,dextrose|corticosteroid,tingling|numbness|carpal tunnel syndrome|pain|decreased grip strength|thumb weakness,corticosteroid|5% dextrose,none,none,none,corticosteroid injection|5% dextrose injection|ultrasound guided intracarpal hydro-dissection of median nerve,normal saline injection|corticosteroid injection|5% dextrose injection|platelet rich plasma injection,corticosteroid injection|5% dextrose injection,carpal tunnel syndrome,dextrose|corticosteroid,middle or ring fingers|numbness|tingling of the thumb and index|carpal tunnel syndrome|pain|decreased grip strength|thumb weakness,corticosteroid|5% dextrose
106,NCT05741853,aphasia,ppa|aim,primary progressive aphasia|progressive aphasia,,not receive intervention,,,,,culturally and linguistically tailored speech-language interventions|tailored speech-language intervention,difficulties|primary progressive aphasia|progressive aphasia,,,,behavioral cognitive-linguistic testing,,,culturally and linguistically tailored speech-language interventions|speech-language treatment|tailored speech-language intervention,difficulties with and language|primary progressive aphasia|progressive aphasia,,,,,,,culturally andally tailored speech-language interventions|speech-language treatment|tailored speech-language intervention,bilingual|difficulties|primary progressive aphasia|progressive aphasia,,,,,,,and linguistically tailored speech-language interventions|speech-language treatment|tailored speech-language intervention,video-implemented script training for aphasia (vista)|lexical retrieval training (lrt),,,,,,,"neurocognitive disorders|primary progressive aphasia|language disorders|aphasia|dementia, frontotemporal|bilingual aphasia|apraxia, motor|dysarthria|communication disorders|alzheimer disease|speech disorders|frontotemporal lobar degeneration|dementia|neurodegenerative diseases",tailored speech-language intervention administered in both languages,none,none,tailored speech-language intervention administered in both languages,tailored speech-language intervention administered in both languages to bilingual individuals with ppa,behavioral cognitive-linguistic testing without intervention,primary progressive aphasia|none,monolinguals|none,primary progressive aphasia|difficulties with speech and language,none,culturally and linguistically tailored speech-language interventions|tailored speech-language intervention administered in both languages to bilingual individuals with ppa,none,none,culturally and linguistically tailored speech-language interventions|magnetic resonance image,tailored speech-language intervention administered in both languages|culturally and linguistically tailored speech-language interventions|magnetic resonance image|speech-language treatment,30 bilingual individuals with ppa completing behavioral cognitive-linguistic testing and not receiving intervention,primary progressive aphasia,none,primary progressive aphasia|difficulties with speech|language problems,none
107,NCT04121780,,growth hormone,growth hormone deficiency,growth hormone,placebo,,,,,,growth hormone deficiency,growth hormone,placebo,,,,,replacement therapy,growth hormone deficiency,growth hormone|growth hormone replacement therapy,place,,,,,,growth hormone deficiency,growth hormone|hormone,place,,,,,growth|replacement therapy,,placebo,growth hormone,,,,,"tbi (traumatic brain injury)|sport injury|hypopituitarism|concussion, brain|anterior pituitary hyposecretion syndrome|growth hormone deficiency",none,growth hormone replacement therapy,none,growth hormone (gh),none,placebo,growth hormone deficiency,growth hormone|none,growth hormone deficiency|cognitive functions,'growth hormone',,,,growth hormone replacement therapy,growth hormone replacement therapy,placebo,growth hormone deficiency,growth hormone,growth hormone deficiency,growth hormone
108,NCT04308577,brain injury,oxygen|as,brain injury|severe brain injury,,,,,,,diet induced ketosis|ketogenic diet|ketogenic diet therapy|ketosis|mct supplementation,brain injury|severe brain injury|tbi,mct,,,,,,diet induced ketosis|ketogenic diet|ketogenic diet therapy|ketosis,brain injury|severe brain injury|tbi,mct,,,,,,diet in ketosis|ketogenic diet|ketosis,brain injury|deficiency|severe brain injury,mc,,,,,,diet|ketogenic diet|ketogenic diet therapy|ketosis,,,,ketogenic diet with added mct,,,,stroke|subarachnoid hemorrhage|brain injuries|traumatic brain injury|anoxic brain injury|neuroinfections,ketogenic diet therapy,none,none,mct supplementation|ketogenic diet,mct supplementation,none,brain injury|none,none,brain cells|severe brain injury|acid formation in the brain|local oxygen deficiency,'mct supplementation',ketosis|ketogenic diet therapy for patients with severe brain injury for six weeks,none,none,ketogenic diet therapy with mct supplementation for six weeks,ketogenic diet with mct supplementation,none,brain injury,none,severe brain injury|acid formation in the brain|brain injury|local oxygen deficiency,none
109,NCT01259388,multiple sclerosis,carbonate|lithium,progressive forms of multiple sclerosis|progressive multiple sclerosis,lithium|lithium carbonate,,,,,,,progressive forms of multiple sclerosis|progressive multiple sclerosis,lithium|lithium carbonate,,,,,,,progressive forms of multiple sclerosis|progressive multiple sclerosis,lithium|lithium carbonate,,,,,,,progressive forms of multiple sclerosis|progressive multiple sclerosis,lithium|lithium carbonate,,,,,,,,,lithium carbonate,,,,,multiple sclerosis,none,none,none,none,none,none,progressive multiple sclerosis,lithium carbonate,progressive multiple sclerosis,lithium carbonate,,,,none,lithium carbonate,,multiple sclerosis|progressive multiple sclerosis,lithium carbonate|lithium,progressive multiple sclerosis,lithium carbonate
110,NCT02866240,seizure|epilepsy|seizures|focal epilepsy,as,focal seizure|medically-refractory focal neocortical epilepsy|medically-refractory neocortical epilepsy|refractory focal epilepsy|seizure|seizures,,,,,,,cathodal tdcs|cathodal transcranial direct current stimulation|tdcs|transcranial direct current stimulation,focal seizure|medically-refractory focal neocortical epilepsy|medically-refractory neocortical epilepsy|refractory focal epilepsy|seizure,,,,,,,cathodal tdcs|cathodal transcranial direct current stimulation|tdcs,focal seizureile|medically-refractory focal neocortical epilepsy|medically-refractory neocortical epilepsy|refractory focal epilepsy|seizure,,,,,,,cathodal tdcs|cathodal transcranial direct current stimulation|tdcs|transcranial direct current stimulation,focal|focal seizure|medical|medically-refractory neocortical epilepsy|refractory focal epilepsy|refractory focal neocortical epilepsy|seizure|seizures,,,,,,,cathodal tdcs|cathodal transcranial direct current stimulation|tdcs,,,,cathodal transcranial direct current stimulation (tdcs).,,,,refractory epilepsy,cathodal transcranial direct current stimulation (tdcs),cathodal transcranial direct current stimulation (tdcs),cathodal tdcs administered to the seizure focus for 10 sessions over a 2-week period with the allowance of make-up sessions in week three,cathodal transcranial direct current stimulation (tdcs),antiepileptic drugs|none,current antiepileptic drugs,focal epilepsy|none,antiepileptic drugs|none,focal spikes|focal epilepsy|focal seizure onsets,none,cathodal transcranial direct current stimulation (tdcs) administered to the seizure focus for 10 sessions over a 2-week period with the allowance of make-up sessions in week three,none,none,cathodal transcranial direct current stimulation (tdcs) for 10 sessions over a 2-week period,antiepileptic drugs|cathodal transcranial direct current stimulation (tdcs),none,refractory focal epilepsy|seizure|medically-refractory focal neocortical epilepsy,none,refractory focal epilepsy|focal spikes|seizure frequency|focal seizure onsets,cathodal transcranial direct current stimulation (tdcs)
111,NCT00381537,epilepsy,phenobarbitone|carbamazepine,epilepsy,carbamazepine|phenobarbitone,,,,,,,epilepsy,carbamazepine|phenobarbitone,,,,,,,epilepsy,carbamazepine|phenobarbitone,,,,,,,epilepsy,carbamazepine|ph,,,,,,,,,phenobarbitone|carbamazepine,,,,,epilepsy,none,none,none,phenobarbitone|carbamazepine,phenobarbitone|carbamazepine,symbol:|returning them in a list separated with the|carbamazepine|ed controlled trial of the use of phenobarbitone and carbamazepine in childhood epilepsy in bangladesh with particular reference to behavioural side effects are phenobarbitone and carbamazepine|phenobarbitone,none|epilepsy,phenobarbitone|carbamazepine,behavioural side effects|childhood epilepsy,phenobarbitone|carbamazepine,,,,none,phenobarbitone|carbamazepine,none,childhood epilepsy,phenobarbitone|carbamazepine,behavioural side effects|childhood epilepsy,phenobarbitone|carbamazepine
112,NCT03529708,,aim,metastatic epidural spinal cord compression|pain|spinal cord compression|spinal metastasis|tumour,,,,,,3d conformal palliative rt|3d conformal radiotherapy|3d crt|radiotherapy|stereotactic body radiotherapy,,advanced malignancy|metastatic epidural spinal cord compression|pain|spinal cord compression|spinal metastasis|tumour,,,,,,,3d conformal palliative rt|3d conformal radiotherapy|3d crt|3dcr|conformal palliative rt|stereotactic body radiotherapy,metastatic epidural spinal cord compression|pain|spinal cord compression|spinal metastasis|t,,radiotherapy|surgical decompression,,,,3d conformal palliative rt|3d conformal radiotherapy|3d crt|stereotactic body radiotherapy,,advanced malignan|am|metastatic epidural spinal cord compression|pain|q|sb|spinal cord compression|spinal metastasis,,,,,,,3d conformal palliative rt|radiotherapy|sequential sbrt boost|stereotactic body radiotherapy|urgent 3d conformal radiotherapy|urgent 3d crt|urgent 3dcrt,,,,,,3d crt plus sbrt boost,,spinal cord compression|cauda equina syndrome|stereotactic body radiotherapy,none,surgical resection|surgical decompression,3d conformal radiotherapy|sbrt,3d conformal radiotherapy (3dcrt)|sbrt|3dcrt|stereotactic body radiotherapy (sbrt),none,3d conformal palliative rt (3dcrt) alone,metastatic epidural spinal cord compression|none,3d conformal radiotherapy|sbrt|none,ambulation|neurologic symptoms|motor function|pain|spinal cord compression|quality of life,3d crt|sbrt,none,none,sbrt boost to urgent 3d crt|urgent 3d conformal radiotherapy|3d conformal palliative rt (3dcrt)|stereotactic body radiotherapy (sbrt) boost,3d conformal radiotherapy (3dcrt)|stereotactic body radiotherapy (sbrt),3d conformal palliative rt (3dcrt)|stereotactic body radiotherapy (sbrt),3d conformal palliative rt (3dcrt) alone|surgical decompression,advanced malignancy|uncontrolled systemic disease|metastatic epidural spinal cord compression|spinal metastasis,none,poor performance status|neurologic symptoms|uncontrolled systemic disease|metastatic epidural spinal cord compression|pain,none
113,NCT03385174,,carbon|as,headache,,,,,,,,headache|monoxide,carbon|carbon monoxide,,,,,,,carbon monoxideache,carbon monoxide,,,,,,,carbon|carbon monoxide headache,monoxide,,,,,,,,,,carbon monoxide,,,,headache disorders,none,none,none,none,none,none,studying carbon monoxide effects on brain vessels in healthy volunteers with magnetic resonance imaging|effects on the brain's vessels and blood flow|carbon monoxide headache triggering properties,carbon monoxide|none,effects on the brain's vessels|headache|blood flow,none,,,,none,carbon monoxide effects on brain vessels with magnetic resonance imaging,,carbon monoxide headache,carbon monoxide,carbon monoxide headache|effects on the brain's vessels|effects on blood flow,carbon monoxide
114,NCT04777500,fibromyalgia,,fibromyalgia|pain,,,,,,,transcutaneous auricular vagus nerve stimulation|transcutaneous electrical nerve stimulation,fibromyalgia|fibromyalgia pain,,,,,,,transcutaneous auricular vagus nerve stimulation|transcutaneous electrical nerve stimulation,fibromyalgia|fibromyalgia pain,,,,,,,tens stimulation|transcutaneous auricular vagus nerve stimulation|transcutaneous electrical nerve stimulation,fi|fibromyalgia|pain,,,,,,,electrical stimulation tool|transcutaneous auricular vagus nerve stimulation|transcutaneous electrical nerve stimulation,,,,auricular transcutaneous electrical nerve stimulation device,,,,fibromyalgia,none,none,none,transcutaneous electrical nerve stimulation (tens)|transcutaneous auricular vagus nerve stimulation,transcutaneous electrical nerve stimulation (tens),none,fibromyalgia,tens|none,fibromyalgia|fibromyalgia pain,none,transcutaneous electrical nerve stimulation (tens)|transcutaneous auricular vagus nerve stimulation,none,,transcutaneous electrical nerve stimulation (tens)|transcutaneous auricular vagus nerve stimulation,transcutaneous electrical nerve stimulation (tens)|transcutaneous auricular vagus nerve stimulation,none,fibromyalgia,none,fibromyalgia|fibromyalgia pain,none
115,NCT02160249,schizophrenia,,schizophrenia,,facility-based care alone,,,,,community-based rehabilitation|facility-based care|rehabilitation intervention,schizophrenia,,facility-based care alone,,community-based rehabilitation|facility-based care|intervention,,,rehabilitation,disability|schizophrenia,,facility-based care alone,rehabilitation intervention,community-based rehabilitation|facility-based care,,,,schizophrenia,,,,,,,community-based rehabilitation plus|facility-based care|facility-based care alone|rehabilitation intervention,community-based rehabilitation,,,facility based care,,,,schizophreniform disorder|schizoaffective disorder|schizophrenia spectrum disorder|schizophrenia,none,none,none,none,none,community-based rehabilitation plus facility-based care|facility-based care alone,schizophrenia|none,none|rise,schizophrenia|disability,none,facility-based care|community-based rehabilitation,none,,facility-based care|community-based rehabilitation,facility-based care|community-based rehabilitation,facility-based care alone,schizophrenia,none,schizophrenia|disability related to schizophrenia,none
116,NCT00135993,restless legs,rotigotine,idiopathic restless legs syndrome|idiopathic restless legs syndrome.|restless legs syndrome,rotigotine|spm 936,placebo,,,,,,idiopathic restless legs syndrome|restless legs syndrome,rotigotine|spm 936,placebo,,,,,,idiopathic restless legs syndrome|rlslessgsdrome,rotigotine|spm 936,placebo,,,,,,idiopathic restless legs syndrome|restless legs syndrome,rotigotine|spm,place,,,,,,,,rotigotine,,,,,restless legs syndrome,none,none,225mg/day rotigotine|675mg/day rotigotine|45mg/day rotigotine|1125mg/day rotigotine,none,none,placebo|675mg/day rotigotine|45mg/day rotigotine|225mg/day rotigotine|1125mg/day rotigotine,restless legs syndrome|none,none|rotigotine,restless legs syndrome|rls,none|rotigotine,none,none,none,transdermal doses of rotigotine 675mg/day|transdermal doses of rotigotine 45mg/day|transdermal doses of rotigotine 225mg/day|transdermal doses of rotigotine 1125mg/day,placebo|rotigotine,placebo,idiopathic restless legs syndrome,placebo|rotigotine,idiopathic restless legs syndrome,rotigotine
117,NCT04330482,dementia,,dementia,,,,,,,care-well app|mobile application|mobile health (mhealth) app,dementia,,,,,,,care-well app|caregiver|mobile application|mobile health (mhealth) app,dementia,,,,,,,care-well app|mhealth) app|mobile application|mobile health (,dementia,,,,,,,care|care-well app|developed|interventions|mhealth) app|mobile application|mobile health,care-well app|internet links,,,,,,,dementia|caregiver burnout|alzheimer disease,none,none,none,none,none,none,dementia|none,care-well app|none,dementia|care-well app|informal dementia caregivers|feasibility trial|acceptability|intervention|outcome measures|mobile application|caregiver|feasibility,none,none,,,none,mhealth app|care-well app,none,dementia,none,dementia,none
118,NCT01609348,neurodegenerative disease,venlafaxine|balance|date|as|norepinephrine|serotonin,alzheimer's disease|depression|major depression,venlafaxine,,,,,,,alzheimer's disease|alzheimer's disease|depression,venlafaxine,,,,,,,alzheimer's disease|alzheimer's disease|depression|major depression,venlafaxine,,,,,,,alzheimer's disease|alzheimer's disease|depression|major depression,ve,,,,,,,,placebo,venlafaxine,,,,,depression|alzheimer's disease,none,none,none,none,none,psychosocial interventions|psychotropic medications,alzheimer's disease|depression,venl|venlafaxine,alzheimer's disease|depression,venlafaxine,none,none,none,none,venlafaxine,none,alzheimer's disease|depression,venlafaxine,depression in alzheimer's disease|alzheimer's disease,venlafaxine
119,NCT04185038,supratentorial tumors,other,diffuse intrinsic pontine glioma|diffuse midline glioma|infratentorial or metastatic/leptomeningeal tumors|recurrent or refractory cns tumors|recurrent or refractory pediatric central nervous system tumors|supratentorial tumors|tumor,,,,,autologous cd4+ and cd8+ t cells lentivirally transduced to express a b7h3-specific chimeric antigen receptor (car) and egfrt|b7-h3 car t cell|b7-h3-specific car t cell|b7h3-specific car t cells|car t cell|car t cells|second-generation car t cell|t cells,,,b7|diffuse intrinsic pontine glioma|diffuse midline glioma|infratentorial|metastatic/leptomeningeal tumors|recurrent or refractory cns tumors|recurrent or refractory pediatric central nervous system tumors|supratentorial tumors|tumor|tumor resection,,,,,,,- generation|- specific chimeric antigen receptor (car) and|autologous cd4 + and cd8 + t cells lentivirally transduced to express a b7|b7-h3-specific car t cell locoregional immunotherapy|b7h3-specific car t cells|car t cell|car t cells|central nervous system (cns) locoregional adoptive therapy with|egfrt|t cells,diffuse intrinsic pontine glioma|diffuse midline glioma|infratentorial or metastatic/leptomeningeal tumors|recurrent or refractory cns tumors|recurrent or refractory pediatric central nervous system tumors|supratentorial tumors|tumor,,,,,autologous cd4 + and cd8 + t cells lentivirally transduced to express a b7h3-specific chimeric antigen receptor car egfr|b7-h3-specific car t cell locoregional immunotherapy|car t cells|car t tumor|central nervous system (|cns) locoregional adoptive therapy|newly engineered t cells|t,,,arm c|arms a|autologous cd4 + and cd8 + t cells|b|chimeric antigen receptor|diffuse intrinsic pontine glioma|diffuse midline glioma|in|metastatic/leptomeningeal tumors|rec|supratentorial tumors|tumor,,,,,car t|car t cell|t cells,,,,,scri-carb7h3(s); b7h3-specific chimeric antigen receptor (car) t cel,,,,,"diffuse midline glioma|medulloblastoma, childhood|glioma|diffuse intrinsic pontine glioma|ependymoma|pineoblastoma, childhood|germ cell tumor|atypical teratoid/rhabdoid tumor|choroid plexus carcinoma|primitive neuroectodermal tumor|central nervous system tumor",none,"t cells collected and bioengineered into a second-generation car t cell|dose of car t cells every other week for 3 weeks, followed by a week off, examination period, and then dosing every other week for 3 weeks|opportunity to continue receiving additional courses of car t cells if patient has not had adverse effects and if more t cells are available|weekly doses of car t cells for three weeks, followed by a week off, examination period, and then another course of weekly doses for three weeks|locoregional adoptive therapy with autologous cd4+ and cd8+ t cells|treatment delivered into the tumor resection cavity or ventricular system|please ted above|patients receive car t cells via indwelling catheter for two courses|patients assigned to one of 3 treatment arms based on location or type of tumor|mri evaluation after two courses","patients in arm a will receive treatment into the tumor cavity|newly engineered t cells will be administered via the indwelling catheter for two courses|if none is found, return only the word 'none'|patients will be assigned to one of 3 treatment arms based on location or type of their tumor|patients in arm c will have treatment delivered into the ventricular system|patients in arm c will receive a dose of car t cells every other week for 3 weeks, followed by a week off, an examination period, and then dosing every other week for 3 weeks|locoregional adoptive therapy with autologous cd4+ and cd8+ t cells lentivirally transduced to express a b7h3-specific chimeric antigen receptor (car) and egfrt|patients in arm b will have treatment delivered into the ventricular system|patients in arms a and b will receive a weekly dose of car t cells for three weeks, followed by a week off, an examination period, and then another course of weekly doses for three weeks|car t cells delivered via an indwelling catheter into the tumor resection cavity or ventricular system",mri evaluation of car t cell effect|b7h3-specific chimeric antigen receptor (car) t cells|weekly doses of car t cells for three weeks|dosing every other week for 3 weeks|evaluation of disease response to b7-h3 car t cell locoregional therapy|locoregional adoptive therapy with autologous cd4+ and cd8+ t cells|indwelling catheter delivery into tumor resection cavity or ventricular system|second-generation car t cell targeting b7h3-expressing tumor cells|evaluation of car t cell distribution in cerebrospinal fluid (csf),"treatment delivery into the tumor cavity or ventricular system based on tumor location or type|administration of car t cells via an indwelling catheter into the tumor resection cavity or ventricular system|disease response evaluation to b7-h3 car t cell locoregional therapy|evaluation of car t cell distribution in the cerebrospinal fluid (csf) and peripheral circulation|adoptive therapy with autologous cd4+ and cd8+ t cells lentivirally transduced to express a b7h3-specific chimeric antigen receptor (car) and egfrt|dosing schedule of car t cells for two courses with specific intervals and examination periods|second-generation car t cell therapy targeting b7h3-expressing tumor cells|not behavioral, surgical, radiotherapy, or physical",arm c|arm b: treatment delivered into the ventricular system for patients with either infratentorial or metastatic/leptomeningeal tumors|arm b|arm a: treatment delivered into the tumor cavity for patients with supratentorial tumors|arm a|arm c: treatment delivered into the ventricular system for patients with diffuse intrinsic pontine glioma (dipg),diffuse midline glioma|diffuse intrinsic pontine glioma|pediatric central nervous system tumors,b7-h3-specific car t cell|none,refractory pediatric central nervous system tumors|dipg|cns tumors|diffuse midline glioma|diffuse intrinsic pontine glioma|recurrent pediatric central nervous system tumors,b7h3-expressing,,cns catheter placement into the tumor resection cavity or into the ventricular system|administration of car t cells via the indwelling catheter into the tumor cavity or ventricular system,none,"car t cells delivered via an indwelling catheter into the tumor resection cavity or ventricular system|treatment delivered into the ventricular system for patients with either infratentorial or metastatic/leptomeningeal tumors|weekly dose of car t cells for three weeks, followed by a week off, an examination period, and then atered through an indwelling cns catheter or delivered directly into the brain via indwelling catheter|treatment delivered into the ventricular system for patients with dipg|administration of newly engineered t cells via the indwelling catheter for two courses|bioengineered t cells that target b7h3-expressing tumor cells|locoregional adoptive therapy with autologous cd4+ and cd8+ t cells lentivirally transduced to express a b7h3-specific chimeric antigen receptor (car) and egfrt|treatment delivered into the tumor cavity for patients with supratentorial tumors",b7h3-specific car t cells|b7-h3-specific car t cell locoregional immunotherapy|autologous cd4+ and cd8+ t cells lentivirally transduced to express a b7h3-specific chimeric antigen receptor (car) and egfrt,none,refractory pediatric central nervous system tumors|leptomeningeal tumors|diffuse intrinsic pontine glioma|supratentorial tumors|metastatic tumors|infratentorial tumors|diffuse midline glioma|recurrent pediatric central nervous system tumors,b7-h3-specific car t cell|b7h3-specific car t cells|egfrt car t cells|b7h3-specific chimeric antigen receptor (car)|b7-h3 car t cell,diffuse midline glioma|diffuse intrinsic pontine glioma|recurrent pediatric central nervous system tumors|refractory pediatric central nervous system tumors,b7-h3-specific car t cell|egfrt|b7h3-specific chimeric antigen receptor (car)
120,NCT00373087,,aim|entacapone,parkinson's disease,entacapone,,,,,,,parkinson's disease,entacapone,,,,,,,parkinson's disease,entacapone|entacaponeparkinsonia,,,,,,,parkinson's disease,cat|en|entacapone,,,,,,,,l dopa versus placebo,entacapone,,,,,parkinson's disease,none,none,none,antiparkinsonian drug|genetic polymorphism|l-dopa metabolism|c-o-methyltransferase (comt) enzyme,none,none,parkinson's disease,none|entacapone,parkinson's disease|none,entacapone,,,none,none,l-dopa|entacapone,none,parkinson's disease,l-dopa|catechol-o-methyltransferase|entacapone,parkinson's disease,entacapone
121,NCT04921592,,,chronic cervical spinal cord injury,,,activity-based recovery training,,,,neuromodulation training|spinal cord transcutaneous stimulation|targeted spinal cord transcutaneous stimulation,chronic cervical spinal cord injury,,,activity-based recovery training|neuromod|training,,,,scts|targeted spinal cord transcutaneous stimulation,chronic cervical spinal cord injury,,,activity-based recovery training|neuromodulation training,,,,spinal cord transcutaneous stimulation|targeted spinal cord transcutaneous stimulation,chronic cervical spinal cord injury,,,activity-based recovery training|neuromodulation training|sc|targeted,,,,spinal cord transcutaneous stimulation,,,,upper extremity stimulation,,,,spinal cord injuries,none,none,none,activity-based recovery training|targeted spinal cord transcutaneous stimulation,targeted spinal cord transcutaneous stimulation (scts),none,chronic cervical spinal cord injury,activity-based recovery training|targeted spinal cord transcutaneous stimulation,chronic cervical spinal cord injury|none,none,activity-based recovery training|targeted spinal cord transcutaneous stimulation (scts),none,,activity-based recovery training|targeted spinal cord transcutaneous stimulation (scts),activity-based recovery training|targeted spinal cord transcutaneous stimulation (scts),none,chronic cervical spinal cord injury,none,chronic cervical spinal cord injury,none
122,NCT04934371,hyperacusis|tinnitus,,hyperacusis|tinnitus,,sham,,,,,active listening therapy|listening therapy|non-invasive transcranial direct current stimulation|noninvasive neuromodulation|transcranial direct current stimulation,hyperacusis|tinnitus,,sham,,,,,active listening therapy|listening therapy|non-invasive transcranial direct current stimulation|noninvasive neuromodulation|tdcs,hyperacusis|tinnitus,,sham,,,,,active listening therapy|listening therapy|non-invasive transcranial direct current stimulation|noninvasive neuromodulation|transcranial direct current stimulation,hyperacusis|tinnitus,,,,,,,active listening therapy|listening therapy|non-invasive|noninvasive neuromodulation and|tdcs|transcranial direct current stimulation,,sham tdcs,,transcranial direct current stimulation (tdcs),,,,"hyperacusis|tinnitus, subjective|hearing disorders",listening therapy,active listening therapy|tdcs,none,non-invasive transcranial direct current stimulation (tdcs)|active listening therapy,non-invasive transcranial direct current stimulation (tdcs),none,hyperacusis|tinnitus,none|tdcs,hyperacusis|tinnitus,none,non-invasive transcranial direct current stimulation (tdcs)|active listening therapy,,none,non-invasive transcranial direct current stimulation (tdcs)|active listening therapy,non-invasive transcranial direct current stimulation (tdcs)|active listening therapy,sham-controlled,hyperacusis|tinnitus,none,hyperacusis|tinnitus,tdcs
123,NCT05716074,,balance|aim,als|early stage als|fatigue,,,low-intensity combined exercises|low-i̇ntensity combined exercises,,,,,als|early stage als|fatigue,,,low-intensity combined exercises,,,,,als|early stage als|fatigue,,,low-intensity combined exercises|low-i̇ntensity combined exercise,,,,,als|balance|early stage als|fatigue,,,low-intensity combined exercises,,,,,,,,supervised exercise|home exercise,,,,amyotrophic lateral sclerosis,none,none,none,low-intensity combined exercises,none,none,als,none|low-intensity combined exercises,fatigue|quality of life|als|balance,'none',low-intensity combined exercises,,,low-intensity combined exercises,low-intensity combined exercises,none,early stage als,none,fatigue|quality of life|balance issues|early stage als,none
124,NCT05464563,schizophrenia,other,disorder of empathy|empathy disorder|lack of self-compassion|schizophrenia|self-awareness disorders|self-compassion deficit,,,,,,,,disorder of|disorder of empathy|empathy disorder|lack|lack of|schizophrenia|self -,,,,,,,,dipathy|empathy disorder|lac|schizophrenia|self-awareness disorders|self-compassion deficit,,,,,,,,-|- awareness|empathy|empathy disorder|of|schizophrenia|self-awareness disorders|self-compassion deficit,,,,,,,,,,,electroencephalogram,,,,schizoaffective disorder|schizophrenia,none,none,none,none,none,none,schizophrenia,none,schizophrenia|self-compassion deficit|empathy disorder,none,none,none,none,none,high-density electroencephalography (eeg),none,schizophrenia,none,disorders of self-awareness|schizophrenia|abnormalities of the self|empathy disorder|self-compassion deficit,none
125,NCT00282152,,levodopa|as,early stage parkinson's disease|levodopa-induced motor complications|pd,,,,,bilateral subthalamic nucleus deep brain stimulation|neurostimulation,,,early stage parkinson's disease|levodopa|pd,,,,,,,b-stn dbs|bilateral subthalamic nucleus deep brain stimulation|neurostimulation,early stage parkinson's disease|pd,ledopa,,,,b-stn dbs,,b-stn dbs|bilateral subthalamic nucleus deep brain stimulation|neurostimulation,early stage parkinson's disease|levodopa-induced|motor complications|pd,,,,,,,b-stn dbs|bilateral sub|ne,,,optimal drug therapy,b-stn dbs,,,,parkinson's disease,none,bilateral subthalamic nucleus deep brain stimulation (b-stn dbs),bilateral subthalamic nucleus deep brain stimulation (b-stn dbs),bilateral subthalamic nucleus deep brain stimulation,deep brain stimulation|neurostimulation|neuroprotection,levodopa-induced motor complications,parkinson's disease|none,bilateral subthalamic nucleus deep brain stimulation (b-stn dbs),levodopa-induced motor complications|parkinson's disease,bilateral subthalamic nucleus deep brain stimulation (b-stn dbs),none,bilateral subthalamic nucleus deep brain stimulation (b-stn dbs),none,bilateral subthalamic nucleus deep brain stimulation (b-stn dbs),bilateral subthalamic nucleus deep brain stimulation (b-stn dbs)|levodopa|neurostimulation,none,levodopa-induced motor complications|parkinson's disease,levodopa,levodopa-induced motor complications|parkinson's disease,b-stn dbs
126,NCT04041063,,aim,nerve transfer surgery|spinal cord injury|tetraplegic,,,"robot-assisted, intensive rehabilitation",,,,,nerve transfer surgery|spinal cord injury|surgical intervention|tetraplegic,,,"rehabilitation|robot-assisted, intensive rehabilitation",,,,,nerve transfer surgery|surgical intervention for spinal cord injury|tetraplegic,,,"re|rehabilitation|robot-assisted , intensive rehabilitation",,,,,nerve transfer surgery|spinal cord injury|tetraplegic,,,rehabilitation|robot,,,,"- assisted, intensive rehabilitation|surgical intervention",,,,upper limb robotic training|nerve transfer surgery,,,,spinal cord injuries|tetraplegia|cervical spinal cord injury,robot-assisted rehabilitation|intensive rehabilitation,nerve transfer surgery,none,robot-assisted rehabilitation,intensive rehabilitation|robot-assisted,none,none|spinal cord injury,nerve transfer surgery|none,hand movements|targeted muscles|arm function|tetraplegic|cortical representations|dexterous hand movements|spinal cord injury|cortical motor map changes,none,"robot-assisted, intensive rehabilitation",nerve transfer surgery,,"rehabilitation|nerve transfer surgery|robot-assisted, intensive rehabilitation",nerve transfer surgery|robot-assisted rehabilitation|tms mapping|cortical remodeling,none,tetraplegia|spinal cord injury,none,dexterous hand movements impairment|hand and arm function loss|tetraplegia|spinal cord injury,none
127,NCT05670158,hearing loss,other,delayed hearing loss|residual audition loss|residual hearing loss|sensorineural hearing loss,,other types of otological interventions,,,cochlear implant|cochlear implantation|cochlear implantation surgery|cohlear implantation,,,- cochlear implantation|cochlear implant|cochlear implantation|delayed hearing loss|post-cohlear implantation|post-implantation residual hearing loss|residual audition loss|residual hearing loss|sensorineural hearing loss,,,,,,,,cochlear implant|cochlear implantation|cochlear implantation surgery|cochlear implantation surgery-cochlear implantation|delayed hearing loss|imp|post-cohlear implantation|residual audition loss|residual hearing loss-implantation residual hearing loss|sensorineural hearing loss,,,,,,,,co|cochlear implant|cochlear implantation surgery|delayed hearing loss|hearing loss|loss|per|post-co|post-cochlear implantation|post-implantation residual hearing loss|residual|sensorineural hearing loss|v,,,,,,,,,,blood sampling,perilymph sampling,,,,sensorineural hearing loss,none,cochlear implantation surgery,none,blood samples collection|blood biomarkers search|perilymph sampling|cochlear implantation surgery|blood sampling,none,other types of otological interventions,none|sensorineural hearing loss,cochlear implant|none,inflammatory reaction|residual hearing loss|immune reaction|sensorineural hearing loss,none,none,other types of otological interventions|cochlear implantation surgery,none,cochlear implantation surgery|otological interventions,cochlear implantation surgery|perilymph sampling|blood sampling,other types of otological interventions,sensorineural hearing loss,none,residual hearing loss'|'sensorineural hearing loss,none
128,NCT01386827,japanese encephalitis,,,bmjev|ixiaro|ixiaro vaccine|je-mb|mouse brain derived japanese encephalitis vaccines|traditional mouse-brain derived vaccine|vero-cell-derived inactivated japanese encephalitis vaccine,,,,,,,japanese encephalitis,bmjev|ixiaro|ixiaro vaccine|je-mb|mouse-brain derived vaccine|mouse brain derived japanese encephalitis vaccines|vero-cell-derived inactivated japanese encephalitis vaccine,,,,,,,,bmjev|ixiaro|ixro|japanese encephalitis|je-mb mouse brain derived japanese encephalitis vaccine|mouse brain derived japanese encephalitis vaccines,traditional mouse-brain derived vaccine,,,vero-cell-derived inactivated japanese encephalitis vaccine,,,b|japanese|mb,ix|ixiaro|je-mb|mouse brain derived japanese encephalitis vaccines|vaccine,,,,encephalitis|mouse-brain derived vaccine|mouse brain derived japanese encephalitis vaccines|vero-cell-derived inactivated japanese encephalit,,,,,mouse brain derived japanese encephalitis vaccine (mb-jev)|primary and booster immunizations with mb-jev|c) primary immunizations with ixiaro|s) ixiaro booster to mbjev primed,,,,,japanese encephalitis,none,primary immunization with bmjev|primary immunizations with ixiaro|primary immunization with mbjev and secondary immunization with ixiaro|primary and secondary immunizations with mbjev,mbjev|bmjev|ixiaro,primary immunization with bmjev|primary immunizations with ixiaro|primary immunization with mbjev and secondary immunization with ixiaro|primary and secondary immunizations with mbjev,immunization with bmjev|immunization with ixiaro,traditional mouse-brain derived vaccine (je-mb)|ixiaro|je-mb,japanese encephalitis|none,mbjev|bmjev|ixiaro|je-mb,japanese encephalitis|adverse effects|immune responses,ixiaro|je-mb,none,none,none,primary immunization with bmjev|primary immunizations with ixiaro|primary immunization with mbjev and secondary immunization with ixiaro|primary and secondary immunizations with mbjev,ixiaro vaccine|japanese encephalitis vaccines|traditional mouse-brain derived vaccine (je-mb)|new vero-cell-derived inactivated japanese encephalitis vaccine (ixiaro),primary immunization with bmjev|primary immunizations with ixiaro|primary immunization with mbjev and secondary immunization with ixiaro|primary and secondary immunizations with mbjev,japanese encephalitis,mbjev|bmjev|ixiaro|je-mb,japanese encephalitis,mbjev|ixiaro
129,NCT01404247,,other|sucrose|as,,,,,,,,,colobomata|diabetic retinopathy|foveal hypoplasia|glaucoma|macular degeneration|melanoma|optic nerve hypoplasia|retinal detachment,cyclo|sugar,,,,,,,ditic retinopathy|gcoma hy|rel detachment,cyclomydril|sugar (sucrose,,,,,,,colob|cy|degeneration|dia|f|g|h|mac|melano|optic nerve hypoplasia|re,,,,,,,,,,,oct imaging.|observational: to better characterize the retina and optic nerve in newborns using spectral domain optical coherence tomography (s-oct).,,,,optic nerve diseases|retinal diseases,none,none,none,administering a few drops of a sugar (sucrose) solution on a pacifier for calming if the baby is fussy|swaddling the baby in one or more blankets|administering sugar solution|placing eye drops for dilation|holding the infant in front of the instrument by a nurse|placing two drops of cyclomydril on the eye for dilation if the pupil is found to be too small|moving the lens of the instrument to about 2 to 4 inches from the baby's eye|holding by nurse|moving lens|swaddling,none,none,melanoma|diabetic retinopathy|neonates|optic nerve hypoplasia|retinal detachments|foveal hypoplasia|glaucoma|macular degeneration|colobomata,melanoma|cyclomydril|diabetic retinopathy|optic nerve hypoplasia|none|s-oct|retinal detachments|foveal hypoplasia|glaucoma|macular degeneration|colobomata,glaucoma|colobomata|foveal hypoplasia|optic nerve hypoplasia,none,none,none,none,swaddling the baby in blankets|placing two drops of cyclomydril on the eye for dilation if the pupil is found to be too small|moving the lens of the instrument to about 2 to 4 inches from the baby's eye|using a mild light from the instrument to enter the eye for a few seconds to obtain the desired image|holding the baby in front of the instrument|spectral domain optical coherence tomography (s-oct) imaging|giving a few drops of a sugar (sucrose) solution on a pacifier for calming if the baby is fussy,spectral domain optical coherence tomography imaging|cyclomydril eye drops|sugar (sucrose) solution,none,melanoma|diabetic retinopathy|optic nerve hypoplasia|retinal detachments|foveal hypoplasia|glaucoma|macular degeneration|colobomata,cyclomydril,melanoma|diabetic retinopathy|optic nerve hypoplasia|retinal detachments|foveal hypoplasia|glaucoma|macular degeneration|colobomata,cyclomydril
130,NCT00675155,stroke,,hemorrhagic stroke|ischemic stroke|stroke,,,,,,far infrared radiation,,hemorrhagic stroke|ischemic stroke|stroke,,,,,,,far infrared radiation,hemorrhagic stroke|ischemic stroke|stroke,,,,,,,far infrared radiation,hem|is|loss|stroke,,,,,,,far infrared radiation,,,,,,far infrared radiation,,stroke,none,none,none,far infrared radiation,far infrared radiation,none,stroke,far infrared radiation|none,rupture of blood vessels in the brain|interruption of blood flow to the brain|stroke|sudden loss of brain function,none,none,,none,far infrared radiation for stroke rehabilitation,far infrared radiation,,stroke|hemorrhagic stroke|ischemic stroke,none,stroke,far infrared radiation
131,NCT00665223,,,huntington's disease,acr16,placebo,,,,,,huntington's disease,acr16,placebo,,,,,,huntington's disease,acr16,placebo,,,,,,huntington's disease,acr16,place,,,,,,,placebo,acr16,,,,,huntington's disease,none,none,none,none,none,placebo placebo,huntington's disease,none|acr16,huntington's disease,acr16,,,,acr16 treatment,placebo|acr16,placebo,huntington's disease,acr16,huntington's disease,acr16
132,NCT02800460,,,parkinson's disease|parkinsonian,,,,,,,,parkinson's disease|parkinson's disease|parkinsonian,,,,,,,deep brain stimulation,parkinson's disease|parkinson's disease|parkinsonia|parkinsonian,,,,,,,deep brain stimulation|stereo,parkinson's disease|parkinson's disease|parkinsonian|severe forms,,,,,,,deep brain stimulation|multi-contrasts|nucleus|of the stn|of the subthalamic nucleus,,,,fmri-3t,,,,parkinson disease,none,deep brain stimulation (dbs) of the subthalamic nucleus (stn),none,deep brain stimulation (dbs) of the subthalamic nucleus (stn),three-dimensional information display|sequences for mri|high-field mri|magnetic resonance imaging (mri) at 3 tesla|anatomic targeting in stereotactic neurosurgery|targeting quality and improvement,deep brain stimulation (dbs) of the subthalamic nucleus (stn),parkinson's disease|none,ghps|mri|pd|dbs|stn,parkinsonian motor symptoms|parkinson's disease|pd,none,,preoperative anatomic targeting in stereotactic neurosurgery|deep brain stimulation (dbs) of the subthalamic nucleus (stn),none,high-field mri for preoperative anatomic targeting in stereotactic neurosurgery|deep brain stimulation (dbs) of the subthalamic nucleus (stn),deep brain stimulation (dbs)|high-field mri,none,parkinson's disease,none,parkinsonian motor symptoms|parkinson's disease,none
133,NCT04117269,,,active diabetic foot ulcer|diabetic foot ulcers,,,,,,,external shoe lift,active|diabetic foot ulcer|diabetic foot ulcers,,,,,,,external shoe lift,active diabetic foot ulcer|diabetic foot ulcers disc,,,,,,,external shoe lift,active diabetic foot ulcer|diabetic foot ulcers,,,,,,,devices|external shoe lift contralaterally to|external shoe lift in the,,,,external shoe lift,,,,peripheral neuropathy|diabetic foot ulcer|treatment adherence and compliance,use of an external shoe lift contralaterally to the affected foot,none,none,external shoe lift,external shoe lift,none,diabetic foot ulcers,none|shoe lift,limb-length discrepancies|diabetic foot ulcers|adherence|offloading devices,none,none,,,external shoe lift in the contralateral limb|use of offloading devices,external shoe lift,none,diabetic foot ulcers,none,diabetic foot ulcers,none
134,NCT01362959,,nicotine,critically ill|withdrawal,nicotine,,,,,,,critically ill|intensive care unit|nicotine withdrawal symptoms|smoking,,,,,,,nicotine replacement therapy|transdermal nicotine replacement therapy,critically ill|intensive care unit|nicotine withdrawal symptoms|smoking,nicotine replacement therapy,,,,,,,critically ill|intensive|nicotine withdrawal symptoms|smoking,nicotine replacement|transder,,,,,,therapy,,,transdermal nicotine patch,"cutaneous patch, containing no active substances",,,,substance withdrawal syndrome|nicotine replacement therapy|psychomotor agitation|delirium,none,none,none,none,none,none,none|nicotine withdrawal symptoms,nicotine|none,nicotine withdrawal symptoms,none,none,,,transdermal nicotine replacement therapy,transdermal nicotine replacement therapy|nicotine replacement therapy,none,nicotine withdrawal symptoms,transdermal nicotine replacement therapy|nicotine replacement therapy,nicotine withdrawal symptoms,transdermal nicotine replacement therapy
135,NCT05462678,multiple sclerosis,other|monitor,cognitive deficits|motor disabilities|ms|multiple sclerosis,,only motor rehabilitation course|rehabilitation alone,motor rehabilitation path with the rehacom program,,,,combined cognitive/motor rehabilitation|combined rehabilitation|rehabilitation of memory deficits|rehabilitation of verbal memory with the rehacom program,cognitive deficits|memory deficits|motor disabilities|ms|multiple sclerosis,,course|only|rehabilitation alone,cognitive|combined|combined rehabilitation|motor|motor rehabilitation|program|rehabilitation|rehaco|rehacom program,/ motor rehabilitation|cognitive/motor rehabilitation|of verbal memory|rehabilitation,,,path,cognitive deficit|memory deficits|motor disabilities|ms|multiple sclerosis,,motor rehabilitation|rehabilitation alone,cognitive/motor rehabilitation|motor rehabilitation path|rehabilitation of verbal memory|rehacom|rehacom program,,,,combined cognitive/motor rehabilitation|combined rehabilitation|re,cognitive deficits|memory deficit|motor disabilities|ms|multiple sclerosis,,,rehabilitation|t,,,,cognitive/motor rehabilitation|memory|motor rehabilitation|motor rehabilitation path|of|rehabilitation|rehacom program,cognitive rehabilitation|combined rehabilitation|motor rehabilitation,,,,,,,multiple sclerosis,"combined rehabilitation, associating a motor rehabilitation path with the rehacom program|only motor rehabilitation course|rehabilitation of verbal memory with the rehacom program","combined rehabilitation, associating a motor rehabilitation path with the rehacom program|only motor rehabilitation course|rehabilitation of verbal memory with the rehacom program",none,only motor rehabilitation course|motor rehabilitation path,"combined rehabilitation, associating a motor rehabilitation path with the rehacom program|only motor rehabilitation course|rehabilitation of verbal memory with the rehacom program|not behavioural, surgical, radiotherapy, or physical are:","combined rehabilitation, associating a motor rehabilitation path with the rehacom program|only motor rehabilitation course|rehabilitation of verbal memory with the rehacom program",multiple sclerosis,rehacom,memory performance|multiple sclerosis|motor disabilities|quality of life|verbal memory|cognitive deficits,none,"combined rehabilitation, associating a motor rehabilitation path with the rehacom program|only motor rehabilitation course|rehabilitation of verbal memory with the rehacom program",none,none,combined cognitive / motor rehabilitation|rehabilitation of verbal memory with the rehacom program|motor rehabilitation path,rehacom program|cognitive / motor rehabilitation|motor rehabilitation course,only motor rehabilitation course|rehabilitation of verbal memory with the rehacom program,multiple sclerosis,none,multiple sclerosis|motor disabilities|memory performance|cognitive deficits,none
136,NCT03578354,vestibular migraine,atenolol,vestibular migraine|vestibular migriane,4-aminopyridine|atenolol,placebo,,,,,,headache|vestibular|vestibular migraine|vestibular migriane,4-aminopyridine|4-aminopyridine|atenolol,placebo,,,,,,vestibular and headache|vestibular migraine|vestibular migriane,4-aminopyridine|4-aminopyridine|atenolol,placebo,,,,,,headache|vestib|vestibular migraine|vestibular migriane,4-aminopyridine|4-aminopyridine|atenolol,place,,,,,,,placebo,4-aminopyridine|atenolol,,,,,vestibular diseases|vestibular migraine|migraine disorders,none,4-aminopyridine|atenolol,4-aminopyridine|atenolol,4-aminopyridine|atenolol,4-aminopyridine|atenolol,4-aminopyridine|atenolol|4-aminopyridine and atenolol,vestibular migraine,4-aminopyridine|atenolol,headache symptoms|vestibular symptoms|vestibular migraine,4-aminopyridine|atenolol,none,,,4-aminopyridine taken by mouth twice a day for 14 weeks|atenolol taken by mouth twice a day for 14 weeks,4-aminopyridine|atenolol|placebo,placebo,vestibular migraine,4-aminopyridine|atenolol,frequency of vestibular symptoms|headache symptoms|severity of vestibular symptoms|vestibular migraine,4-aminopyridine|atenolol
137,NCT05240976,schizophrenia,enhancer|nmda|clozapine,schizophrenia|ultra-resistant schizophrenia,clozapine,,,,,,drug with anti-inflammatory property|drugs with anti-inflammatory properties|nmda-enhancer|nmda-enhancing agent|nmda-enhancing and anti-inflammatory treatments,schizophrenia|ultra-resistant schizophrenia,anti|clozapine|nmda,,,,,,-|- enhancer|- enhancing agent|anti-inflammatory treatments|nmda-enhancing,schizophrenia|ultra-resistant schizophrenia,clozapine|nmda-enhancer|nmda-enhancing agent|nmda-enhancing anti-inflammatory|nmda-enhancer,,,,,,,schizophrenia|ultra-resistant schizophrenia,cloza|nm,,,,,,anti -|nmda-enhancer|nmda-enhancer,,nmdae plus placebo cap,nmdae plus aifa,,,,,schizophrenia,none|nmda-enhancing agent|anti-inflammatory properties,none,none,nmda-enhancing agent|anti-inflammatory properties,anti-inflammatory drugs|nmda-enhancing agent,clozapine|drugs with anti-inflammatory properties,schizophrenia|none,clozapine|none,cognitive function|anti-inflammatory properties|ultra-resistant schizophrenia|clinical symptoms,clozapine|nmdae,none,none,,clozapine|nmda-enhancer (nmdae)|nmda-enhancing agent|drugs with anti-inflammatory properties,clozapine|nmda-enhancer (nmdae)|nmda-enhancing agent|drugs with anti-inflammatory properties,none,schizophrenia,clozapine|nmda-enhancing agent,cognitive function|ultra-resistant schizophrenia|clinical symptoms,clozapine|nmda-enhancing agent|nmdae
138,NCT03799887,,balance|aim|as,fatigue|moderate to advanced pd|parkinson's disease,,,body weight supported treadmill training,,,,,fatigue|moderate to advanced pd|parkinson's disease|parkinson's disease,,,body weight supported treadmill training,,,,,fatigue|moderate to advanced pd|parkinson's disease|parkinson's disease,,,body weight supported treadmill training,,,,,fatigue|impaired|moderate to advanced pd|neurological|parkinson's disease|parkinson's disease,,,body weight supported treadmill training,,,,,0% unweighed bwstt|10% unweighed bwstt|20% unweighed bwstt|0% unweighed bwstt|10% unweighed bwstt|20% unweighed bwstt,,,,,,,parkinson disease,body weight supported treadmill training (bwstt),body weight supported treadmill training (bwstt),none,body weight supported treadmill training (bwstt),none,none,parkinson's disease,bwstt|pd,parkinson's disease|balance|gait|fatigue|quality of life,none,body weight supported treadmill training (bwstt),,,body weight supported treadmill training (bwstt),body weight supported treadmill training (bwstt),none,parkinson's disease,none,parkinson's disease|balance|gait|fatigue|quality of life,none
139,NCT01405833,sciatica,neublastin|no|as,pain|sciatica,bg00010|neublastin,placebo,,,,,,pain|sciatica,bg00010|neublastin,placebo,,,,,,pain|sciatica,bg00010|neublastin,placebo,,,,,,pain|sci,bg00010|ne,place,,,,,,,placebo,bg00010 (neublastin),,,,,sciatica,none,none,none,none,pain reduction potential of bg00010|immunogenicity of bg00010|intravenous injections of bg00010,a placebo|placebo,sciatica,bg00010|none,sciatica,bg00010,none,none,none,3 intravenous (iv) injections of bg00010,intravenous (iv) injections of bg00010|multiple-dose administration of bg00010,placebo,sciatica,bg00010|neublastin,pain|sciatica,bg00010|neublastin
140,NCT03130608,,,chronic liver disease|post liver transplant|post-liver transplant,,the usual post-transplant care|usual care,inspiratory muscle strengthening exercise|inspiratory muscle training,,,,usual post-liver transplant care,-|chronic liver disease|liver transplant|muscle wasting|post -|post-liver transplant|transplant surgery,,usual care|usual post-transplant care,inspiratory muscle strengthening exercise|inspiratory muscle training|usual,-,,,care|post,chronic liver disease|muscle wasting|post-liver transplant|transplant surgery liver transplant liver transplant,,usual post-liver transplant care|usual post-transplant care,inspiratory muscle strengthening exercise|inspiratory muscle training care,,,,,-|chronic liver disease|liver transplant|muscle wasting|post|post-liver|post-liver transplant,,post,-|inspiratory muscle strengthening exercise|inspiratory muscle training|post|usual care,,,,- liver transplant|liver|transplant,,,,inspiratory muscle training,,,,muscle weakness|respiratory insufficiency|liver disease chronic,inspiratory muscle training|usual care,liver transplant surgery,inspiratory muscle strengthening exercise|usual post-liver transplant care,inspiratory muscle training|usual care,none,usual post-liver transplant care,respiratory mechanics|none|chronic liver disease|liver transplant,inspiratory muscle training|none,chronic liver disease|pulmonary function|respiratory muscle strength|respiratory mechanics|quality of life|functional performance|muscle wasting,none,inspiratory muscle training|usual post-liver transplant care,none,none,inspiratory muscle training|usual post-liver transplant care,inspiratory muscle training|usual post-liver transplant care,usual post-transplant care,chronic liver disease,none,muscle wasting post-liver transplant|chronic liver disease|impaired respiratory muscle strength post-liver transplant,none
141,NCT05101837,migraine|neuropathic pain,aim|as,chronic pain|migraine|neuropathic pain|pain,,,,home-program|mindfulness|mindfulness guided face-to-face program,,,mindfulness delivered mainly by a specific app|specific app to delivery mindfulness sessions,chronic pain|migraine|neuropathic pain|pain,,,mindfulness,- program|approach base on mindfulness|behavioural approach based on mindfulness|guided face-to-face program|practice|sessions,,,behavioural|home|specific app|specific app on android|standardized|technology with android,chronic pain|migraine|neuropathic pain|pain,,mindfulness guided face-to-face program,,behavioural approach based on mindfulnessp,,,behavioural approach base on|mindfulness|mindfulness practice|mindfulness sessions|s app to del|technology with,chronic pain|mig|ne|pain,,,,,,,android|approach|behavioural approach|home-program|mindfulness|mindfulness guided face-to-face program|mindfulness practice|mindfulness sessions|on|specific app|specific app on android,,,,home program,,,,migraine|neuropathic pain,mindfulness guided face-to-face program|behavioural approach based on mindfulness|mindfulness practice|home-program for patients with pain conditions|technology with android for mindfulness sessions,none,none,mindfulness practice|mindfulness guided face-to-face program,none,a standardized behavioural approach based on mindfulness delivered mainly by a specific app on android,neuropathic pain|migraine,none,neuropathic pain|migraine,none,home-program for patients with different pain conditions to learn mindfulness practice|mindfulness practice delivered by a specific app on android|daily practice of mindfulness sessions delivered with android technology|regular mindfulness guided face-to-face program,,,home-program for patients with different pain conditions to learn mindfulness practice|use of a specific app on android to receive mindfulness sessions for daily practice|regular mindfulness guided face-to-face program,regular mindfulness guided face-to-face program|mindfulness practice|android technology to receive mindfulness sessions for daily practice|home-program for patients with different pain conditions,none,neuropathic pain|chronic pain conditions|migraine,none,neuropathic pain|migraine|chronic pain,none
142,NCT03012971,delirium|analgesia,dexmedetomidine,cancer surgery|delirium|inflammatory response|metastasis|stress|surgery for malignant tumors|tumor recurrence,dexmedetomidine,,,,,,,cancer surgery|delirium|malignant tumors|postoperative tumor recurrence|surgery,dexmedetomidine,,,,,,,cancer surgery|delirium|malignant tumors|metastasis|postoperative tumor recurrence|surgery,dexmedetomidine,,,,,,,cancer surgery|del|malignant tumors|meta|postoperative tumor,dexmedetomi,,,,,,,,,dexmedetomidine supplemented morphine analgesia|morphine analgesia,,,,,analgesia|surgery|long-term outcome|elderly|dexmedetomidine,none,surgery for malignant tumors,none,none,dexmedetomidine supplemented analgesia,none,cancer|none|tumors,dexmedetomidine,delirium incidence|cancer|metastasis|immune function|inflammatory response|analgesic efficacy|postoperative tumor recurrence|sleep quality|stress,dexmedetomidine,none,none,none,dexmedetomidine supplemented analgesia|cancer surgery,dexmedetomidine supplemented analgesia,none,cancer,dexmedetomidine,delirium|inflammatory response|tumor recurrence|cancer|metastasis|stress,dexmedetomidine
143,NCT01875445,trichotillomania|schizophrenia|panic disorder,inositol|lithium|cholesterol|as,compulsive hair pulling|trichotillomania,inositol,placebo,,,,,,attention deficit-hyperactivity disorder|attention deficit-hyperactivity disorder|compulsive hair pulling|trichotillomania,inositol,placebo,,,,,,alzheimer's disease|attention deficit-hyperactivity disorder|attention deficit-hyperactivity disorder|cancer|compulsive hair pulling|depression|diabetic nerve pain|ins|panic disorder|szophrenia|trichotillomania,inositol,lit|placebo,,,,,,ad|alzheimer's disease|attention deficit -|autism|cancer|compulsive hair pulling|depression|di|dia|disorder|hair growth|high cholesterol|hyperactivity disorder|ins|nerve pain|panic disorder|ps|schizophrenia|skin disorder|tri|trichotillomania,in,place,,,,,,,placebo,inositol,,,,,hair pulling|trichotillomania,none,none,none,inositol,"in the clinical trial mentioned, the therapeutic intervention other than behavioural, surgical, radiotherapy, or physical interventions is inositol|inositol",placebo,trichotillomania,inositol,trichotillomania|compulsive hair pulling,inositol,none,none,none,none,placebo|inositol,placebo,schizophrenia|trichotillomania|diabetic nerve pain|high cholesterol|cancer|autism|depression|alzheimer's disease|attention deficit-hyperactivity disorder|insomnia|panic disorder|psoriasis,inositol|lithium,trichotillomania,inositol
144,NCT04847089,stroke,,stroke,,,,,,,feedback in real time|feedback training|motor imagery|motor imagery training|real-time feedback,stroke,,,feedback training|motor imagery|motor imagery training,,,,feedback in real time|real-time feedback,stroke,,,motor imagery training,,,,feedback training|motor imagery|real-time feedback,stroke|stroke rehabilitation,,,,,,,feedback training|motor imagery|motor imagery training|real-time feedback,,,,motor imagery bci training,,,,stroke|hemiparesis,none,none,none,motor imagery training|real-time feedback,electroencephalography (eeg),none,stroke,motor imagery|none,functional recovery|feedback|electroencephalography|stroke|motor imagery training|hand|brain activity|stroke rehabilitation,none,motor imagery training with real-time feedback from electroencephalography (eeg),,,motor imagery training with real-time feedback from electroencephalography (eeg),electroencephalography (eeg) feedback training|motor imagery training,none,stroke,none,stroke|functional recovery of the hand,none
145,NCT01997255,weber syndrome|seizures|epilepsy,everolimus|afinitor,epilepsy|seizures|sturge weber syndrome|sturge-weber syndrome,afinitor|everolimus|rad 001,,,,,,,epilepsy|seizures|sturge-weber syndrome|sturge weber syndrome,afinitor|everolimus|rad 001,,,,,,,epilepsy|seizures|sturge-weber syndrome|sturge weber syndrome,afin|everolimus|rad 001,,,,,,,epilepsy|seizures|sturge-weber syndrome|sturge weber syndrome,,,,,,,afinitor|everolimus|rad 001,,,everolimus,,,,,sturge weber syndrome,none,none,none,none,none,none,none|epilepsy|sturge-weber syndrome,none|everolimus,seizures|sturge weber syndrome|eye problems|epilepsy|red mark on facial skin,afinitor|everolimus,none,none,none,everolimus (rad 001) therapy,everolimus (rad 001)|anti-epileptic medication|everolimus (afinitor®),none,epilepsy|sturge-weber syndrome,afinitor|everolimus,seizures|red mark on facial skin|eye problems|epilepsy|sturge-weber syndrome,everolimus
146,NCT02846415,dementia,pid|same,early to moderate dementia,,wait-list,,,,,pid programme|play intervention for dementia,early to moderate dementia,,wait-list,,dementia|intervention|programme,,,for|for dementia|pid programme|play|play intervention for dementia,dementia|early to moderate dementia,,wait-list,,play intervention for|play intervention for dementia,,,,dementia|early to moderate dementia|function|pi|play intervention for dementia,,,,pi|play,,,-|intervention|pi,play intervention for dementia,,,,,,,dementia|alzheimer disease,play intervention for dementia for promoting cognitive function,play intervention for dementia for promoting cognitive function,none,play intervention for dementia,montreal cognitive assessment|modified verbal fluency test|play intervention for dementia (pid)|fuld object memory evaluation,wait-list controlled groups,dementia,play intervention for dementia|pid,cognitive function|dementia|montreal cognitive assessment|modified verbal fluency test|fuld object memory evaluation,none,play intervention for dementia (pid),none,none,"facilitation by a play specialist, trained elderly volunteers, and centre staffs|play intervention for dementia (pid) programme consisting of 12 weekly sessions, each lasting for 45-75 minutes",play intervention for dementia (pid) programme,wait-list controlled groups,dementia,none,dementia|cognitive functions,none
147,NCT02892097,stroke,,stroke|unilateral spatial neglect,,,arm rehabilitation training|repetitive task-specific practice|rtp|task-specific practice,,,,non-invasive brain stimulation|tdcs|transcranial direct current stimulation,stroke|unilateral spatial neglect|unilateral spatial neglect post stroke,,,arm rehabilitation training|rehabilitation training|repetitive task-specific practice|rtp|task-specific practice,,,,non-invasive brain stimulation|tdcs|transcranial direct current stimulation,stroke|unilateral spatial neglect|unilateral spatial neglect post stroke,,,arm rehabilitation training|rehabilitation|repetitive task-specific practice|rtp|task-specific practice,,,,non-invasive brain stimulation|tdcs|transcranial direct current stimulation,stroke|unila|unilateral spatial neglect,,,arm rehabilitation training|rehabilitation training sessions|repetitive task-specific practice|rtp|task-specific practice,,,,non-invasive brain stimulation|rt|td|transcranial direct current stimulation,repetitive task-specific practice (rtp),sham tdcs,,tdcs,,,,stroke|hemispatial neglect,repetitive task-specific practice (rtp)|arm rehabilitation training,none,none,repetitive task-specific practice (rtp)|arm rehabilitation training,none,"non-invasive brain stimulation (transcranial direct current stimulation, tdcs) with arm rehabilitation training (repetitive task-specific practice, rtp)",excitability|attention|unilateral spatial neglect|stroke|arm movement ability,rtp|tdcs,excitability in the brain|unilateral spatial neglect|attention to the affected side|stroke|arm movement ability,'rtp'|'tdcs',task-specific practice|arm rehabilitation training|transcranial direct current stimulation,none,none,task-specific practice|arm rehabilitation training|transcranial direct current stimulation,repetitive task-specific practice|transcranial direct current stimulation,none,stroke|unilateral spatial neglect post stroke,none,attention to the affected side|unilateral spatial neglect post stroke|arm movement ability,repetitive task-specific practice|transcranial direct current stimulation
148,NCT00433667,seizures|epilepsy,as,epilepsy|partial onset seizures,rwj-333369,,,,,,,epilepsy|partial onset seizures,rwj-333369,,,,,,,epilepsy|partial onset seizures,rwj-333369,,,,,,,epilepsy|partial onset seizures,rwj-33336,,,,,,,,,rwj-333369,,,,,"complex partial seizures|epilepsy, focal|epilepsy, complex partial|seizure disorder|epilepsy",none,none,none,none,none,none,none|epilepsy,rwj-333369,epilepsy|partial onset seizures,rwj-333369,,,,none,rwj-333369,,epilepsy|partial onset seizures,rwj-333369,epilepsy|partial onset seizures,rwj-333369
149,NCT02139436,immobility,as,acute sci|cardiovascular declines|cardiovascular disease|declines in physiologic function|sci|spinal cord injury,,arms-only exercise|arms-only-rt|time (wait-list) control|time control,fes-rt|functional electrical stimulation (fes) row training (rt)|hybrid-fes exercise,,,,,acquired cardiovascular disease|acute sci|cardiovascular compromise|cardiovascular declines|cardiovascular disease|sci|spinal cord injury,,arms-only-rt|arms-only exercise|time|wait-list,exercise|fes-rt|functional electrical stimulation (fes) row training|hybrid-fes exercise|rt,,,,,acute sci|cardiovascular compromise|cardiovascular declines|cardiovascular disease|cardiovascular disease decline|sci|spinal cord injury,,arms-only-rt|arms-only exercise|exercise|time|time control|wait-list,exercise|fes) row training rt|fes-rt|functional electrical stimulation (|hybrid-fes exercise|volitional arm and electrically controlled leg exercise,,,,,acquired cardiovascular disease|acute declines|acute sci|cardiovascular|cardiovascular declines|cardiovascular disease|profound|sci|spinal cord injury,,,- only-rt|arms-only-rt|arms-only exercise|electrically controlled leg exercise|exercise|fes|fes-rt|functional electrical stimulation|hybrid-fes exercise|row training|rt,,,,fe,,time control,,fes-row-training|arms-only-row training,,,,spinal cord injury,functional electrical stimulation (fes) row training (rt)|therapeutic behavioural interventions extracted from the clinical trial:|exercise therapy,none,functional electrical stimulation (fes) row training (rt),arms-only-rt|functional electrical stimulation (fes) row training (rt),functional electrical stimulation (fes) row training (rt),time (wait-list) control|arms-only-rt|arms-only-rt and a time (wait-list) control,cardiovascular disease|none|spinal cord injury,none|fes-rt,lipid profile|cardiovascular disease|visceral adiposity|baroreflex function|ventricular wall thickening|insulin sensitivity|ventricular function,functional electrical stimulation (fes) row training (fes-rt),functional electrical stimulation (fes) row training (rt)|volitional arm and electrically controlled leg exercise|arms-only exercise group,none,none,arms-only-rt|functional electrical stimulation (fes) row training (rt)|volitional arm and electrically controlled leg exercise,functional electrical stimulation (fes) row training (rt)|arms-only exercise|large muscle mass exercise|exercise therapy,arms-only-rt|time control,cardiovascular disease|spinal cord injury,none,reduced insulin sensitivity|cardiovascular disease|ventricular wall thickening|worsening lipid profile|spinal cord injury|increased visceral adiposity|compromised baroreflex function|declining ventricular function,none
150,NCT02751905,,balance|whole blood,,[14c]-biib074|biib074,,,,,,,,biib074,,,,,,,,biib074,,,,,,,,[ 14c ] -|biib07|biib074,,,,,,,,,biib074,,,,,neuropathic pain,none,none,none,none,"additional metabolites of biib074 in plasma, urine, and feces|pharmacokinetics (pk) of biib074 and its known metabolites|safety and tolerability of biib074 in healthy participants|disposition profiles of total radioactivity in whole blood and plasma",none,none|biib074,biib074,none,biib074,none,none,none,none,single oral dose of biib074,none,none,biib074,none,biib074
151,NCT03170856,concussion,,concussion,,,sub-maximal exercise program|sub-maximal exercise protocol,,,,,concussion,,,exercise|sub-maximal exercise program|sub-maximal exercise protocol,,,,,concussion|su a,,,sub-maximal exercise program|sub-maximal exercise protocol,,,,,concussion,,,sub-maximal exercise program|sub-maximal exercise protocol,,,,,,,,sub-maximal exercise,,,,"concussion, brain|exertion; excess|concussion, severe|concussion, mild",sub-maximal exercise program,none,none,sub-maximal exercise protocol,none,none,none|concussion,sub-maximal exercise program|none,symptom severity|cerebrovascular function|concussion|heart rate|exercise volume,none,sub-maximal exercise protocol,,,sub-maximal exercise protocol,sub-maximal exercise protocol,,concussion,none,symptom severity|cerebrovascular function|concussion|heart rate|exercise volume,
152,NCT03661411,stroke|intracranial hemorrhage,tpa|aspirin|clopidogrel|as|alteplase|no,acute ischemic stroke|acute mild ischemic stroke|acute minor stroke|minor stroke|stroke,alteplase|antiplatelet|aspirin|clopidogrel|r-tpa|rt-pa,,,,,,,acute ischemic stroke|acute mild ischemic stroke|acute minor stroke|minor stroke|stroke|tia,alteplase|antiplatelet|aspirin|clopidogrel|r-tpa|rt-pa thrombolytic,,,,,,antithrombolytic therapy|antithrombotic therapy|therapy|thrombolysis|thrombolytic,acute ischemic stroke|acute ischemic strokebolytic|acute mild ischemic stroke|acute minor stroke|minor stroke|stroke|tia,alteplase|alteplasecal hemhage|antiplatelet|antithrombolytic therapy|antithrombotic therapy|aspirin|clopidogrel|r-tpa|rt-pa thrombolytic therapy,,,,,,thrombolys|thrombolytic,acute ischemic stroke|acute mild ischemic stroke|acute minor stroke|ai|minor stroke|stroke|thrombolysis|tia,alteplase|anti|antith|antithrombotic|as|clopidogrel|r -|rt-pa th|th,,,,,,antith|therapy,,,aspirin|clopidogrel 75mg|alteplase,,,,,stroke,none,intravenous thrombolytic therapy with alteplase,none,intravenous thrombolytic therapy with alteplase|antithrombotic therapy|aspirin with clopidogrel,aspirin|clopidogrel,aspirin with clopidogrel|alteplase,ais|tia|minor stroke,none|alteplase,nihss score ≤ 3 or 5|symptomatic intracranial hemorrhage|acute ischemic stroke|ais|abcd2 < 4|tia|minor stroke,aspirin|clopidogrel|alteplase,none,none,none,intravenous thrombolytic therapy with alteplase|aspirin with clopidogrel therapy,antithrombotic therapy|aspirin with clopidogrel|intensive antithrombotic therapy|intravenous thrombolytic therapy with alteplase|antiplatelet therapy,aspirin with clopidogrel,acute mild ischemic stroke|acute ischemic stroke,aspirin|rt-pa|clopidogrel|alteplase,symptomatic intracranial hemorrhage|minor stroke|acute ischemic stroke,aspirin|clopidogrel|alteplase
